The health of nations: the value of a statistical life by unknown
THE HEALTH OF NATIONS:
THE VALUE OF A 
STATISTICAL LIFE
JULY 2008
The Health of Nations:  The Value of a Statistical Life 
Australian Safety and Compensation Council, [March 2008] i 
The Health of Nations: The Value of a Statistical Life 
Acknowledgement 
This research was commissioned by the Office of the Australian Safety 
and Compensation Council (the Office of the ASCC), in the Department of 
Education, Employment and Workplace Relations (DEEWR). The review 
was undertaken by Access Economics, which provided this research 
report. 
Access Economics acknowledges with gratitude the inputs and comments 
from the many stakeholders consulted in the preparation of this report. 
Particular thanks are extended to: 
Mark Harvey and Tim Risbey, Bureau of Transport and Regional 
Economics; 
David Pattie and Fred Fernandes, Civil Aviation Safety Authority of 
Australia; 
David Hensher, Institute of Transport and Logistics Studies. 
Disclaimer 
The information provided in this document can only assist you in the 
most general way. This document does not replace any statutory 
requirements under any relevant State and Territory legislation. The 
Office of the ASCC accepts no liability arising from the use of or reliance 
on the material contained on this document, which is provided on the 
basis that Office of the ASCC is not thereby engaged in rendering 
professional advice. Before relying on the material, users should carefully 
make their own assessment as to its accuracy, currency, completeness 
and relevance for their purposes, and should obtain any appropriate 
professional advice relevant to their particular circumstances. 
To the extent that the material on this document includes views or 
recommendations of third parties, such views or recommendations do not 
necessarily reflect the views of Office of the ASCC or indicate its 
commitment to a particular course of action. 
The Health of Nations:  The Value of a Statistical Life 
Australian Safety and Compensation Council, [March 2008] ii 
Copyright Notice 
© Commonwealth of Australia 2007 
ISBN 978 0 642 32816 8 
This work is copyright. You may download, display, print and reproduce 
this material in unaltered form only (retaining this notice) for your 
personal, non-commercial use or use within your organisation. Apart 
from any use as permitted under the Copyright Act 1968, all other rights 
are reserved. Requests and inquiries concerning reproduction and rights 
should be addressed to Commonwealth Copyright Administration, 
Attorney-General’s Department, Robert Garran Offices, National Circuit, 
Barton ACT 2600 or posted at http://www.ag.gov.au/cca  
  
The Health of Nations:  The Value of a Statistical Life 
Australian Safety and Compensation Council, [March 2008] iii 
Table of Contents 
The Health of Nations: The Value of a Statistical Life .......................... i 
Acknowledgement ......................................................................... i 
Disclaimer .................................................................................... i 
Copyright Notice............................................................................ii 
Table of Contents ......................................................................... iii 
List of Tables .............................................................................. viii 
List of Figures............................................................................... ix 
Glossary ....................................................................................... xi 
Executive Summary.................................................................... xiii 
Scope ....................................................................................... xiii 
Findings .................................................................................... xiii 
Measurement approaches .............................................................xv 
There are two empirical methods of determining VSL using WTP.. xvi 
VSL and VSLY estimates in the literature ...................................... xvii 
The role of VSLY in decision-making.............................................. xix 
Best practice principles and next steps ...........................................xx 
Chapter 1: Introduction................................................................. 1 
Methods...................................................................................... 2 
Literature Review....................................................................... 2 
Consultation Processes ............................................................... 3 
Structure of this Report ................................................................. 6 
Chapter 2: Microeconomics and Valuing Life ................................. 8 
Metrics of Wellbeing...................................................................... 8 
Dead Or Alive............................................................................ 8 
Quality Adjusted Life Years (QALYS) ............................................. 9 
Standard Gamble ...................................................................10 
Time Trade-Off ......................................................................11 
Rating Scale..........................................................................11 
The Health of Nations:  The Value of a Statistical Life 
Australian Safety and Compensation Council, [March 2008] iv 
Converting Utilities To QALYs...................................................12 
Disability Adjusted Life Years (DALYS) .........................................13 
Strengths And Criticisms Of QALY and DALY Metrics ......................16 




Market Tradeability ...................................................................24 
Other Matters: The Labour-Leisure Choice.......................................25 
Chapter 3: Measurement Approaches .......................................... 27 
The Value of A ‘Statistical’ Life.......................................................27 
Traditional Productivity Approaches................................................28 
Human Capital and Frictional Approaches .....................................28 
‘Mark-Ups’ for Leisure and Other Variations ..................................30 
Willingness to Pay Approaches.......................................................31 
Stated Preference Valuation Methods...........................................33 
Summary – advantages of stated preference approaches.............40 
Summary – issues and limitations of stated preference approaches40 
Revealed Preference Valuation Methods .......................................43 
Converting VSL to VSLY: Discount Rates.........................................45 
General Critique and Overview of WTP Methods ...............................47 
Chapter 4: VSL and VSLY Estimates from the Literature .............. 50 
Findings from the Literature..........................................................50 
Health And Safety Sectors .........................................................51 
Health ..................................................................................53 
Australian VSL estimates......................................................53 
International VSL estimates ..................................................54 
VSLY estimates ...................................................................54 
Occupational Safety ...............................................................55 
Australian VSL estimates......................................................55 
The Health of Nations:  The Value of a Statistical Life 
Australian Safety and Compensation Council, [March 2008] v 
International VSL estimates ..................................................55 
VSLY estimates ...................................................................56 
Other Sectors...........................................................................56 
Transport..............................................................................57 
Australian VSL estimates......................................................58 
International VSL estimates ..................................................58 
VSLY estimates ...................................................................59 
Environmental Protection ........................................................59 
Australian VSL estimates......................................................59 
International VSL estimates ..................................................60 
VSLY estimates ...................................................................60 
Others..................................................................................61 
Australian VSL Estimates......................................................61 
International VSL estimates ..................................................61 
VSLY estimate ....................................................................62 
Summary Of Simple Analysis......................................................62 
Meta-Analysis of Selected Studies..................................................68 
Discussion and Conclusions...........................................................74 
Different Methodological Approaches, Similar Answers?..................74 
Age-Gender Patterns.................................................................75 
Socioeconomic Status And Ethnicity ............................................79 
Health Status, Risk Preferences AND Other Stratification ................81 
‘Net’ Values and Other Adjustments ............................................83 
Chapter 5: The Role of VSLY in Decision Making.......................... 86 
Core Issues ................................................................................86 
Large Estimates and Budget Constraints ......................................86 
Whose Value? ..........................................................................88 
Stratification of the VSLY ...........................................................89 
Efficiency Evaluation in Policy Making .............................................91 
Other Public Financing Considerations ............................................93 
The Health of Nations:  The Value of a Statistical Life 
Australian Safety and Compensation Council, [March 2008] vi 
Thresholds and Benchmarks..........................................................96 
Indexation Over Time ..................................................................99 
Best Practice Principles and Next Steps.........................................100 
Appendix A – Studies In The Literature Analysis ....................... 103 
Range of Statistical Life Values by Study and Country – Health and 
Occupational Safety (2006 A$Million) ...........................................103 
Appendix B – Disability Weights ................................................ 117 
Appendix C – Example of a RIS Cost Benefit.............................. 131 
Analysis ...................................................................................131 
Step 1: Identify Options, Costs, Benefits and Timeframes ...............132 
Identify Conceptual Costs and Benefits ......................................133 
Timeframes ...........................................................................134 
Step 2: Establish a Methodology for Quantifying Costs and Benefits..134 
Consultation Processes ............................................................135 
Literature And Data Searches ...................................................135 
Falls incidents in mining, jurisdictions with and without regulation and 
Australian total, 2000-2005 (per 1,000 workers).........................137 
Falls incidents in mining, jurisdictions with and without regulation 
and Australian total, 2000-2005 (per 1,000 workers) ................138 
Falls incidents in mining, financial costs per claim, Nominal and 
real, Australia, 2000-2005.....................................................138 
The NOHSC (2004) Report .......................................................139 
Average financial cost per incident, 2000-01............................142 
Step 3: Estimate Costs and Benefits.............................................142 
Compliance Costs for Firms and Workers....................................142 
Cost of changing to the new regulation borne by firms and workers, 
jurisdictions without regulation, 2008 and future years (2008 
dollars)...............................................................................142 
Additional Costs for Governments .............................................143 
Cost of changing to the new regulation borne by state/territory 
governments, jurisdictions without regulation, 2008 and future 
years (2008 dollars) .............................................................144 
Benefits of Greater Consistency ................................................144 
The Health of Nations:  The Value of a Statistical Life 
Australian Safety and Compensation Council, [March 2008] vii 
Benefits of greater consistency from changing to the new regulation 
for firms, all jurisdictions, 2008 and future years (2008 dollars) .144 
Benefits of Reduced Incidents...................................................145 
Number of incidents .............................................................145 
Falls in mining, incidents, 2008-2017, Option 1 and Option 2 .....145 
Financial cost per incident .....................................................146 
Mean cost per fall in mining (2008 dollars) ..............................146 
Falls averted in mining, financial benefits, 2008-2017, Option 2  
(2008 dollars) .....................................................................146 
Burden of Disease...................................................................147 
Average duration of OHS incidents .........................................148 
Falls in mining, burden of disease averted and its value, 2008-
2017, Option 1 and Option 2 .................................................149 
Step 4: Report Findings and Sensitivity Analysis ............................149 
Cost Benefit and Cost Effectiveness Analysis...............................149 
Cost benefit and cost effectiveness summary, 2008-2017 ..........150 
Summary of financial benefits and net benefits by bearer, 2008-
2017 ..................................................................................150 
Sensitivity Analysis .................................................................151 
Base case, high and low scenario of VSL and VSLY....................151 
References ................................................................................ 153 
 
The Health of Nations:  The Value of a Statistical Life 
Australian Safety and Compensation Council, [March 2008] viii 
List of Tables 
Histogram of VSL Estimates (Excluding Far Right Tail) ........................ xix 
Table 4—1  VSL estimates for health, Australian studies, 2006 A$million54 
Table 4—2  VSL estimates for health, international studies, 2006 
A$million ......................................................................................54 
Table 4—3  VSLY estimates for health, 2006 A$..................................54 
Table 4—4  VSL estimates for occupational safety, Australian studies, 
2006 A$million...............................................................................55 
Table 4—5  VSL estimates for occupational safety, international studies, 
2006 A$million...............................................................................55 
Table 4—6  VSLY estimates for occupational safety, 2006 A$................56 
Table 4—7  VSL estimates for transport safety, Australian studies, 2006 
A$million ......................................................................................58 
Table 4—8: VSL estimates for transport safety, international studies, 
2006 A$million...............................................................................59 
Table 4—9  VSLY estimates for transport safety, 2006 A$ ....................59 
Table 4—10  VSL Estimates for environmental protection, Australian 
Studies, 2006 A$million ..................................................................60 
Table 4—11  VSL estimates for environmental protection, international 
studies, 2006 A$million...................................................................60 
Table 4—12  VSLY estimates for environmental protection, 2006 A$......61 
Table 4—13  VSL estimates in other sectors, Australian studies, 2006 
A$million ......................................................................................61 
Table 4—14  VSL estimates in other sectors, international studies, 2006 
A$million ......................................................................................62 
Table 4—15  VSLY estimates in other sectors, 2006 A$........................62 
Table 4—16  Summary of VSL and VSLY estimates .............................63 
Table 4—17  Ranges of VSL estimates by country, 2006 A$million.........66 
Table 4—18  Worked example of netting out costs borne by the individual85 
Table 5—1  Likelihood of PBAC acceptance for listing, econometric results95 
Table 5—2  Average VSLY under different longevity and discount rate 
assumptions (2006A$)..................................................................102 
 
The Health of Nations:  The Value of a Statistical Life 
Australian Safety and Compensation Council, [March 2008] ix 
List of Figures 
Figure 2—1 Effect of a hypothetical intervention on QALYS and DALYS: 
Example .......................................................................................16 
Figure 2—2  Positive externalities in the market for healthy life ............22 
Figure 2—3  Negative externalities (risks to healthy life) in product 
markets ........................................................................................23 
Figure 2—4  Comparing interventions using a welfare economics 
framework ....................................................................................24 
Figure 3—1  VSL estimate dependent on base level of risk (Broome 
theory) .........................................................................................32 
Figure 3—2  The identification problem in revealed preference studies ...44 
Figure 3—3  The marginal utility of income effect................................45 
Figure 4—1  Range of VSL estimates (means) by study and country – 
health and occupational safety, 2006 A$million ..................................52 
Figure 4—2  Range of VSL estimates (medians) by study and country – 
health and occupational safety, 2006 A$million ..................................52 
Figure 4—3  Range of VSL estimates (means) by study and country – 
other sectors, 2006 A$million...........................................................57 
Figure 4—4  Range of VSL estimates (medians) by study and country – 
other sectors, 2006 A$million...........................................................57 
Figure 4—5  Summary of VSL estimates (means) by sector and 
Australia/international, 2006 A$million ..............................................64 
Figure 4—6  Summary of VSL estimates (medians) by sector and 
Australia/international, 2006 A$million ..............................................64 
Figure 4—7  Histogram of all VSL estimates .......................................65 
Figure 4—8  VSL estimates by country (2006 A$million) ......................65 
Figure 4—9  VSL estimates by study type (2006 A$million) ..................67 
Figure 4—10  VSLY estimates by country (2006 A$)............................67 
Figure 4 – 11 Standard Forest Plot, Random Effects ............................71 
Figure 4—12  Funnel plot ................................................................72 
Figure 4—13 Exclusion Sensitivity Plot ..............................................73 
Figure 4—14  The N curve (inverted U curve) .....................................76 
Figure 4—15  ‘Flat’ VSLY and downward-sloping VSL ...........................76 
The Health of Nations:  The Value of a Statistical Life 
Australian Safety and Compensation Council, [March 2008] x 
Figure 4—16  Murphy and Topel relationship between VSL and age .......79 
Figure 4—17  An example of a labelled stated choice situation..............82 
Figure 4—18  Steps in designing a stated choice situation ....................83 
Figure 5—1  Increased use of CMA and CUA in PBAC submissions over 
time .............................................................................................91 
Figure 5—2  Public financing decision box ..........................................92 
Figure 5—3  Likelihood of PBAC acceptance for listing, Australia ............95 
 
The Health of Nations:  The Value of a Statistical Life 
Australian Safety and Compensation Council, [March 2008] xi 
Glossary 
AIHW  Australian Institute of Health and Welfare 
ASA   Air Services Australia 
CASA   Civil Aviation Safety Authority 
CBA   cost benefit analysis 
CEA   cost effectiveness analysis 
CMA   cost minimisation analysis 
COAG  Council of Australian Governments 
CUA   cost utility analysis 
CV   contingent valuation 
DALYs  Disability Adjusted Life Years 
DoHA  Department of Health and Ageing 
DOTARS  Department of Transport and Regional Services 
EPA   Environmental Protection Agency 
GDP   gross domestic product 
ICER   Incremental Cost Effectiveness Ratio 
ITLS   Institute of Transport and Logistics Studies 
LYG   Life Year Gained 
LYS   Life Year Saved 
MBS   Medicare Benefits Scheme 
NPV   net present value 
OBPR   Office of Best Practice Regulation 
OHS   occupational health and safety 
PBAC   Pharmaceutical Benefits Advisory Committee 
PBS   Pharmaceutical Benefits Scheme 
QALY   Quality Adjusted Life Years 
QoL   quality of life 
RIS   Regulatory Impact Statement 
SES   socioeconomic status 
VRR   Value of Risk Reduction 
The Health of Nations:  The Value of a Statistical Life 
Australian Safety and Compensation Council, [March 2008] xii 
VSL   Value of a Statistical Life 
VSLY   Value of a Statistical Life Year 
WHO   World Health Organization 
WTA   willingness to accept 
WTP   willingness to pay 
YLD   Years of healthy life Lost due to Disability 
YLL   Years of Life Lost due to premature mortality 
The Health of Nations:  The Value of a Statistical Life 
Australian Safety and Compensation Council, [March 2008] xiii 
Executive Summary 
Australians born today live more than 20 years longer than our 
counterparts a century ago1. This 38% gain in our longevity, together 
with other improvements in our health, has been achieved through a 
variety of incremental improvements in health and aged care 
expenditure, occupational safety, environmental interventions (in 
particular in relation to water and sanitation), and technological advances 
driven by research and innovation together with concern for public 
welfare and social justice. Such investments reflect the value we place on 
life, health and wellbeing. 
Scope 
This report is similarly motivated. The Office of the ASCC commissioned 
Access Economics on 30 May 2007 to conduct a comprehensive review of 
the available Australian and international literature, presenting the 
microeconomic framework and different methodologies for valuing life, 
with a view to deriving low, base and high values for the value of a 
statistical life (VSL) and the value of a statistical life year (VSLY) for use 
as inputs in cost effectiveness analysis (CEA) and cost benefit analysis 
(CBA). VSL is understood broadly as the marginal dollar value of a 
human life while VSLY is understood broadly as the marginal dollar value 
of a year of healthy human life. The latter is particularly important in 
practical applications, since most interventions and regulation are aimed 
at averting injuries and disease and most of these are not immediately 
fatal. In occupational health and safety (OHS), only around 0.2% of 
compensated injuries are fatal, and permanently disabling incidents are 
more substantially more costly than fatalities (NOHSC, 2004). The brief 
included a consultation process with stakeholders in other Australian 
Government portfolio areas that may have an interest in the calculation 
and use of the VSLY in public decision making processes. 
Findings 
Healthy life is a unique and exceptional commodity. It does not fit neatly 
into the traditional neoclassical framework because it is a prerequisite to 
deriving utility from all economic activities, including income from 
production and utility from consumption. Healthy life may, for certain 
periods, impart utility requiring neither income nor consumption. Healthy 
life can be measured in units that reflect mortality 
– eg, ‘fatalities averted’ or ‘life years saved (LYS)’, but this is not the only 
aspect of healthy life that is valued. Quality of life (QoL) is also a source 
                                      
1 http://www.aihw.gov.au/mortality/data/life_expectancy.cfm 
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of utility and attempts to measure this utility for different health states 
have resulted in the metrics of Quality Adjusted Life Years (QALYs) and 
Disability Adjusted Life Years (DALYs). 
A QALY is derived by multiplying the utility of a health state by its 
duration, with 0 equivalent to death and 1 equivalent to perfect health. 
There can be difficulties converting utility values to QALYs across 
conditions and a standard approach is preferred here to an individually 
determined one due to the variability between individual and the policy 
implications of utility values less than zero. As such, the DALY approach 
is suggested, where international experts have agreed consistent weights 
for a broad range of health states (Appendix B). However, as well as the 
difference in who does the valuing, a DALY (where 0=perfect health and 
1=death) is the reverse of a QALY. Hence, semantically, DALYs are 
averted while QALYs are sought in policy interventions. Like QALYs, 
DALYs comprise both mortality and morbidity components. 
Healthy life (QALYs) is not generally tradeable between people or across 
time periods, due to physiological and technological limitations. To an 
individual, the price they would be willing to pay (WTP) to avoid 
imminent death is almost infinite. However, this dilemma is rarely faced. 
Rather, in the real world the value that people place on their own lives is 
largely reflected in decisions about how much they would be WTP to 
purchase small increases in health or reduced risk to their life or health, 
or how much they would be willing to accept (WTA) to compensate for 
increases in risk or loss of health. In many settings including OHS, people 
(or regulators on behalf of workers) may purchase units of safety.  
However, the ability for people to accurately assess these commonly tiny 
risks or safety enhancements is limited by imperfect information and, at 
times and in particular for some groups (eg, the mentally ill, children or 
the frail aged), by irrational behaviour. Fear of particular situational 
threats, belief in abilities to beat the odds, the complications of addictive 
substances and other constraints mean that some of the fundamental 
tenets of the Walrasian general equilibrium world – perfect information 
now and in the future, rationality, and free competitive markets – are 
brought into question in relation to individual decisions to purchase safe, 
healthy life through various interventions. 
Moreover, other positive and negative externalities exist which mean that 
resources invested in interventions to achieve health and safety are not 
optimally allocated by market forces alone. In this situation, principles of 
welfare economics suggest that social utility is optimised by government 
intervening to reallocate resources. Typically this is achieved by paying in 
part or in full for health interventions and by regulating safety 
requirements with which firms must comply.  
 
A final complexity is that decisions about healthy life outcomes are made 
over the entire lifespan, rather than over short periods such as a year. 
Time is optimally allocated in a way that, for most people, places most 
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leisure in the early and late stages of life, and most labour in the middle. 
This means that utility or value to the individual does not reflect 
productivity age patterns. This and other factors have led to the 
discrediting of the traditional productivity approaches to valuing human 
life. 
Measurement approaches 
The literature refers to the ‘value of a statistical life’ (VSL) and, while this 
is a somewhat flawed concept to capture measurement of the value of 
healthy life, the terminology is retained in this report due to its 
widespread use. 
Productivity approaches to measuring the VSL or the value of a statistical 
life year (VSLY) are based on the expected earnings of the individual (a 
measure of lost production). Frictional approaches are appropriate to 
measure productivity losses in the short term or in situations of a 
relatively large unemployment pool. Human capital approaches are 
appropriate in the longer term in economies like Australia operating at 
near full employment. Although both approaches have their place in 
measuring productivity losses, the loss of human life is viewed as more 
than earnings, incorporating both the value of unpaid work and the utility 
value of leisure. As such, the human capital valuation could be 
considered to be an absolute lower bound on the VSLY. 
> In attempting to take account of the value of unpaid work and leisure, 
a hybrid or markup approach has been adopted in some cases where 
the value is estimated typically as 30% or 40% of the value of 
earnings. Other early approaches to valuing life included the 
discounted consumption approach, the implicit value approach (based 
on past investments by public policy makers), the insurance value 
approach and the court award approach. 
> A hybrid approach is currently used in the Australian transport sector, 
although this was acknowledged by DOTARS as sub-optimal 
conceptually. 
Willingness to pay (WTP) approaches to valuing human life have been the 
focus of the literature on the economics of life saving since the 1960s. 
WTP assumes that a person’s utility depends on their income and their 
health, although the complexities of the interactions are not always taken 
into account. The person’s WTP, with their available income, to avoid a 
risk to their health is then able to be translated mathematically into an 
estimate of their VSL. A criticism of the approach is the observation that 
at some critical level of risk individuals are not willing to trade off any 
more health and the VSLY approaches infinity; moreover, this suggests 
that the WTP changes depending on the base level of risk/safety or 
wellbeing. This helps explain why people tend to value specific lives 
under threat (eg, Beaconsfield miners) as more valuable than 
incremental risks to anonymous lives. It also helps explain why people 
may have more concern about losing more health if they are already very 
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unwell, compared to moving from perfect health to mild sickness for a 
period. 
There are two empirical methods of determining VSL using WTP: 
> stated preference valuation methods; and 
> revealed preference valuation methods. 
The terminology in this field is ambiguous but, essentially, stated 
preference and contingent valuation are fairly synonymous, while noting 
that some people prefer to distinguish stated choice methods as more 
sophisticated and valid. There are many stated preference methods, 
which include methods used in measuring utility values – rating scales, 
standard gambles, time trade-offs and person trade-offs. Most methods 
involve surveys, which can be ex-post, ex-ante or ex-ante (insurance 
based) and may use open-ended or closed-ended scales (eg, discrete 
choice, bidding games, paired rating and contingent ranking).  
The defining characteristic of stated preference methods is that they do 
not infer values from actual real world decisions, but are either 
hypothetical or use referencing to enhance realism. This is both their 
greatest strength and their greatest weakness. Although stated reference 
models have the potential to generate highly stratified granular results – 
by virtually any attribute one can desire including age, gender, 
socioeconomic status (SES), time, location, situation – their findings are 
not believed by many people. Caution is suggested in relation to 
spending often large sums to obtain results that may vary greatly 
depending on the framing of the survey questions, the context, the level 
of risk and other factors such as whether the person is asked about their 
own life or someone else’s. Stated preference approaches may also 
(sample) bias upwards the VSL(Y) of working age people and may also 
suffer from information, non-response and strategic biases, ‘embedding’ 
effects, ‘warm glow’ effects and the ‘ordering problem’. However, well 
designed and implemented surveys may eliminate these biases. 
In contrast, revealed preference studies are generally considered 
superior to measure individual WTP as they are based on real world 
empirical, binding market transactions. They are self-validating since the 
WTP is derived from actual risk-taking behaviours – most commonly 
compensating wage differentials, but also product market studies, 
housing decisions, compensation decisions and public sector decisions. 
Compensating (hedonic) wage studies use information on people’s job 
choices to estimate WTP for job risk changes. However, their limitations 
include potential asymmetries and imperfect information in labour 
markets and variability with the base level of risk. The latter may be able 
to be controlled for in multiple regression analysis, although the 
econometric interpretation of revealed preference studies may then 
suffer the identification problem due to selection bias. A weakness and 
strength of revealed preference is that people are subject to budget 
constraints, so correlation of VSL with SES is strong (although this also 
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can be controlled econometrically). Moreover, revealed preference 
studies can only reflect an individual’s value for their own life. 
A mixture of revealed preference and stated choice studies, as well as 
other studies valuing life, was considered the best way to proceed in 
estimation of the VSL and VSLY (in accord with Rose et al, in press 
2008). 
VSL and VSLY estimates in the literature 
The literature review was undertaken in conjunction with the DEEWR 
library. The search protocol included all journal articles and reports in the 
period 2005 to June 2007 with ‘value of a statistical life’ in the title of the 
document, and an internet search. Seminal studies from earlier periods 
were also retrieved and reviewed, and stakeholders provided other 
relevant material. 
VSL estimates were identified from 244 ‘western’ studies (17 Australian 
and 227 international studies) between 1973 and June 2007, although 
these contained only 19 explicit VSLY estimates (nine Australian and ten 
international studies). Estimates were converted to 2006 Australian 
dollars and analysed by: 
> sector – health, occupational safety, transport, environment, ‘other’; 
> country – Australia’s VSL was 5th (lowest) of 14 economies included; 
> broad methodology – stated preference, revealed preference, mixed, 
other/unknown; 
> age of the study. 
Where needed, a discount rate of 3% was considered appropriate for 
healthy life years, which aligns generally with the literature and the 
current practice of the Australian Institute of Health and Welfare (AIHW). 
Simple analysis of all these data (regardless of study quality) showed: 
> a mean VSL of $9.4 million for all countries and a median of $6.6 
million; 
> a mean VSL for Australia of $5.7 million and a median (taking into 
account a large number of implicit valuation estimates based on past 
policy decisions) of $2.9 million; 
> a mean VSLY of A$433,437 and a median of A$119,589 (also 
influenced by the skew towards Australian estimates used in previous 
policy-making); 
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> revealed preference estimates were slightly lower than stated 
preference estimates2; but 
> lower estimates for older studies; and 
> significant differences by sector in means/medians: health ($4.0/$3.7 
million), transport ($7.9/$5.4 million), ‘other’ (consumer choice, crime 
and fire safety – $8.5/$6.0 million), environment ($11.2/$8.1 million) 
and occupational safety ($11.1/$7.4 million). 
A random effects meta-analysis was performed, using MIX software, of 
the higher quality studies (ie, studies from 1980 on that had either a 
midpoint and standard deviation or other minimum-maximum range, and 
were not outliers). This eliminated many of the implicit evaluation studies 
(which helps to remove the circularity effect of future policy being based 
on speculative past policy). 
> The meta-analysis yielded an average VSL of $6.0 million in 2006 
Australian dollars with a range of $5.0 million to $7.1 million based on 
exclusion sensitivity analysis. 
> No publication bias was evident from the funnel plot and the meta-
analysis was also robust in relation to exclusion sensitivity analysis. 
> However, because of the greater variability shown across all the 
source studies, particularly across sectors, the suggested range for 
sensitivity analysis is based on the ‘raw’ study median values, which 
ranged from $3.7 million in the health sector to $8.1 million in the 
environment sector. 
Data constraints prevented analysis of some items of interest such as the 
average age of the study group (which it is expected may account for a 
great deal of variation in VSL estimates), the base level of risk/wellbeing 
and whether the individual’s valuation is for their own or another’s life. 
However, these factors were accounted for by using a random effects 
meta-analysis technique, which is designed to allow for other underlying 
variables. 
The literature review concluded that attempts to empirically determine 
the relationship between VSL and age have been inconclusive. The ‘n-
curve’ relationship found in some studies may result from sample bias or 
from the exclusion of non-income, non-consumption aspects of utility. 
Moreover, the early implied curvature may be very slight, suggesting that 
the VSLY is likely to be fairly constant by year of age. There was 
correlation found with income, wealth and ethnicity but no correlation 
with baseline health status. A plethora of attributes are available from 
stated preference models, although these may have more application in 
the private sector than for public policy making. 
                                      
2 We suspect that higher revealed preference estimates are masked by the ‘other’ category being clustered as low (implicit) 
valuation estimates and high (revealed) preference estimates; further research is indicated here. 
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Note: This figure excludes 18 studies with a VSL of over A$30 million, 
and does not control for the age of the person or study population at the 
time of the study, which would account for some of the variability. 
Social utility preferences were expressed to: avoid severe health states 
and catastrophes; protect children and disadvantaged groups; and 
protect more when private costs of risk aversion are high. 
The literature suggests that the VSLY should be adjusted if necessary for 
any benefits (and costs) to third parties. It is also important, in a cost 
effectiveness application, to net out any other costs or benefits to the 
individual to avoid double counting. 
The role of VSLY in decision-making 
The VSLY estimated from the meta-analysis reflects what individuals and 
society on average will currently pay for any life-enhancing opportunities 
currently available, based on various risk and wellbeing scenarios. Since 
many of the source studies reflected changes at the margin, it thus may 
become less appropriate to apply this relatively high price to very large  
changes in health states for large populations, since such changes (if 
they were technologically possible) may challenge the budget constraint 
imposed by current income and wealth and may alter general equilibrium 
optimal pricing. However, since most public policy interventions are also 
incremental, the VSLY estimates derived from the literature are 
appropriate to use in public decision making. 
It is important to emphasise that the decision about whether an 
intervention should be publicly financed is separate from the decision 
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The latter decision is based on the cost effectiveness of the intervention 
and the valuation of human life and wellbeing, while the former decision 
is based on views about the extent to which governments should 
intervene in the particular market under consideration. Many factors 
enter into that consideration process, including the overall government 
budget constraint and the relative strength of social utility impacts in 
relation to different externalities. Indeed, analysis of public financing 
decision making revealed the tension between the incremental cost 
effectiveness ratio (ICER), budget constraints and other considerations, 
with an econometric analysis showing that the probability of 
pharmaceutical subsidisation in Australia gradually falls, for example, as 
ICER rises, rather than a simple threshold being evident. 
Best practice principles and next steps 
In designing analyses for public decision making purposes regarding 
regulation and financing interventions to enhance safety and wellbeing in 
Australia going forward, the following principles are suggested. 
1. Be aware that any attempt to value life in dollar terms is limited 
by the unique nature of healthy life and that neoclassical 
assumptions of perfect information and rationality may not 
apply. It is the extent of these market failures and externalities 
that is the raison d’etre for the government intervention, rather 
than the value of human life per se. 
2. Measuring changes in risks to life provides a value for safety 
while valuing the utility of different health states provides 
estimates of wellbeing. Estimate safety/wellbeing in QALYs or 
DALYs, preferably with separate estimates of life years saved 
(LYS) and morbidity avoided as per Begg et al (2007). 
3. For health states other than mortality, use disability weights 
from DALY tables (Appendix B) to allocate utility associated with 
various health states. If a disability weight is required that is not 
available in the table, use the most robust utility value available 
from the literature (or expert opinion in the worst case) and 
triangulate it against similar health states that have weights in 
the table; conduct sensitivity analysis around the disability 
weight. (Use the metric ‘$/QALY’ rather than ‘$/DALY averted’ for 
simplicity of terminology. 
4. Calculate all of the costs and benefits associated with the 
intervention by who bears them – individuals (if families are 
included use the term ‘households’), Federal and State 
governments, employers, and other relevant entities in society. 
The net costs to the individual must be netted out of from the 
gross value of wellbeing. 
5. A variety of techniques may be used to evaluate the efficiency of 
an intervention, including: 
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> cost benefit analysis (CBA), which measures the net present 
value (NPV) of dollar costs compared to the net present value 
of dollars saved; 
> cost efficacy analysis, which measures the net costs 
(excluding the dollar value of QALYs) per LYS (or another 
outcome measure); and 
> cost utility analysis (CUA), which measures the net costs 
(excluding the dollar value of QALYs) per QALY gained. If the 
net cost is negative (ie, if there is a net benefit excluding the 
dollar value of QALYs), the intervention’s CUA could be 
described as cost saving rather than cost effective. 
6. Because the dollar value for the VSLY estimate is likely to be   
large and associated with a higher level of uncertainty than most 
financial estimates, it is suggested that: 
> sensitivity analysis accompanies the estimates, for example 
using high and low levels of a VSLY; and 
> cost utility analysis (CUA), and potentially also $/LYS, is used 
alongside cost benefit analysis (CBA) in public decision 
making so that the dollar value of the QALY benefit is 
transparently reported. 
7. Avoid productivity or hybrid approaches to value 
safety/wellbeing, although the productivity impacts may still 
need to be calculated as part of the analysis. 
> In general, if the goal is to measure individual utility, and 
revealed preference data are available, they should be used, 
reflecting consumer sovereignty. 
> If no revealed preference data are available, or if the goal is 
to measure social or private utility in specific situations, 
stated preference approaches may be more appropriate. 
8. A suggested ballpark average VSL is $6.0 million in 2006 
Australian dollars with sensitivity analysis suggested at $3.7 
million and $8.1 million. 
> This equates to an average VSLY of $252,014 ($155,409 to 
$340,219), using a discount rate of 3% over an estimated 40 
years remaining life expectancy. 
9. The empirical evidence appears inadequate currently to robustly 
stratify the average VSLY on the basis of age. 
10.The externalities that provide the raison d’etre for government 
interventions are based largely on social utility from enhancing 
socioeconomic equity and health equity, so it would seem self-
defeating to stratify VSLY on the basis of income, wealth, 
ethnicity, or other criteria that correlate strongly with SES, in 
public policy making. 
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11.Naturally policy makers are still able to take factors other than 
the social utility into account in their decisions. An important 
consideration is the budget constraint, which may vary across 
different portfolios of interventions given different types of 
externalities in different sectors (eg, some sectors may have 
more ‘public good’ characteristics than others) and given 
imperfect historical budget allocation mechanisms. Thus the 
value of the marginal intervention displaced may not equate 
across portfolios. 
12.While the VSLY should be used in public decision making, as 
needed, to apply to individual’s own valuation of healthy life, 
social valuations for public financing decisions should be based 
on thresholds reflecting the extent of externalities and budget 
constraints. 
13.The decision rule to approve an intervention should be (CUA): 
                                       ΔC/ ΔQ < λi 
Where ΔC is the change in costs of the intervention, ΔQ is the 
change in the QALYs and λi is the ICER threshold for portfolio i. 
Rearranging, the CBA decision rule is: 
                                   λi * ΔQ$ -Δ C > 0 
                                where ΔQ$= ΔQ*VSLY. 
14.It will therefore be important to determine financing thresholds 
in different sectors/portfolios. Further carefully designed 
research may be desirable to this end, using specialists capable 
in experimental design theory and practice. 
>  Portfolio thresholds should also be surrounded with 
sensitivity analysis based on high and low bounds, as with 
VSLY. 
15.Since the VSLY and portfolio thresholds are expressed in dollar 
terms, they should be indexed over time to inflation (CPI is 
suggested here), reviewing λi/VSLY over time for each portfolio 
to reflect potential changes in technology and preferences. 
Access Economics 
14 January 2008 
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Chapter 1: Introduction 
Access Economics was commissioned on 30 May 2007 by the Office of the 
ASCC, DEEWR3, to conduct a comprehensive review of the available 
Australian and international literature, presenting the microeconomic 
framework and different methodologies for valuing life, with a view to 
deriving low, base and high values for the value of a statistical life (VSL) 
and the value of a statistical life year (VSLY) for use as inputs in cost 
effectiveness analysis (CEA) and cost benefit analysis (CBA). VSL is 
understood broadly as the marginal dollar value of a human life while 
VSLY is understood broadly as the marginal dollar value of a year of 
healthy human life. The latter is particularly important in practical 
applications, since most interventions and regulation are aimed at 
averting injuries and disease and most of these are not immediately 
fatal. In occupational health and safety (OHS), only around 0.2% of 
compensated injuries are fatal, and permanently disabling incidents are 
more substantially more costly than fatalities (NOHSC, 2004). The brief 
included a consultation process with stakeholders in other Australian 
Government portfolio areas that may have an interest in the calculation 
and use of the VSLY in public decision making processes. 
The brief included addressing complex issues in the economics of life 
saving, such as the treatment of the productivity component of the VSL, 
irrational behaviour, imperfect information and inter-temporal (lifetime or 
even intergenerational) allocation of labour-leisure choices, which may 
lead, among other factors, to potential variation in VSLY estimates by 
age and gender, health and socioeconomic status. In addition, the brief 
included a discussion of the role of the VSLY and its appropriate 
application in public financing decisions across different interventions and 
even different sectors, including distinguishing the dollar estimate of the 
VSLY from ‘threshold’ views regarding reimbursement decisions.  
A final aspect of the brief was to conduct a brief consultation process to 
ascertain the views of other key stakeholders, including in the transport 
sector and other national portfolio areas that may have an interest in the 
calculation and use of the VSLY in public decision making processes. 
                                      
3  The Office of the ASCC leads and coordinates Australia's national effort to promote best practice in OHS, improve 
workers' compensation arrangements and improve rehabilitation and return to work of injured workers.  The role of the 
Office of the ASCC is to develop national OHS and workers' compensation policy, to encourage policy discussion and 
research and to promote consistency in legislation developed by states and territories. 
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One of the stakeholders in the consultation process was the Office of Best 
Practice Regulation (OBPR), part of the Productivity Commission4, who is 
keen to encourage more consistency and comparability of VSL estimates 
across government. For regulations that might reduce the risk of 
fatalities, OBPR’s guidance material currently encourages agencies to 
include the value of a risk reduction as a benefit of the regulatory 
proposal. However, OBPR does not explicitly require this assessment nor 
provide guidance on a generally accepted value (or values) of a statistical 
life to use to estimate this benefit. As a result, agencies’ regulation 
impact analyses often do not value these benefits in dollars or, when 
they do, the estimate of the benefits may be based on different VSLs. 
Such differences create difficulty in comparing regulatory proposals 
across agencies. Moreover, in many cases, the benefits reduce the risk of 
non-fatal injury, which appears less of a focus for OBPR despite the fact 
that the overwhelming proportion of OHS incidents (over 99%) and costs 
(89%) are non-fatal (NOHSC, 2004). 
Methods 
The review focused primarily on a review of the literature, together with 
a summary of the theoretical underpinnings of the economics of life-
saving and a brief consultation process with key stakeholders. 
Literature Review 
The literature review was undertaken in conjunction with the Office of the 
DEEWR library. Access Economics specified the initial search protocol as 
all journal articles or reports in the period 2005 to 2007 with ‘value of a 
statistical life’ in the title of the document (which also captured 
documents with ‘value of a statistical life year’ in the title). 
The library prepared a bibliography based on this protocol, as well as a 
list of documents available from an internet search. Access Economics 
reviewed the list, identified relevant items – with an emphasis on 
Australian literature and on meta-analyses – and reviewed these articles 
as retrieved from electronic journals and databases. Seminal studies from 
earlier periods (based on citation reoccurrence) were also retrieved and 
reviewed, identified from the bibliographies of the most recent literature. 
In addition, articles, reports and books were provided by stakeholders in 
the course of the consultation processes, which were also included in the 
literature review. 
                                      
4 OBPR shares the PC’s statutory independence, with a central role in assisting departments and agencies to meet the 
Australian Government's regulatory impact analysis requirements and in monitoring and reporting on their performance. It 
also serves a similar role for the Council of Australian Governments (COAG) in relation to national regulatory proposals. 
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The results of the literature review are woven throughout this report, in 
relation to the different chapters and issues as they arise. A list of 
references is provided at the end of the report. 
Access Economics would like to acknowledge with appreciation the role of 
Ms Thea Moyes (Library and Information Services, DEEWR) and Dr 
Anthony Hogan (Research Section, the Office of the ASCC, DEEWR) in 
expediting and assisting with the literature review process. 
Consultation Processes 
An important part of the review, identified early on, is the need for 
general consensus among key stakeholders in relation to the 
methodologies adopted to value the quantity and quality of life, the 
resulting estimates, and the application of such estimates in public 
reimbursement, regulation or other policy decision making processes. 
There were two steps in the consultation process. 
First, a group of key stakeholders were identified who were known to be 
familiar with this issue or who were considered may have an interest in 
the calculation and use of the VSLY in their portfolio decision making 
processes. These stakeholders were provided with a draft report 
structure outlining the issues to be covered in the report, and meetings 
were held with each stakeholder over June 2007 where their views and 
inputs were sought on each aspect of the report – namely: 
> the background, context, processes and methods (literature search, 
consultation, report); 
> the microeconomics of valuing life, including metrics of wellbeing (ie, 
valuing healthy life lost from disability as well as from fatality) and the 
applicability of classical microeconomic assumptions; 
> measurement approaches including human capital and the different 
types of willingness to pay (WTP) approaches; 
> VSL and VSLY estimates used in their portfolio area, with rationale 
(including for the discount rate), ‘netting’ processes and sensitivity 
analysis; 
> consideration of the policy implications of stratification of the VSLY by 
age, gender and other factors; and 
> the role of the VSLY in policy decision making more generally through 
CEAs and CBAs across sectors, including the appropriateness of 
thresholds or benchmarks, indexation and the need for best practice 
guidelines. 
The eight stakeholders with whom consultation was sought comprised: 
1   Office of the ASCC; 
2   Office of Best Practice Regulation (OBPR); 
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3   Civil Aviation Safety Authority (CASA); 
4   Department of Transport and Regional Services (DOTARS); 
5   Institute of Transport and Logistics Studies (ITLS); 
6   Department of Health and Ageing (DoHA); 
7   Attorney General’s Department; and 
8   Department of Defence. 
Contact officers were identified in each of the first five organisations and 
interviews were conducted; for the other three stakeholder bodies, 
difficulties in locating relevant contact officers precluded consultation 
processes in June. 
The second phase of consultation occurred between July and December 
2007 and involved the circulation of the draft report to other 
stakeholders (including jurisdictional stakeholders) by the Office of the 
ASCC. 
A brief summary of the reasons for selecting the eight key stakeholders 
chosen is provided below. 
1.  The Office of the ASCC commissioned the report and use VSL and 
VSLY in their assessment of benefits from reducing the risk of workplace 
incidents, either through injury or disease OHS exposures. The Office of 
the ASCC includes the value of the potential healthy life saved in their 
CBAs for Regulatory Impact Statements that, in turn, are also assessed 
by OBPR. 
2.  OBPR were keen that the study explain the various strengths and 
weaknesses of each approach and suggest which approach, and 
importantly which value, is most appropriate in various circumstances. 
OBPR considered that it would be useful from a pragmatic policy 
perspective if, at some point in the future, a best practice standard for 
valuing risk reduction benefits were developed, so that the same life-
saving benefits are given the same value for different regulations, 
allowing resources to be directed to where they save the most lives. 
OBPR suggested that the review by Access Economics could be a useful 
‘first step’ along this path. Appendix C has been included in this report 
subsequently to this end, as an example of application in an OHS setting. 
3.  CASA have taken on the role previously undertaken by Air Services 
Australia (ASA) of regulating airspace, and use VSL and VSLY in their 
CBA calculations of the impacts of airspace regulation. Access Economics 
has previously worked with ASA in providing such CBAs. CASA have a 
well-developed understanding of the different methodological approaches 
to valuing life, as well as the parameters for VSL and VSLY utilised in 
Australia and by their counterpart air safety organisations overseas, due 
to the particular need in their case to be cognisant of international air 
safety protocols and obligations. 
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4.  DOTARS also have a well-developed understanding of the ‘state of 
play’ in relation to use of willingness to pay methodologies, which is 
balanced against their need to consult widely (including at jurisdictional 
level) if there were to be any consideration of changing their sector’s 
current ‘hybrid’ approach to measurement of VSL and VSLY in road and 
rail transport policy processes. Their current (Austroads) VSL estimates 
are widely used for cost benefit analyses of road infrastructure projects 
to measure safety benefits. For major road infrastructure projects, the 
safety benefits are a small percentage of the total – savings in time and 
vehicle operating costs predominate. ‘Black Spot’ projects are at the 
other extreme, being small projects with safety benefits predominating. 
Then there are a range of projects in between, for which benefit cost 
rates would have varying degrees of sensitivity to the VSL. Road 
agencies tend to use technical criteria to determine speed limits on 
individual roads rather than cost benefit analysis. For example, DOTARS 
commented that it is not known whether school zones have proven safety 
benefits, but they may create a perception of safety, which gives parents 
greater confidence to allow their children to walk to school, rather than 
take them by car. The Bureau of Transport and Road Economics (BTRE, 
2003) has produced a short paper on trade-offs between speed, safety 
and other factors. 
5.  ITLS has been active in the area of measurement of VSL and VSLY eg, 
in relation to valuing the time element of travel for toll road users using 
stated choice methods. ITLS have recently completed a large survey in 
NSW relating to safety in the road environment, applying random utility 
theory to develop sophisticated stated choice WTP methodology, the 
findings of which may become available later in 2008. In road safety the 
term ‘Value of Risk Reduction’ (VRR) is sometimes used rather than VSL. 
6.  DOHA has a long history of assessing the value for money of health 
and aged care interventions, including in order to list pharmaceuticals on 
the Pharmaceutical Benefits Scheme (PBS) through the Pharmaceutical 
Benefits Advisory Committee (PBAC) processes and to provide services 
under the Medicare Benefits Scheme (MBS) and under special program 
funding arrangements. 
7.  The Attorney General’s Department provides expert support to the 
Government in the maintenance and improvement of Australia's system 
of law and justice and its national security and emergency management 
systems, including through the National Security and Criminal Justice 
Group. In cases of crime prevention, protective security and emergency 
management, the decision to incur government expenditure in order to 
reduce risks to human life is evident. 
8.  Similarly, in cases of national Defence and anti-terrorism initiatives, 
Australian Government expenditure is directed primarily to the reduction 
in risk to the life and health of Australians. 
A number of other organisations might also be interested in this analysis. 
For example, the Department of the Environment and Water Resources 
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may use CBAs to assess potential expenditures on initiatives to reduce 
toxins into the environment that impose risks to human life, and hence 
may potentially call on the use of VSLYs to assess benefits. DOTARS 
noted that state jurisdictions in the road and rail transport sector may 
also be interested, as may the Australian Institute of Health and Welfare 
(AIHW). 
Structure of this Report 
The remainder of this report addresses the findings from the literature 
analysis and consultation processes. 
Chapter 2 addresses first principles by briefly summarising 
microeconomic frameworks for valuing (and saving) life and the metrics 
of wellbeing that have been developed to measure the quantity and 
quality of life. Two common metrics, Disability Adjusted Life Years 
(DALYs) and Quality Adjusted Life Years (QALYs) are compared and 
contrasted. The applicability of classical (Walrasian) theoretical 
assumptions are discussed, such as rationality of consumers, perfect 
information and externalities, to ascertain: the confidence that might be 
placed in the methods of valuation; and the extent that imperfect 
information, irrationality and market failure form a basis for government 
intervention and the provision of public goods. The constraints to market 
tradability in human life are noted, as are the complex intertemporal 
aspects of the labour-leisure choice and the relationship between 
consumption and utility. 
Chapter 3 summarises measurement approaches to valuing healthy life, 
as they emerged historically, starting with productivity approaches, 
including ‘human capital’ and ‘frictional’ approaches as well as ‘mark-ups’ 
for leisure that can lead to hybrid valuations. Willingness to pay (WTP) 
approaches are summarised, including stated and revealed preference 
approaches, covering issues such as contingent valuation, hedonic wage 
pricing and the conversion of a VSL to VSLY (and vice versa), including 
appropriate discount rates. 
Chapter 4 summarises VSL and VSLY estimates from the literature 
review, stratified by the type of study, the country and sector. The range 
of outcomes is discussed, particularly in the context of the nature and 
limitations of the source studies. Conclusions are drawn from meta-
analysis of higher quality studies for the feasible range of the VSL and its 
applications, noting that the metric of more interest appears to be the 
VSLY. Stratification in the VSLY by age, gender, socioeconomic status 
(SES) and other factors are discussed; sensitivity analysis around the 
VSLY is also based on the literature and the issue of ‘net’ values is 
discussed to avoid double counting in CBAs. 
Finally, Chapter 5 discusses the role of using the VSLY in decision making 
in various types of analysis – cost benefit analysis (CBA), cost utility 
analysis (CUA), cost efficacy analysis and cost minimisation analysis – 
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see Box below (based on Drummond, 2005). Decision making is 
discussed in the context of the occupational health and safety (OHS) 
sector as well as other sectors, where different and various public 
financing considerations come into play. Thresholds and benchmarks are 
discussed that have been or might be adopted. The issue of whether and 
how the VSLY and thresholds should be indexed over time is also 
addressed. Suggestions for consideration in the development of best 
practice guidelines are presented in the final section. 
Cost benefit analysis – net present value (NPV) of dollar costs 
compared with the NPV of benefits. 
Cost utility analysis – dollar costs per disability adjusted life year 
(DALY) averted or quality adjusted life year gained (QALY). 
Cost efficacy analysis – dollar costs per outcome measure, such as $ 
per life years saved (LYS). 
Cost minimisation analysis – the achievement of the same value of 
benefits at the same or lower cost, compared to an alternative. 
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Chapter 2: Microeconomics and Valuing Life 
This chapter starts by describing and contrasting two common metrics of 
wellbeing – Disability Adjusted Life Years (DALYs) and Quality Adjusted 
Life Years (QALYs). The rest of the chapter looks at pricing issues using a 
neoclassical microeconomic framework and notes the constraints in 
relation to this framework in real world applications that value life in 
dollars. The economic basis for government intervention is also presented 
(with discussion of externalities and public goods). The final section notes 
different views on the allocation of choices over time in relation to labour, 
leisure, consumption and utility. 
Metrics of Wellbeing 
Wellbeing comprises the quantity and quality of life. The starting point for 
valuing human life is to define a ‘unit’ of human life. 
Dead Or Alive 
Early and fairly non-controversial metrics were based on mortality alone, 
effectively distinguishing only two health states – dead or alive. In early 
studies in OHS, a common metric was the ‘fatality avoided’ and this 
remains the case in current applications in other sectors where actuarial 
risk trees essentially have only two probable paths – death or healthy 
survival. In other words, the risk of survival in another health state is 
insignificantly small (eg, an aeroplane crash). 
A refinement to the simple ‘dead or alive’ metric is the concept of ‘life 
years saved’ (LYS). While mortality remains the only outcome measure, 
age at death and life expectancy are taken into account as well in this 
metric as is, in some cases, a discounting process such that immediate 
years of life saved are valued more highly than distant years, reflecting 
the common principle of positive time preference (ie, people prefer to 
enjoy utility and consumption now rather than in the future). 
Outcome measures such as fatalities avoided or LYS are commonly used 
as the denominator in cost efficacy analysis in public decision making 
processes.  
However, longevity is not the only aspect valued in life. QoL is also 
valued, and this arises in public decision making in interventions that 
avoid non-fatal but disabling incidents or that enhance people’s 
functionality and wellbeing. The ability to distinguish different health 
states has been addressed in two different ways – Quality Adjusted Life 
Years (QALYs) and Disability Adjusted Life Years (DALYs). 
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Quality Adjusted Life Years (QALYS) 
The QALY was developed as an attempt to reflect that health is a function 
of length and QoL, by multiplying the value assigned to different health 
states by their duration. QALYs value a year of perfect health as unity 
(1), a year of less than perfect health as less than unity and death as 
zero. They provide a standard unit for measuring health gain across 
diseases and population groups. 
QALYs had their origins in disease specific measures of utility states and 
were designed to compare treatments for a particular disease, especially 
in the context of different arms of randomised controlled clinical trials, 
rather than using a plethora of (efficacy) outcome measures whose 
comparability was varied – eg, blood pressure level, visual acuity,  
functionality score in activities of daily living, Mini-Mental State 
Examination (cognitive) score, score on a depression-anxiety scale, bone 
mineral density measure, and so on. 
Utility states are cardinal values representing the strength of an 
individual’s preferences for specific health states under conditions of 
uncertainty (Petrou, 2001). Utility studies address very similar 
methodological issues to studies that value life, so this section addresses 
them in some detail. However, it should be remembered that a key 
aspect of consumer theory is that utility (even if measured cardinally) is 
not necessarily comparable or able to be aggregated across individuals. 
Measuring utilities involves four steps. 
1. Defining the health states of interest. The measurement 
instrument should include appropriate health attributes eg, physical, 
social and cognitive function, psychological wellbeing, symptoms and 
pain. The number of attributes in a health state should be less than nine 
since humans cannot simultaneously process more than nine pieces of 
information (Miller, 1956). 
2. Identifying individuals to provide judgements of the 
desirability of each health state. Utilities are usually obtained from: 
clinicians or other experts – who tend to be knowledgeable and 
accessible; patients – since they are the ones impacted; and the general 
public – since decisions pertinent to public policy should be based on 
public opinion (Drummond et al, 1987). There is some evidence that 
utilities differ among different population groups. In general, the 
correlation between patient and proxy responses varied by health 
dimension, but proxy ratings tended to be lower than patient ratings, 
especially for older people (Sackett and Torrance, 1978; Llewellyn- 
Thomas et al, 1991; Carter et al, 1976; Rothman et al, 1991). 
3. Determining the appropriate preference scaling method to 
elicit utilities. The methods that have been used to collect data on 
utilities include the standard gamble approach, the time trade-off 
approach and rating scales (see sections below).  
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4. Aggregating across individuals to determine scaled values for 
each health state (Torrance et al, 1982), minimising the impact of 
‘context effects’. Most inconsistencies result from differences in 
perspective that can arise from the way a health state or treatment is 
presented to the respondent. Preference ratings have been shown 
(Kaplan and Ernst, 1983; Froberg and Kane, 1989) to be affected by: 
‘labelling effects’ ie, using specific terms); ‘anchor effects’ e.g., if the 
anchor (see Section 2.1.2.3) is ‘death’ or ‘worst possible health’; and 
prognosis/duration of the health state (little is known about the impact of 
culture). Context effects can be minimised by careful attention to 
construction and presentation of the health states including: using states 
of the same duration; avoiding inclusion of diagnosis, disease labels, 
laboratory test results and prognosis in health-state descriptions; using 
trained personnel to collect data; posing questions to the respondent in 
an unbiased manner to reduce framing effects; using a variety of 
administration techniques to reduce cognitive burden (for example, props 
that allow presentation of the task in a clear and concise manner and 
presentation of subsets where the total number of health states is large). 
Standard Gamble 
The standard gamble approach is the classic method of measuring 
preferences in economics, first presented by von Neumann and 
Morgenstern (1953). It uses hypothetical lotteries as a means of 
measuring people’s preferences. These lotteries involve a choice between 
two alternatives: the certainty of one outcome and a gamble with two 
possible outcomes (see Box). 
 
The standard gamble approach in practice: An individual might be 
asked to choose between the certainty of surviving for a fixed period in a 
particular state of ill health and a gamble between surviving for the same 
period without disability on the one hand and immediate death on the 
other. The probability of surviving without disability, as opposed to dying, 
is then varied until the person shows no preference between the certain 
option and the gamble. This probability then defines the utility of an 
individual for the disabled state on a scale between 0 and 1, whose end-
points are death and perfect health (Petrou, 2001). 
Breyer and Fuchs (1982) used the standard gamble approach to 
investigate two alternative treatments where one offered a fixed health 
effect and the other offered two possible outcomes – a more favourable 
and a less favourable health effect. The individuals exhibited risk-averse 
behaviour towards positive health outcomes (opting for the certain and 
intermediate outcome) and risk-seeking behaviour towards negative 
health outcomes (they are willing to take more of a risk in order to have 
a chance of experiencing the most positive outcome on offer). 
The Health of Nations: The Value of a Statistical Life 
Australian Safety and Compensation Council, [March 2008] 11 
Time Trade-Off 
The time trade-off approach involves asking subjects to consider the 
relative amounts of time they would be willing to trade in order to survive 
in various health states. The choice is often between continuing in a 
present defined state of ill health and moving to a shorter but healthier 
life. The duration of survival in the healthier state is varied until the 
subject indicates no preference between the two alternatives (similar to 
the standard gamble). 
Rating Scale 
The rating scale is based on psychometric theory. It consists of a single 
line with anchors representing best possible health and death (or some 
alternative). Respondents are asked to place each health state on the line 
such that the intervals between the placements reflect their perceived 
differences between the health states. Rating scale estimates are 
consistently lower than those obtained via the standard gamble or time 
trade-off methods. Rating scales are often used to introduce the standard 
gamble exercise because they allow the respondent to become familiar 
with the health states and with ranking.5 
 
                                      
5 Two additional techniques, equivalence technique and ratio scaling, have also occasionally been used to measure health 
state utilities, but they are not widely used and will not be discussed here. 
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Comparing preference-scaling methods (Petrou, 2001): While each 
scaling method has its advocates, none has been proven superior. The 
advantage of the rating scale approach is its efficiency, 
straightforwardness, wide applicability and the fact that it is quick and 
inexpensive to employ. However, there is a temptation for subjects to 
spread their responses evenly across categories. 
The standard gamble remains the gold standard for many health 
economists because it is based on decision-making under conditions of 
uncertainty, a component of most studies in healthcare. However, this 
approach is relatively time-consuming and people often have difficulties 
understanding the concept of probabilities. Moreover, utilities or 
preference values can be strongly influenced by the way questions are 
framed (Read et al, 1984). 
Despite the fact that the time trade-off approach has advantages over 
standard gamble and is reliable, practicable, and a reliable measure of 
utility, it does have some drawbacks. As Rosser and Kind (1978) point 
out, the approach is based on the assumptions that the perception of time 
is linear and that the perception of the severity of illness is independent of 
the time spent in this state. In addition, the trade-off concept is difficult for 
many people to understand.   
The standard gamble approach reflects risk aversion, while the time-trade 
off reflects discounting.  Commonly used value matrices of different 
health states in practice include the SF-36 (standard gamble) and the 
EQ-5D (time trade off). 
Converting Utilities To QALYs 
All these approaches yield utilities that range from 0-1, where a higher 
score represents better health-related QoL. These utilities have been 
widely used as the preference weights (quality levels) for QALYs, noting 
that a utility-weighted QALY is not in itself a utility (Torrance and Feeny, 
1989:569). QALYs can then be used in cost utility analysis or converted, 
using VSLY from WTP analysis, to a monetary input to CBAs.  
The major disadvantage of QALY measures is that they remain, in 
general, a conversion metric from outcome measures based on the views 
of individuals in a sample who are assessing their own (or others’) 
relative utility from different health states. As such, there can be 
substantial variation in QALY scores for health states and there is a need 
to account for a variety of effects. 
Response shift: As people’s health status changes, their emotions may 
change or settle as may their perspective on the problem. With a simple 
‘before and after’ analysis there is not necessarily an ability to separate 
the impacts of the health state with those of response shift. For example, 
if a person loses their finger in a workplace accident, they may initially be 
devastated by the injury and rank their health state very low. Over time, 
they may adjust to the loss of the finger and their health state ranking 
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may return closer to unity. For this reason, many people who are born 
blind or deaf or with other congenital conditions, for example, have 
higher utility values for their health state than people with the same level 
of impairment who have acquired the sensory loss or disability 
(Heydebrand et al, 2005). 
Halo effects: Conversely, when people receive an intervention that 
improves their health state or offers hope of relief, the immediate effect 
may be a sharp rise in their utility valuation. This seems particularly the 
case for pain relief, after cancer surgeries or following self efficacy or 
behaviour modification programs, for example (Lorig et al, 2005). 
However, in time, the higher utility values may not be sustained. 
Confounding factors: It may be difficult for people to separate out the 
impacts of different comorbid conditions on their overall utility, to 
separate out the impacts of other significant life events (that may have 
occurred recently or in the distant past) and to separate the effects of 
concurrent interventions. 
Effect size problems: It may be difficult for people to measure very 
small changes in health states or changes that occur very gradually over 
long periods of time. Symptom reduction may be measured rather than 
the elimination of the problem, per se (Osborne et al, 2006). 
Health profiles: People may value states differently according to where 
on a timeline or life cycle that they occur. 
Heterogeneity between respondents: People of different ages, 
gender, ethnicity, socioeconomic status or outlook on life may rank the 
utility of the same clinical health states very differently. They may have 
different needs that are not well reflected in ‘average’ measures and may 
be at very different states of psycho-social readiness for interventions. 
Some depressed respondents, for example, may rank their QoL as less 
than zero, which presents difficulties in a policy-making setting. 
Disability Adjusted Life Years (DALYS) 
The World Health Organization (WHO), the World Bank and Harvard 
University developed a comprehensive assessment of mortality and 
disability from diseases, injuries and risk factors in 1990, projected to 
2020 (Murray and Lopez, 1996), known as the burden of disease and 
injury approach. Methods and data sources are detailed further in Murray 
et al (2001). 
Like QALYs, the approach is non-financial, where pain, suffering and 
premature mortality are measured according to a scale of ‘disability 
weights’ which, conversely to a QALY, range from 0 representing a year 
of perfect health and 1 representing death. The DALY approach has been 
adopted and applied in Australia by the AIHW with a separate 
comprehensive application in Victoria. Mathers et al (1999) from the 
AIHW estimate the burden of disease and injury in 1996 and Begg et al 
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(2007) have recently updated these estimates, including separate 
identification of premature mortality (Years of Life Lost due to Premature 
Mortality or YLL) and morbidity (Years of Healthy Life Lost due to 
Disability or YLD) components. 
A DALY consists of two components: premature mortality (Years of Life 
Lost - YLL) and morbidity (Years of Life Lost due to Disability - YLD), 
which is based on the disability weight of a condition. 
DALYs = YLLs + YLDs 
In any year, the disability weight of a disease (for example, 0.18 for a 
broken wrist) reflects a relative health state. In this example, 0.18 would 
represent losing 18% of a year of healthy life because of the inflicted 
injury, if this level of disability were sustained over a full year. 
The determination of disability weights in the DALY approach is based on 
the views of international experts using extensive referencing and 
consultation processes. The approach has been successful in avoiding the 
subjectivity of individual valuation inherent in the QALY approach and 
avoids the problem of utility values worse than death. It has been 
criticised by some, however, as being paternalistic, ‘lumpy’ (values are 
discrete whereas severity of health states may be a continuous scale), as 
lacking comprehensiveness (some conditions are not included) and as 
failing to account for individual differences (although this latter aspect is 
seen by others as a strength of the approach). 
That said, the DALY approach has its critics. Drummond (2005) criticises 
the consultation process in Geneva in 1995 as not being extensive 
enough, and not adequately passing on the time trade off or standard 
gamble methods. He also criticises the limited inputs to DALY weights 
and age weighting (although both these problems have been overcome in 
Australia, the latter by dropping the age weighting). Others, such as the 
National Institute of Clinical Excellence (NICE) in the UK, prefer to return 
to SF-36 and EQ-5D values6, and indeed these are necessary to calculate 
the values of the diseases missing from the original WHO report. Access 
Economics understands that the burden of disease and injury 
methodology may be revisited by the WHO with a view to update. 
In Australia the AIHW has adopted particular disability weights in its 
burden of disease analysis, based on those adopted globally by the WHO. 
These weights are presented in Appendix B and are suggested by Access 
Economics for use in Australia when valuing different health states, for 
consistency and as the best currently available. These weights also have 
the major virtue of being transparent. In the absence of such weights, 
policy makers and workers in the field may fall back on other methods, 
                                      
6 SF-36 is a short form survey of QoL comprising 36 questions http://www.sf-36.org/tools/SF36.shtml, while EQ-5D stands 
for the ‘European quality of life – 5 dimensions’ measure http://www.euroqol.org/ 
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including a role for arbitrary judgements. That is, judgements will always 
be made about the value of different health states. It is best practice that 
those judgements be explicit, rather than implicit and unexamined. 
It should be noted, however, that for some health states, particular 
weights are not available and, in these cases, decision makers may need 
to refer to the published literature on QALYs for those health states, with 
triangulation and reality testing in relation to comparator conditions from 
the AIHW list of disability weights.  
A final point to note is that years of life lost (YLL) is calculated relative to 
life expectancy based on the benchmark of the highest reported national 
life expectancy in the world (Japanese women). To calculate YLL a life 
table is constructed. 
A useful software tool for use in calculating burden of disease (eg, 
calculating prevalence when incidence, remission and mortality are 
known) is DISMOD-II, which can be downloaded from 
http://www.who.int/healthinfo/boddismod/en/index.html 
A graphical representation of a hypothetical intervention that increases 
longevity and QoL is depicted in Figure 2—1. In this example, a person 
has close to perfect health to age 40 years and then loses QoL due to one 
or more health conditions7 until expected death at 80 years (the x-
intercept of the curve). The hypothetical intervention increases the 
person’s life expectancy to age 85 years by delaying onset of morbidity 
to age 60 years and reducing its impacts thereafter at each year of age. 
The heavy shading represents QALYs prior to the intervention while the 
lighter shading represents QALYs after the intervention. 
                                      
7 Occupational exposures and hazards accounted for some 2% of the total burden of disease and injury in Australia in 2003 
(Begg et al, 2007). 
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Strengths And Criticisms Of QALY and DALY Metrics 
The attempt to place value or to rank different health states has been 
strongly criticised in some quarters due to the uncertainty and variability 
surrounding the rankings and their implications in terms of potential 
rationing of health services (some groups may receive services while 
others are excluded). Others (eg, some disability groups) criticise the 
implicit principle that the quality of some lives is less than the quality of 
other lives, and dislike the terminology ‘burden of disease’, holding the 
view that neither the people nor the health states represent a ‘burden’ to 
society (preferring ‘wellbeing’ terminology). While weighting disability 
states does bias against lifesaving interventions for disabled persons, it 
also biases towards QoL-improving interventions as there is more gain to 
be had. For people with chronic diseases, this is considered likely to be a 
positive trade-off. 
Another criticism is that the metrics may fail to adequately account for 
the proportion of remaining lifespan. For example, some argue that a 
20% reduction in lifespan would have the same value if one had five 
remaining years of life or 50 remaining years of life, while others claim 
that the only aspect of value is the dead-alive state, so any years 
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remaining have the same value. Note that this policy would bias 
interventions against young people. 
Advantages of the QALY and DALY metrics are that they are able to 
facilitate comparability between individuals with different conditions and 
across nations (including nations with different national incomes). 
However, some nations have subsequently adopted variations in 
weighting systems for DALYs that limit this comparability. For example, 
in some countries DALYs are age-weighted although, in Australia, DALYs 
are considered equal for people of all ages. 
The main problem with the DALY/QALY approach is that it is not financial 
and is thus not directly comparable with most other cost measures. 
Health and wellbeing is currently not included in gross domestic product 
(GDP), yet it may have been one of the greatest sources of growth in 
living standards in the past century (Murphy and Topel, 2005), with the 
economic value from reduced mortality estimated by Yale University at 
around 40% of consumption (Nordhaus, 1999:15). The potential scale of 
the value of this ‘intangible’ has thus resulted in an attempt to develop 
appropriate economic frameworks to estimate the value of life and accord 
a ‘shadow price’ to a unit of healthy life (ie, VSL or VSLY). These 
frameworks are based on traditional neoclassical assumptions, which are 
examined in the next sections.  
Applicability of Walrasian Assumptions 
Leon Walras (1834-1910) made the first attempt in neoclassical 
economics to model a set of prices for a whole economy at which all 
markets would clear, providing general equilibrium. Every general 
equilibrium position is Pareto efficient (ie, no one can be made better off 
without making someone else worse off), but a number of assumptions 
must hold – consumer preferences must be locally non-satiated (ie, there 
is always a preferable level of consumption close to any given level of 
consumption); consumers must be rational; markets must be complete; 
there must be no externalities and information about all prices (both now 
and in the future) must be perfect. 
Moreover, since every efficient allocation of resources can be supported 
by some set of prices, all that is required to reach a particular outcome is 
a redistribution of initial endowments, after which the market can be left 
alone to do its work and there will be no trade off between efficiency and 
equity. However, the conditions for this to occur require that consumers' 
preferences are convex (ie, they reflect diminishing marginal utility). 
Under these assumptions, rational individuals and firms acting in free, 
well informed competitive markets will generally maximise social welfare. 
Prices in markets will adjust in response to individuals and firms 
exercising choice. 
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> Individuals will seek to maximise their welfare (utility), taking into 
account their own wants and needs (preferences), their budget 
constraint and the prices they face. Conceptually they may also take 
into account the utility they derive from changes in others’ utility (eg, 
altruism). 
> Firms choose what, how and where to produce with the aim of 
maximising profits. Competition will drive firms to meet evolving 
consumer preferences at least cost, using increasingly efficient 
techniques.  
While in many cases a free, well informed, competitive market will 
achieve welfare-maximising outcomes, often there exists market failure 
due to the breakdown of one or all of these assumptions. The following 
sections address why this may occur in the ‘market’ for life. 
Rationality 
People do not always appear to behave rationally, even in making 
decisions that affect the length and quality of their life (as well as more 
minor decisions). Particular cases in point include people with a mental 
illness, people who are addicted to abusive substances (including illicit 
drugs, alcohol and tobacco), children, and the frail aged, particularly 
people with dementia. 
> Some 25.7% of Australians (4 million adults in 2005) have a mental 
illness (Access Economics, 2007 based on ABS, 1997 and interim 
health and demographic data). Anxiety disorders (11.9% of 
Australians), substance abuse (8.7%; principally alcohol abuse, 6.5%) 
and depression (6.2% prevalence), are the most common mental 
illnesses in Australia. In 2003, mental illnesses accounted for over 
13% of the burden of disease (Begg et al, 2007), not accounting for 
downstream effects such as suicide and self-harm, which are higher 
for people with a mental illness. There is uncertainty in relation to 
whether such actions could be considered fully rational.  
> In addition, around 3.2 million Australians in 2005 (21.3% of 
Australians aged 18 years and over) smoked tobacco daily (ABS, 
2006). Since 38.3% of all adult smokers have a mental illness (Access 
Economics, 2007), around 2.0 million Australians are estimated to 
smoke who do not have a mental illness. There is debate in relation to 
the degree of rationality involved in harmful addictive behaviours. 
> In addition to the adults, there are an estimated 4.8 million Australian 
children (aged under 18 years) and some 200,000 Australians with 
dementia. 
From these data, a case might be made that around half the Australian 
population may not meet the rationality criterion. While some (including 
eminent) economists might argue that these agents are all behaving 
rationally as utility maximisers at some level (eg, Becker and Murphy, 
1988; Cawley, 1999), the literature generally reflects concerns that 
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addictive behaviours, particularly among people with severe mental 
illness, bring into serious question the applicability of traditional 
neoclassical microeconomic assumptions and hence frameworks of utility 
maximisation. Caplan (2006) states that: 
‘Even confirmed economic imperialists typically acknowledge that 
economic theory does not apply to the seriously mentally ill.’ 
Friedman (1962) argues this is because children and the mentally ill do 
not have stable, well-ordered preferences so rational behaviour and full 
information breaks down. In Australia in relation to tobacco smoking, 
Professors David Collins (Dept of Economics, Macquarie University) and 
Helen Lapsley (School of Medicine, University of Queensland) have 
written on the costs of smoking in Australia for various government 
agencies, including the cost of tobacco as a real cost to society (Collins 
and Lapsley, 2005). They argue that if all drug abuse ceased to exist, the 
consequent reduction in consumption would release resources which 
could be used for other consumption or investment uses, with ‘abusive’ 
defined as a substance that a) has an overall negative attributable 
fraction in burden of disease analysis, and b) is addictive. In contrast to 
the ‘rational addiction’ literature, they thus conclude that smoking is a 
‘bad’ and its consumption is not easily explicable in rational neoclassical 
terms (see also Section 2.2.3). 
Information 
People also do not always have access to perfect information, but must 
navigate complex systems in order to derive current information eg, in 
relation to risk of injury, compensation payments or specialist clinical 
data relevant to their health outcomes. In the health sector, consumers 
generally do not have the necessary expertise to make decisions by 
themselves that would optimise their own best interests – they need to 
rely on the advice of their doctors and pharmacists (information 
asymmetries). 
Accessing perfect information regarding future health outcomes is even 
more unlikely. Collins and Lapsley (2005) note that neoclassical theory 
demands a situation of full knowledge of the future consequences of a 
behaviour at the time at which an action was undertaken, and that a high 
proportion of tobacco and other addictions are acquired in early or mid 
teens when the presence of full information (as well as rationality) is  
questionable.8  The growing prevalence of childhood obesity is a particular  
                                      
8 They also argue that, with addictive products such as tobacco, the objective of 
consumption is often to avoid highly unpleasant effects of withdrawal – rather 
than to gain any positive benefits.  Since the withdrawal effects result from 
previous consumption of the addictive drug, avoidance of such effects cannot be 
viewed as a ‘benefit’ of consumption 
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concern of policy makers in part because it is a predictor of obesity and 
associated worse health outcomes in later life (cardiovascular disease, 
diabetes, cancers and osteoarthritis), that children are unlikely to fully 
take into account in their diet and exercise consumption ‘choices’ today 
(Ebbeling et al,2002). 
In addition, it can be very difficult to accurately assess the impacts of 
very small changes in risks, either currently or in the future. For 
example, rational consumers may make decisions to go parachuting or 
bungee jumping, despite increased risk to life, because their perception 
of the risk may be smaller than it actually is. This is also complicated by 
the fact that healthy life is a joint product in the consumption and 
production of all other goods and services. 
Externalities 
An externality is a cost or benefit resulting from an economic transaction 
that falls on third parties in society ie, agents not directly involved in the 
transaction. Externalities can be positive, when an external benefit is 
generated, or negative, when an external cost is imposed upon others. 
Externalities often occur in relation to the use of a public good. For 
example, air is a public good and production that causes air pollution 
may impose costs on others, including potentially worse health 
outcomes. 
Because the participants who are party to the transaction do not bear all 
the costs or reap all the gains, in a competitive market too much or too 
little of the good or service may be produced and consumed from the 
point of view of social welfare optimisation. If third parties benefit 
substantially, such as in areas of education or safety, then the good will 
be underprovided and/or under-consumed; if costs to ‘the public’ exceed 
costs to the individual, then the good will be over-provided. For example, 
returning to the example of smoking, the costs are not borne fully by the 
smoker but have detrimental impacts on others, including passive 
smokers and particularly children who are adversely impacted by greater 
risk of low birth weight, Sudden Infant Death Syndrome, asthma and 
other health conditions. In addition, taxpayers pay for health system 
expenditures and other costs associated with smoking. 
In health and safety there are numerous external benefits and costs for 
the rest of society. 
> External benefits: For example, if a person chooses to vaccinate 
against an infectious disease, they also decrease the risk of 
transmitting the disease to non-vaccinated members of society. Thus 
they do not capture the full benefit of their actions, while the third 
parties can ‘free ride’ on external benefits that they have not paid for. 
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> External costs: People who experience a workplace incident or who 
have poor health are more likely to require care (sometimes provided 
for ‘free’ by friends or family carers), to have higher government 
service use (more hospital and GP visits9, more likelihood of receiving 
the Disability Support Pension or other welfare transfers) and to have 
lower productivity (thus lower taxation revenue). Thus they do not 
capture the full cost of their actions and this presents another moral 
hazard dilemma. Examples of potentially fatal externalities include 
drink driving victims or bystanders in occupational accidents. 
In the transport sector, positive externalities of transport networks may 
include the ability to provide emergency services, increases in land value 
and agglomeration benefits. Negative externalities are wide-ranging and 
may include local air pollution, noise pollution, light pollution, safety 
hazards, community severance and congestion. The contribution of 
transport systems to potentially hazardous climate change is a significant 
negative externality which is difficult (but not impossible) to evaluate 
quantitatively. 
A key externality of improving an individual’s poor health state, or 
improving their safety in relation to the risk of adverse health states, is 
the social utility derived from improving equity. Some arguments 
justifying the pursuit of a minimum level of health and safety in the 
population include (Marmor and Boyum, 1999, reflective also perhaps of 
Amartya Sen’s work): 
> healthy life is the most basic and fundamental of all human needs; 
> health is central to the ability of individuals to pursue their life as they 
would choose ie, healthy life is an input into all other consumption and 
production; 
> market based rewards are justifiable only if people are healthy 
enough to participate in the economy; 
> the initial endowment of health is a requirement for equity in 
opportunity, so differences in income should be based on effort rather 
than ‘bad luck’ in health; 
> the health and safety of children is of particular importance due to 
long term impacts; and 
> health and safety are needed to exercise political freedom. 
Figure 2—2 illustrates positive externalities in the market for healthy life 
or, in practice, for interventions that generate healthy life. The private 
demand curve D for these interventions is lower than the social demand 
curve D’ due to the presence of these externalities (lack of information 
                                      
9Around 70% of health expenditures are financed by Federal and State 
Governments, with very low marginal (out of pocket) costs to health service 
consumers.  
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and rationality that cause consumers to under-consume, social utility 
from improving health equity), crossing the supply curve S at point B 
(the social equilibrium) rather than A (the private market equilibrium). If 
governments provide a subsidy to consumers of P’-P per unit of the 
intervention, then the amount of health interventions consumed (and 
hence healthy life gained) will increase from H to H’. 









H H' (units of healthy life,
or of an efficacious health intervention)  
Figure 2—3 illustrates the converse case where negative externalities 
(risks to healthy life) are not taken into consideration by producers. In 
these cases, governments may regulate a particular level of safety to be 
achieved, which will increase costs to producers by P’-P (per unit of 
production), causing a shift upward in the supply curve from S to S’ and 
a contraction of production from Q to Q’. 
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Q' Q (units of production)
 
In health in civil societies (including Australia), delivering equitable health 
outcomes to different population groups is considered a social objective – 
as, for example, reflected in the principle of universal entitlement 
embedded in Medicare and the PBS and the priority given to safety 
regulation – such that people in different regions, with different 
socioeconomic status, of different ethnicities or gender, and with different 
health conditions have equal access to services that enable equitable 
health outcomes in terms of mortality and morbidity. In particular, 
societies believe that budget constraints should not unduly limit access to 
a minimum level of health. 
The way this type of social welfare optimisation framework works in 
choosing between different interventions is represented in Figure 2—4, 
which depicts an iso-welfare curve where society is indifferent between 
trading off the utility of UA, the health of the less advantaged group and 
UB, the health of the more advantaged group. Suppose I is the initial point 
before an intervention, X is the outcome offered by Intervention 1, and 
the horizontal broken line is the set of options (1 to n) offered by 
Intervention 2 (say, in relation to indigenous health). Then Y is the point 
at which society is indifferent between the two interventions. The 
framework is also useful in explaining altruism, by changing the shape of 
the iso-welfare function. 
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Figure 2—4  Comparing interventions using a welfare economics 
framework 
 
While externalities exist, Governments can intervene in health and safety 
markets to increase the likelihood that scarce resources are efficiently 
allocated (and thus maximise society’s welfare, including health and 
safety equity) through taxation or subsidisation, regulation, and the 
provision or funding of products or services. 
Market Tradeability 
A final fundamental assumption is the operation of free and competitive 
markets in which goods and services can be traded. There are a number 
of reasons why this assumption may not hold in the ‘market’ for life. 
> Biological and physiological constraints: In many cases it is not 
possible for people to reallocate units of healthy life among each 
other. While markets in organs exist (although these are not generally 
condoned), in most cases it is difficult for one person to transfer units 
of healthy life to another person. 
> Technological constraints: It is also currently technologically 
impossible to indefinitely prolong healthy life for any individual. For a 
majority of lost DALYs, there is no ability to change the outcome for 
the individual. 
> Budget constraints: As noted in the previous section, budget 
constraints may limit socially optimal allocations of resources to 
purchase healthy life years for the most disadvantaged, if these 
externalities are not addressed through government interventions. 
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Other Matters: The Labour-Leisure Choice 
There are other matters that are not well explained by economic theory. 
The shadow price for a ‘resource’ (healthy life) that is jointly consumed in 
all other consumption is difficult to estimate from a Lagrangian function. 
There is also the issue of whether utility is derived solely from 
consumption of goods and services and the extent to which utility 
involves various non-consumption benefits (eg, positive relationships 
with others). A final matter is the way that the same activity might be 
valued in different contexts – eg, tasks like cooking or driving can be 
counted as paid work and included in GDP, domestic chores or leisure 
activities, and economic frameworks do not cope well with this variability. 
There is one other area of economic theory that needs to be mentioned 
in a little more detail in this context, which relates to the theory of the 
allocation of time. Becker (1965:299) foreshadowed that: 
Economic development has led to a large secular decline in the work 
week, so that whatever may have been true of the past, today it is 
below fifty hours in most countries, less than a third of the total time 
available. Consequently, the allocation and efficiency of non-working 
time may now be more important to economic welfare than that of 
working time; yet the attention paid by economists to the latter 
dwarfs any paid to the former. Fortunately, there is a movement 
underway to redress the balance.’ 
Becker applied consumer theory to the labour-leisure choice where 
leisure is considered one good and labour the other (in a two-good 
world). A consumer has a finite and scarce amount of time (known as the 
time endowment or T) and must make a choice between labour (L), 
which earns income for consumption and leisure (l), which does not. 
                         ie, l + L = T and l + (T-l) = T 
If the individual consumes what they earn then their consumption (C) is: 
                  C = w*(T-l) where w is their wage rate. 
Consumer theory can then be applied (substitution and income effects) to 
investigate the impacts of policies such as welfare benefits and labour 
taxation. 
The labour-leisure choice is deemed to occur ‘in any period’. In reality, 
people tend to make these choices over a lifetime. Most people in 
western economies spend little time during childhood in the workforce 
and plan for increased leisure in retirement as well. The labour-leisure 
choice is thus a lifetime allocation decision, rather than one based on a 
particular year. This has implications how the lifetime value of production 
should be ascribed by age. For example, if the value of life at each year 
of age mapped income or even consumption, it might be lumpy, with a 
peak in the prime working years. Due to the intertemporal nature of the 
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labour-leisure choice, utility from each year of life may be much more of 
a constant. 
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Chapter 3: Measurement Approaches 
Until recently many economists and policy makers argued that it was not 
possible to place a value on human life. Irving Fisher observed in 1909 
that ‘it is impossible in any true sense to measure human life in dollars 
and cents’ (Motha, 1990). Broome (1978) argued that if death is 
immediate and no bequests are permitted, the dollar value of life is 
infinite, since money is of no use to a dead person, and CBAs involving 
deaths are thus inappropriate.  
Despite the difficulties of measuring the value of life, most economists 
and public policy makers recognise that, given the scarcity of resources 
for public projects and the consequent need for efficient allocation, if 
such valuations are not made explicitly then they will be made implicitly 
through decisions about which projects proceed and the funding accorded 
to competing projects. Any allocative decision that affects individual risk 
levels implicitly places a priority or a value on life and a major purpose of 
CBAs, and of this review, it to assist in making these values more 
explicit. 
The Value of A ‘Statistical’ Life 
‘The valuation of life is generally an emotive issue fraught with 
philosophical and conceptual problems. Consequently, it is an issue 
riddled with controversy and debate. It is also associated with seeming 
irrationalities. For example, society will usually go to great lengths to 
save identified lives such as sailors stranded in mid-ocean or a child in 
need of expensive surgery. However, when the lives to be saved are 
anonymous, as for example in the case of funding research into cures for 
disease that would save lives in the future, public response may not be 
quite as generous. This apparent irrationality may be due to the greater 
sense of responsibility and claims of conscience associate with identified 
lives as opposed to anonymous lives.’ Motha (1990:1). 
The concept of a ‘statistical’ life has evolved in order to distinguish the 
value of the life of an anonymous or unknown individual from the life of a 
known or particular person. The distinction, however, implicitly makes 
value judgements: that the utility value of healthy life to the person 
whose life it is, or to those known to that person, is not relevant and that 
the anonymous valuation is the correct perspective from which to make 
an assessment. Corollaries, also arguable, are that anonymous valuation 
will be considerably less than that of the individual and those known to 
him/her and that policy decisions based on such valuations can be 
removed from their downstream impacts on specific lives. While these 
aspects will be discussed in subsequent sections, the terminology 
‘statistical’ is retained in this report. 
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Traditional Productivity Approaches 
The lost productivity method to estimating VSL and VSLY is based on the 
expected earnings of the individual, and is based on neoclassical 
economic theory. Wages and other marginal costs are assumed to equal 
the value of the marginal revenue generated by an additional worker 
under conditions of full employment (Berger et al, 2001). Lost product is 
thus the value of the wages (measured as average earnings) plus other 
inputs to production (capital, plant and equipment, land, enterprise etc) 
multiplied by the number of workdays missed. For reduced productivity 
while working, a percentage of this calculation is generally used. 
Human Capital and Frictional Approaches 
Nevertheless productivity approaches have been used in the absence of 
other methods to impute a value for lost life essentially as the market 
value of lost earnings. 
> The human capital approach estimates the net present value (NPV) of 
the future stream of lost earnings as a result of a reduced health 
state. 
                     NPV = ΣYi/(1+r)^i where i=0,1,2….n where 
  Yi = income in year i, n = years of remaining life and r = discount 
rate.10 
> The frictional approach is used in situations of high unemployment11 or 
in short term situations to estimate only the production lost (or 
additional costs incurred) between when a person stops working and 
when they return to work, are replaced by another worker or, 
alternatively, for the time period required to restore production to its 
pre-incident state (Koopmanschap et al, 1995; Brady et al, 1997). 
                                      
10 Some calculations truncate the income stream at average retirement age, 
while more sophisticated calculations estimate the probability of employment 
each year and multiply that by the expected income stream in employment in 
each year. 
11 In this situation society may not suffer as large a loss, as the previously 
unemployed worker who generated no income now generates an income, while 
the injured worker no longer generates an income. 
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The human capital approach is an accounting approach that uses the 
discounted present value of a worker’s future earnings as a proxy for the 
cost of premature death, injury or illness.  It characterises people as a 
labour source and input to the production process and implies the value 
to society of preventing an incident is the saving in potential output or 
productivity capacity (BTE, 2000:19-20). 
The frictional approach is not generally applicable in Australia in cases of 
severe injury or disease that result in death, exiting the workforce or 
reduction in hours worked over the long term. This is because, in an 
economy operating at near full employment, there is not an unemployed 
labour pool from which to draw idle resources. Rather, markets and 
wages must adjust slightly and, overall, there is a reduction in productive 
capacity as a result of the reduced availability of the labour input. The 
human capital method is the appropriate method to use in such cases, 
and also reflects the investment in trained labour. 
The human capital method generally has been preferred to the frictional 
approach in western countries in relation to OHS interventions designed 
to prevent serious injuries and disease (eg, Leigh et al, 2000 in the US; 
NOHSC, 2004 in Australia). The reason for choosing the human capital 
method tends to be a general recognition that after the initial disruption 
until production is restored to former levels (most relevant for minor 
injuries), there is essentially the loss of the labour resource (when there 
is permanent disability or fatality) over the longer term, which reduces 
the capacity of the economy to produce at any given level of 
unemployment. An implicit assumption is that the change is of 
insufficient size to affect the overall clearing of the labour market. For 
large shocks, the validity of this assumption needs to be reconsidered. 
The human capital approach is useful to estimate productivity losses, as 
they are of interest to policy makers, but form only a component of the 
VSLY. The human capital valuation could be considered to be an absolute 
lower bound on the VSLY. 
The lost productivity approach is the simplest methodology to use, but 
may suffer from several serious drawbacks as a measure of VSL and 
VSLY (O’Brien and Gafni 1996:289; Berger et al, 2001). 
> It violates basic economic fundamentals regarding individual 
sovereignty, measuring not how much the individual values healthy 
time, but rather what others value as their healthy time. 
> The approach assumes that there are no imperfections in the labour 
market such as discrimination, free movement of labour, and so on. 
> Unpaid work, such as household production and caring for others, are 
largely ignored. 
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> The choice of wage rate can be an issue – most studies use an all-
industry average wage rate, whereas some use a minimum wage or 
industry-specific rate.12 
> The choice of time period can also be an issue, with some studies 
using a fixed period, and other using a variable period (such as life 
expectancy). 
> It does not capture the value of all the other reasons for living other 
than to work (consumption, other sources of utility from leisure) – ie, 
the quality of healthy life aspects. 
> It raises equity issues regarding the VSLY of the disabled, aged, 
children and others not in the paid workforce. 
‘Mark-Ups’ for Leisure and Other Variations 
In attempting to take account of the value of unpaid work and leisure, a 
hybrid approach has been adopted in some cases where the value of lost 
leisure time (or time spent in unpaid work) is estimated as some 
proportion of the value of earnings. Common proportions are 30% or 
40% (eg, Hogan, 2003). 
Other early approaches to valuing life are listed below (Motha, 1990). 
> The discounted consumption approach measures the total gain (in 
terms of value of consumption) that an individual receives for 
remaining alive. 
> The implicit value approach involves determining the value from past 
investments by public policy makers that have reduced mortality 
rates. 
> The insurance value approach uses the insurance premium paid and 
probability of death to calculate the VSL. 
> The court award approach uses the value awarded by courts to the 
next of kin as compensation for the death of an individual, payable by 
the one held responsible for the death. 
In the Australian transport sector, a hybrid approach has been adopted. 
Austroads (2007, 2006) values cost per crash (2005 prices) by severity 
ranging (by jurisdiction) from $1.93- $2.07 million for non-urban 
fatalities and $1.65-$1.82 million for urban fatalities. Serious injuries 
range from $453,600-$530,800 (non-urban) and $416,000-$441,600 
(urban). Minor injuries range from $18,600-$20,100 (non-urban) and 
$18,000-$$19,600 (urban). Austroads recommends use of per casualty 
level data to develop crash costs for specific situations (eg, for people 
seriously injured in a fatal crash in an outer metro area in Victoria). 
                                      
12 This has been a particular issue in compensation payments to people who are 
higher than average income earners (Pope, 2006). 
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These costs are based on Austroads (2003) – which in turn is based on 
earlier reports including BTE (2000) and Bureau of Transport and 
Communications Economics (1996) – and includes labour lost ‘in the 
workplace’ and lost ‘in the household’ and the value of the ‘QoL’. 
Household labour is valued at 83% of the workplace labour for all 
crashes, while the ‘QoL’ is valued at 92% and 209% of the workplace 
labour respectively for fatal and serious injury crashes. Costs other than 
these three are workplace disruption, criminal prosecutions, correctional 
services, ambulance, hospital inpatient and other medical costs, long 
term care costs, funeral and coroner costs, vehicle costs (mainly repairs), 
insurance claims (potentially double-counting the vehicle repair and 
ambulance costs) and general costs (such as travel delays, insurance 
administration and police/fire attendance). These other costs represented 
11% of total costs for fatal accidents, 76% for serious accidents and 83%  
for other accidents. Essentially the hybrid approach to costing developed 
in 1996 has been serially updated based on CPI and allowing for 
compositional effects (eg, changes in the severity patterns of incidents). 
Willingness to Pay Approaches 
An alternative approach to valuing human life is the willingness to pay 
(WTP) approach, which originated in the 1960s (eg, Schelling, 1968). 
Since this time, the economic literature has focused on people’s WTP (or 
willingness to accept) changes in actual or risked tradeoffs between 
healthy life and money. 
The willingness to pay approach estimates the value of life in terms of the 
amounts that individuals are prepared to pay to reduce risks to their lives.  
It uses stated or revealed preferences to ascertain the value people place 
on reducing risk to life and reflects the value of intangible elements such 
as QoL, health and leisure.  While it overcomes the theoretical difficulties 
of the human capital approach, it involves more empirical difficulties in 
measurement (BTE, 2000:20-21). 
‘The economic question being dealt with here is not about how much an 
individual would be willing to pay to avoid his or her certain death or how 
much compensation that individual would require to accept that death. In 
this respect, the term ‘value of life’ is an unfortunate phrase that does 
not reflect the true nature of the question at hand. Most people would be 
willing to pay their total wealth to avoid certain death; and there is 
probably no finite sum of money that could compensate an individual for 
the sure loss of life. Rather, the economic question is about how much 
the individual would be willing to pay to achieve a small reduction in the 
probability of death during a given period or how much compensation 
that individual would require to accept a small increase in that 
probability.’ Freeman (1993) 
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To illustrate how the VSL is estimated, suppose that an individual is 
willing to pay (accept) $20 for a reduction (increase) of risk of death of 1 
in 100,000. Thus the VSL is 20*100,000 = $2 million. Alternatively if an 
individual is willing to pay $0.25 for a reduction in the risk of 1 in 
100,000 of paraplegia for 1 year with a disease weighting of 0.5, then 
the VSLY is $50,000. To extrapolate this to the VSL then the simplest 
approach is: 
                                     VSL = VSLY * E 
where E is the individual’s life expectancy or, taking into account time 
preferences: 
                  VSL = ΣVSLYi/(1+r)^i where i=0,1,2….n where 
 VSLYi = VSLY in year i, n = years of remaining life and r = discount          
rate. 
This approach assumes that the VSLY does not change with the base 
level of risk, however. Broome (1978) argued that at some level of 
critical risk individuals are not willing to trade off any more health and 
the VSLY approaches infinity, and thus the value of at which you measure 
risk influences the final estimated VSL (Figure 3—1). 
Figure 3—1  VSL estimate dependent on base level of risk 
(Broome theory) 
Safety →
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This concept helps explain why people tend to value specific lives under 
threat (eg, Beaconsfield miners) as more valuable than anonymous lives, 
in contrast to most WTP source studies, which are based on purchasing a 
minor reduction in the risk of death rather than buying out the risk of 
certain death. We now turn to these different empirical valuation 
methods. In general, there are two main methods for empirically 
measuring VSL: 
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> stated preference valuation methods; and 
> revealed preference valuation methods. 
Stated Preference Valuation Methods 
Stated preference approaches attempt to elicit VSL or VSLY through 
hypothetical or referenced evaluation. They can be used to estimate the 
benefits of policies that place people beyond the range of their choice 
making experience (eg, changes in job risk not experienced, new life 
saving drugs, OHS interventions). They avoid issues such as the ability to 
pay and provide greater control over scenarios (disease, potential 
treatments, risk faced, and so on), information and externalities. For 
example, the individual being asked about preferences may be asked to 
‘exclude the impact on future earnings’. They circumvent the absence of 
markets for healthy life by presenting consumers with hypothetical 
markets in which they have the opportunity to pay for the outcome in 
question. The hypothetical market may be modelled after either a private 
goods market or a political market. However, because reality checks may 
be difficult and decision-makers in some studies may have unlimited 
budgets, there can be questions regarding the validity of the values 
selected (more so than the ranking). That said, better-designed studies 
use referencing and can hence pivot attribute levels to trade around real 
world levels experienced, a way of making estimates more realistic. 
The terminology varies in relation to stated preference approaches. 
‘Stated choice’ models tend to refer to more recent and sophisticated 
stated preference models used widely in transport safety, while 
‘contingent valuation’ (CV) has more of an association with older, 
American and possibly more controversial stated preference models used 
in environmental valuations, where CV remains the most widely used 
method for estimating non-use values13. The CV method involves directly 
asking people, in a survey, how much they would be willing to pay or 
accept for specific outcomes eg, the amount of compensate on they 
would be willing to accept to give up a wetland (or a year of healthy life). 
It is called ‘contingent’ valuation because people are asked to state their 
WTP contingent on a specific hypothetical scenario. In this sense there 
seems little difference in the terms CV and stated preference. In both 
cases the defining characteristic is that they do not infer values from 
                                      
13 Because CV is used to value non-market purchases that may not involve direct 
participation, these values are sometimes referred to as ‘passive use’ values.  In 
the environmental applications, they include everything from the basic life 
support functions associated with ecosystem health or biodiversity, to the 
enjoyment of a scenic vista or a wilderness experience, to appreciating the 
option to fish or bird watch in the future, or the right to bequest those options to 
your grandchildren. It also includes the value people place on simply knowing 
that giant pandas or whales exist. 
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actual real world decisions, as the revealed preference methods do (see 
Section 3.3.2). 
> Another difference is between the choice and the valuation. The main 
differences are in the design of the question(s), and the data analysis. 
The statistical analysis for stated choice is often more complicated 
than that for stated valuation, requiring the use of discrete choice 
analysis methods to infer WTP from the tradeoffs made by 
respondents. Rizzi and Ortuzar (2006) state that: 
‘CV usually implies a trade-off between probabilities of risk and money in 
a context not completely specified… The context in which we set up the 
choice situations here [in their study] is well defined, easily understood 
by most people, and real market restrictions are introduced to prevent 
respondents producing unlikely responses. This has the effect of 
tempering responses, and precluding people to produce ‘outliers’. De 
Blaeij et al (2002) reported a similar finding.’ 
Stated preference surveys were first applied in the 1960s when surveys 
were used to estimate the value that hunters and tourists placed on a 
particular wilderness area. The survey results were compared to an 
estimation of value based on travel costs and good correlation was found. 
In the 1980s the CV method rose to prominence in the US when CV 
surveys were used for quantitative valuations in relation to the Exxon 
Valdez oil spill in Prince William Sound. The technique has also been used 
in Australia to value areas of the Kakadu National Park (Carson et al, 
1994). 
The fact that stated preference models are based on what people say 
they would do, as opposed to what they are observed to do, is the source 
of their greatest strengths and its greatest weaknesses. The conceptual, 
empirical, and practical problems associated with developing dollar 
estimates of economic value on the basis of how people respond to 
hypothetical questions about hypothetical market situations (with 
hypothetical budgets) are debated constantly in the economics literature. 
Although researchers are attempting to address these problems, many 
economists, jurists, policy-makers, psychologists and sociologists, for 
many different reasons, do not believe the dollar estimates that result 
from stated preference models are valid and will not accept their results. 
Caution is suggested in relation to spending money on stated preference 
studies and about using their results. 
There are essentially three stated preference approaches that may be 
used to estimate the VSL or the VSLY. 
> Ex-post: if you were experiencing condition x, how much would you 
be willing to pay for obtaining the benefits from intervention z? 
> Ex-ante: if the chance of experiencing condition x were y%, how 
much would you be willing to pay for obtaining intervention z? 
> Ex-ante (insurance based): what would you be willing to pay for an 
insurance against incurring costs for intervention z in case of condition 
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x? (This method is claimed to be most reflective of real world 
situations.) 
In general, due to the presence of risk aversion, a larger WTP will result 
from an ex-post approach compared to ex-ante, and a larger WTP will 
result from an ex-ante approach (not insurance based) compared to an 
ex-ante approach (that is insurance based). 
Both the nature of the intervention and of the alternative influence the 
results. If the intervention is life-saving, then risk aversion is taken into 
account; if it is life-extending, then the length of time left is taken into 
account, compared to if the intervention only improves QoL but not 
longevity. If the individual is comparing the intervention to no 
intervention, then Broome’s argument may come into play (see previous 
section) and the value of large changes in risk can be accounted for. If 
the intervention is one that the person does not prefer to no treatment, 
some approaches might force the individual to place a positive (or zero) 
WTP value on the treatment (when in fact it would be negative), which 
would bias the results upwards (Donaldson et al, 2006). 
Surveys are commonly used in the stated preference approach. The 
survey method of eliciting values also impacts on the estimated VSLY 
(O’Brien and Gafni, 1996). 
> Open-ended scale: how much would you be willing to pay? This can 
be cognitively difficult, as most people are not used to specifying their 
‘price’, rather than shopping around or bargaining. 
> Closed-ended scale: also known as a discrete choice approach, 
where respondents are simultaneously shown two or more different 
alternatives and their characteristics, and asked to identify the most 
preferred alternative in the choice. 
Take-it-or-leave-it/dichotomous choice: respondents are asked whether 
they are willing to pay a certain amount (random price given) for a 
particular described benefit. Often the results are in the high WTP range 
because there is no income constraint. 
Bidding games: respondents are provided with changing proposed 
amounts until they are indifferent between choosing the intervention or 
not. The result often depends on the range provided, methodology used 
(bottom-up, top-down or ping-pong) and the starting point. Standard 
gambles, time tradeoffs and other techniques listed in Section 2.1.2 are 
also used. 
Paired rating: respondents are asked to compare two alternate situations 
and are asked to rate them in terms of strength of preference. For 
instance, people might be asked to compare two OHS programs and their 
outcomes, and state which is preferred, and whether it is strongly, 
moderately, or slightly preferred to the other program. 
Contingent ranking surveys ask individuals to compare and rank alternate 
program outcomes with various characteristics, including costs. For 
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instance, people might be asked to compare and rank, in order of 
preference, several mutually exclusive programs under consideration, 
each of which has different outcomes and costs. 
Mathers et al (1999:10) summarise the four main methods as per the 
box. 
Rating Scales – a chart displays two health states with the most 
preferred rated at 100 and the least preferred rated at 0.  Individuals must 
indicate on the chart where other health states would fall. 
Standard Gamble – Individuals must consider two alternatives.  In the 
first, their health state is certain.  In the other, there are two possible 
health states, one better than the certain state (ie, ideal health) and one 
worse (ie, death).  The probability that the best state occurs is varied until 
the subject is indifferent to their health state being certain.  This 
probability, or point of indifference, is the ‘utility’ of the health state under 
consideration. 
Time trade-off – Individuals are asked to choose between a longer life, 
or a shorter life but in good health.  The length of the shorter life is varied 
until the individual is indifferent between the two. 
Person trade-off – An individual must choose between a lesser health 
benefit for a larger number of people, or a larger health benefit for a 
smaller number of people.  For example, saving a larger number of lives 
but having less than ideal health, and saving a smaller number of lives 
but with ideal health. 
Framing effects, the level of ignorance (realism versus full information), 
and the presence of a strategic incentive to truthfully reveal their WTP 
also impact on the stated preference measure of VSL and VSLY. Some 
example survey questions for a private good and a public policy are 
presented below, adapted from Johannesson et al (1996).  
Private good: ‘In the US, about 1 in 5,000 people die annually in traffic. 
A possible measure to reduce the traffic risk is to equip cars with safety 
equipment, such as airbags. Imagine a new type of safety equipment. If 
this equipment is installed in your car, the risk of dying in a traffic accident 
will be cut in half for you and everyone else travelling in the car. This 
safety equipment must be tested and serviced each year to make sure 
that it is working correctly. Would you choose to install this safety 
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Public policy: ‘In the US, about 1 in 5,000 people die annually in traffic. 
The number of deaths can be reduced if we devote more resources to 
preventing traffic accidents. We can, for example, straighten out turns, 
build safer crossings, and increase the supervision of traffic. Imagine a 
program that cuts in half the risk of you and everyone else dying in a 
traffic accident. Are you willing to pay $A per year more in taxes on your 
car for this program?’ [YES or NO] 
With both questions, A might take on values of $30, $150, $300, $750, 
$1500, or $3000 for each survey respondent. The VSL would be 
calculated as equal to the average WTP divided by the reduced risk of 
death (δR). The reduced risk of death is equal to the number of lives 
saved divided by the affected population. If the average WTP = $500 and 
δR = .0001 (1 in 10,000), then VSL = 500/.0001 = $5 million. 
Although stated preference models have the potential to generate highly 
stratified results based on age, gender, SES, time, location, type and 
situation/setting of the trade-off, and any other granularity desired, the 
major limitations are: 
> it is not clear that the variation in responses reflects actual/real 
variation since answers are not validated; 
-this is an important consideration, particularly if such variation is 
then used to determine different access for different groups to life-
enhancing interventions; 
> variability does not just reflect strata but varies depending on how a 
question is framed and the survey approach adopted, and is highly 
sensitive to what people believe they are being asked to value, as well 
as the context that is described in the survey; 
> in many studies, people are making decisions about the value of 
others’ ‘statistical’ lives rather than their own, which (like the human 
capital approach) violates individual sovereignty and may result in 
inaccurate accounting for the value of certain lives. 
In relation to the latter point, for example, the people asked in the 
survey to value the life of a child would not include that child’s future 
children, so there is likely to be a bias towards the age-group surveyed 
(and away from younger or older people). This also becomes relevant in 
explaining the ‘n’-curve observed in some studies using this approach 
(Section 4.3.2). 
In addition, the application of a stated preference approach is generally a 
complicated, lengthy, and expensive process. In order to collect useful 
data and provide meaningful results, the survey must be properly 
designed, pre-tested, and implemented. Survey questions must focus on 
specific outcomes and contexts that are clearly defined and understood 
by respondents. Section 4.3.4 provides an example of good stated choice 
experimental design provided by ITLS. Carson (2000), as well as 
summarising the major issues and positions taken in the technical debate 
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over the use of stated preference (CV) approaches, presents key design 
and implementation issues involved in undertaking a survey and the 
reader is provided with a set of factors to examine in assessing the 
quality of a CV study. Some criteria for good stated preference survey 
design are provided in the following box. 
Tips for stated preference survey design to value life14 
Before designing the survey, learn as much as possible about how 
people think about the health outcome. Consider people’s familiarity with 
the outcome, as well as the importance of such factors as quality, 
quantity, accessibility, the availability of substitutes, and the reversibility 
of the change. 
 Choose the survey sample based on the appropriate population. 
The choice scenario must provide an accurate and clear description of 
the change in health status associated with the event, program, 
investment, or policy choice (intervention) under consideration. If 
possible, convey this information using photographs, videos, or other 
multi-media techniques, as well as written and verbal descriptions. 
Unlike ordinary survey questions, which sometimes ask respondents 
whether they are willing to pay x dollars to improve ‘air quality,’ the nature 
of the changes to be valued must be specified in detail. It is also 
important to make sure that respondents do not inadvertently assume 
that other non-health improvements are included. For example, if people 
are asked to value only reductions in air pollution as it affects their health, 
it would be important to make sure that they do not include their value for 
the environmental benefits in their stated WTP amount. 
 
                                      
14 Adapted from 
http://www.ecosystemvalutation.org/contingent_choice.htm 
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Discrete choice format is generally accepted as preferable to open-ended 
format.  
The survey must specify the mechanism by which the WTP payment will 
be made, for example through increased taxes. The respondent must 
believe that if the money was paid, whoever was collecting it could effect 
the specified change.  
Respondents should be given budget constraints. 
Specify whether comparable services are available from other sources, 
when the intervention is going to be provided, and whether the losses or 
gains are permanent or temporary (and if so for how long). 
Respondents should understand the frequency of payments required, for 
example monthly or annually, and whether or not the payments will be 
required over a long period of time in order to maintain the change. They 
should also understand who would have access to the intervention and 
who else will pay for it, if it is provided. 
In the case of collectively held goods, respondents should understand 
that they are currently paying for a given level of supply. The scenario 
should clearly indicate whether the levels being valued are improvements 
over the status quo, or potential declines in the absence of sufficient 
payments. 
If the household is the unit of analysis, the reference income should be 
the household’s, rather than the respondent’s, income. 
Thoroughly pre-test the valuation questionnaire for potential biases. Pre-
testing includes testing different ways of asking the same question, 
testing whether the question is sensitive to changes in the description of 
the outcome being valued, and conducting post-survey interviews to 
determine whether respondents are stating their values as expected. 
Include validation questions in the survey, to verify comprehension and 
acceptance of the scenario, and to elicit socioeconomic and attitudinal 
characteristics of respondents, in order to better interpret variation in 
responses across respondents. 
The in-person interview is the most expensive survey administration 
format, but is generally considered to be better than telephone interviews 
or mail surveys, especially if visual materials are to be presented. 





The Health of Nations: The Value of a Statistical Life 
Australian Safety and Compensation Council, [March 2008] 40 
Achieve a high response rate and a mix of respondents that represents 
the population. 
Whatever survey instruments and survey designs are used, and whatever 
response rate is achieved, make sure that survey results are analysed 
and interpreted by professionals before making any claims about the 
resulting dollar values. 
This presentation of stated preference approaches is lengthy, more so 
than for the revealed preference section following. The balance in the 
report derives from the balance in the literature. A summary is provided 
below. 
Summary – advantages of stated preference approaches 
> They are very flexible and can be used to estimate the economic value 
of virtually anything. However, they are best able to estimate values 
for goods and services that are easily identified and understood by 
users and that are consumed in discrete units (unlike healthy life), 
and only if there is no observable behaviour available to deduce 
values through other means. 
> CV is the most widely accepted method for estimating total economic 
value, including all types of non-use, or ‘passive use,’ values. CV can 
estimate use values, as well as existence values, option values and 
bequest values. 
> Though stated preference models require competent survey analysts 
to achieve defensible estimates, the results tend not to be too difficult 
to analyse and describe. Dollar values can be presented in terms of a 
mean or median value per capita or per household, or as an 
aggregate value for the affected population. 
> Stated preference models have been widely used, and a great deal of 
research is being conducted to improve methods, make results more 
valid and reliable, and better understand strengths and limitations. 
Internal validity can often now be checked (ie, whether the data are 
consistent with theory such as positive income elasticities), and 
sometimes also externally validated if there is a real world situation 
which is similar enough to use as a benchmark. 
> Some people prefer the stated preference approach due to the 
weaknesses of the revealed preference approach – self-selection, 
information and market imperfections, base level of risk and budget 
constraints. 
Summary – issues and limitations of stated preference 
approaches 
> Although stated preference methods have been widely used for the 
past three decades, there is considerable controversy over whether 
they accurately measure people's WTP. 
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> People have practice making choices with market goods, so their 
purchasing decisions in markets are likely to reflect their true WTP. 
Surveys assume that people understand the outcome in question and 
will reveal their preferences in the contingent market just as they 
would in a real market. However, most people are unfamiliar with 
placing dollar values on health outcomes and may not have an 
adequate basis for stating their true value, particularly in the absence 
of specific context (Sunstein, 2000). 
> The expressed answers to a WTP question in a stated preference 
format may be biased because the respondent is actually answering a 
different question from the one the surveyor had intended. Rather 
than expressing value for the good, the respondent might actually be 
expressing their feelings about the scenario or the valuation exercise 
itself. For example, respondents may express a positive WTP because 
they feel good about the act of giving for a social good eg, to save 
someone’s life (referred to as the ‘warm glow’ effect); they may state 
a positive WTP in order to signal that they place importance on 
improved health outcomes in general (Subramanian and Cropper, 
2000). 
> Respondents may give different WTP amounts, depending on the 
specific payment vehicle chosen. For example, some payment 
vehicles, such as taxes, may lead to protest responses from people 
who do not want increased taxes. Others, such as a contribution or 
donation, may lead people to answer in terms of how much they think 
their ‘fair share’ contribution is, rather than expressing their actual 
value for the good. 
> Some researchers argue that there is a fundamental difference in the 
way that people make hypothetical decisions relative to the way they 
make actual decisions. For example, respondents may fail to take 
questions seriously because they will not actually be required to pay 
the stated amount. Responses may be unrealistically high if 
respondents believe they will not have to pay for the good or service 
and that their answer may influence the resulting supply of the good. 
Conversely, responses may be unrealistically low if respondents 
believe they will have to pay. 
> The payment question can either be phrased as the conventional 
‘What are you willing to pay (WTP) to receive this outcome?’, or in the 
less usual form, ‘What are you willing to accept (WTA) in 
compensation for giving up this health state?’ In theory, the results 
should be very close. However, when the two formats have been 
compared, it has been consistently found that people treat gains and 
losses asymmetrically and require a substantially larger increase in 
wealth to compensate for a loss than the amount they would be 
willing to pay for an equivalent gain (Guria et al, 2005). The higher 
valuation in willingness to accept approaches has been explained as a 
cognitive problem; WTA gives individuals the perception of a property 
right over the decision of getting in a risky situation (Marquez, 2006). 
Critics have claimed that this result invalidates the stated preference 
The Health of Nations: The Value of a Statistical Life 
Australian Safety and Compensation Council, [March 2008] 42 
approach, showing responses to be expressions of what individuals 
would like to have happen rather than true valuations. 
> If people are first asked for their WTP for one part of an outcome (eg, 
averting an accident where they damage a single leg bone) and then 
asked to value a more serious outcome (eg, the whole leg), or vice 
versa, the amounts stated may be similar. This is referred to as the 
‘embedding effect.’ 
> In some cases, people’s expressed WTP for something has been found 
to depend on where it is placed on a list of things being valued. This is 
referred to as the ‘ordering problem.’ 
> Many early studies attempted to prompt respondents by suggesting a 
starting bid and then increasing or decreasing this bid based upon 
whether the respondent agreed or refused to pay such a sum. 
However, it has been shown that the choice of the starting bid affects 
respondents’ final WTP response. 
> Strategic bias arises when the respondent provides a biased answer in 
order to influence a particular outcome. If a decision to deliver an 
OHS intervention such as regular ergonomic checks, for example, 
depends on whether or not the survey produces a sufficiently large 
value for the benefits of the checks, the respondents who are prone to 
back pain may be tempted to provide a higher value than their true 
valuation. 
> Information bias may arise whenever respondents are forced to value 
attributes with which they have little or no experience. In such cases, 
the amount and type of information presented to respondents may 
affect their answers. In addition, people tend to think that a certain 
risky event is more likely to occur or has greater impact than other 
events if they have a memory of its occurrence, so people tend to 
overestimate WTP for highly publicised events and under-estimate 
less publicised events. Sunstein (2005) argue that fear and other 
irrational motivators can have major impacts on stated preference 
findings. 
> Non-response bias is a concern when sampling respondents, since 
individuals who do not respond are likely to have, on average, 
different values from individuals who do respond. 
> Estimates of the value of life using stated preference are difficult to 
validate externally. 
> When conducted to the exacting standards required, stated preference 
methods can be very expensive and time-consuming, because of the 
extensive pre-testing and survey work. 
> Many people, including jurists, policy-makers, economists, and others, 
do not believe the results of stated preference approaches. 
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Revealed Preference Valuation Methods 
In the revealed preference approach (also known as the ‘hedonic pricing’ 
or ‘hedonic wage’ approach), real world empirical studies are used to 
seek information about people's behaviour when actually faced with 
trade-offs. These studies are limited in that only those trade-offs 
experienced by people can be used to infer the VSL. 
A major advantage is that the approach is self-validated, since the prices 
derived are from actual purchases, risk-taking behaviours or other 
exchanges, which commonly include:  
> compensating wage differentials; 
> product market studies eg, cost of airbags actually purchased or fire 
safety devices (such as smoke alarms) installed; 
> housing decisions eg, the discount in rent demanded to live near 
chemical factories (Hatfield et al, 2002); 
> compensation through the civil court system, less preferable because 
decisions are often based on financial impacts and may be blurred by 
the existence of punitive damages; and 
> public sector decisions, also less preferable because of the circularity 
problem ie, was the original societal decision maker correct in the first 
place? 
Compensating wage differentials, the most common type of study 
(Marquez, 2006), use information on people's job choices to estimate 
WTP for job risk changes. The WTP for a risk change is equal to the wage 
differential generated from labour markets. Suppose that there is a 5 in 
10,000 chance of a job fatality (this is a high job risk, higher than for the 
mining industry). If there are 10,000 workers, there will be 5 random 
deaths, but we can reduce the job risk and the number of deaths by 20% 
(from 5 to 4 in 10,000), at a cost. If the individual is willing to accept a 
wage $0.25 lower per hour for the lower job risk (but no less), then the 
annual value of the risk change is $0.25*2000 = $500 (assuming 2,000 
hours worked per year). With 10,000 workers, VSL = 
$500*10,000=$5,000,000. 
The advantage of labour market studies is the availability of data and 
different levels of risks which allow researchers to conduct multivariate 
econometric studies and successfully control for a variety of potentially 
confounding factors (Fried, 1969) using the function:  
                  Y = α + βRisk + λEducation + θGender +… + ε 
Where Y is the income, Risk is the number of fatalities (or injuries) over 
the number of cases and Education, Gender and so on are other variables 
that affect and control the estimation of the coefficients. The 
identification of the β coefficient then defines the VSL as the social mean 
marginal rate of substitution of own wealth for safety (Dranove, 2003). 
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Limitations of the revealed preference approach are: 
> potential imperfections or extraneous influences in labour (or product) 
markets such as imperfect information, and income/wealth or power 
asymmetries that can may difficulty in correctly perceiving the risk or 
in negotiating an acceptable change in wage (price); 
> variability with the base level of risk (Broome theory, as previously 
discussed); 
> blurring the health benefits with the non-health benefits such as 
compensation for a poorer work environment or the process of care; 
> selection bias, where individuals may self-select into particular jobs 
depending on other non-observable characteristics that econometric 
analysis cannot control for, such as the level of risk aversion – 
consequently econometric analysis may actually be formulating a 
demand curve for risk based on a series of points on different demand 
curves (known as the identification problem – see Figure 3—2), which 
would result in an underestimation of the WTP for a decrease in risk 
(and thus an underestimation of the VSLY). It may be possible to 
investigate the level of self-selection by asking pre-questions about 
risk-aversion, although this is still experimental. 










curves for safety 
Estimated demand 
curve for safety 
 
For revealed preference studies, individuals take into account their ability 
to pay or their marginal utility of income (as income rises, the value an 
individual places on an additional dollar falls– see Figure 3—3). 
Consequently an individual with a lower level of income may be more 
willing to accept an increase in risk to health compared to an individual 
with a higher level of income. Empirical studies show that the SES of the 
population surveyed impacts strongly on estimates of the VSL. 
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The Office of Best Practice Regulation (2007:124-6) appears to prefer 
revealed preference to stated preference methods. 
‘As a rule, estimates of individuals’ valuations of goods and services from 
observing their behaviour in markets tend to be more credible than those 
from survey questionnaires. Observing purchasing decisions directly 
reveals preferences, whereas surveys elicit statements about 
preferences. Survey respondents may have little incentive to take the 
question seriously, invest in obtaining the information necessary to 
answer it accurately, or be truthful. They bear little cost for inaccurate or 
ill-considered answers and may have an incentive to exaggerate.’ 
Converting VSL to VSLY: Discount Rates 
In both stated and revealed preference estimates the most common 
output is VSL rather than VSLY (see the private good/public policy 
example and the wage-risk example in the previous sections), since in 
most cases the risk of death is the outcome of interest. Hence most 
studies require conversion of the VSL to a VSLY. Some source studies, in 
particular those focused on different health states (morbidity) rather than 
mortality, need to convert the VSLY to VSL, as in the preambular 
introduction to Section 3.3. That section presented the formula for the 
conversion as: 
VSL = ΣVSLYi/(1+r)^i where i=0,1,2….n         where 
VSLYi = VSLY in year i, n = years of remaining life and r = 
discount rate. 
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Clearly there is a need to know n (the years of remaining life), to 
determine an appropriate value for r (the discount rate), and to know any 
variation in VSLY by age or be prepared to use an average (the latter 
approach is suggested in Section 5.1.3). The years of remaining life at 
any given age should be based on average life expectancy tables. 
Choosing an appropriate discount rate is a subject of some debate, as it 
varies depending on what type of future income or cost stream is being 
considered. The discount rate for VSL/VSLY conversions needs to 
appropriately take into account risks, inflation, positive time preference 
and expected productivity gains. 
> Risk and positive time preference: The absolute minimum option that 
one can adopt in discounting future expected healthy life streams is to 
set future values on the basis of a risk free assessment about the 
future ie, assume the future flows are similar to the certain flows 
attaching to a long-term Government bond. From recent history the 
long term nominal bond rate has averaged 5.8% per annum (see the 
following chart). If there were no positive time preference, people 
would be indifferent between having something now or a long way off 
in the future, so this applies to all flows of goods and services. 
 
- Nonetheless some studies do include a risk premium, although in many 
cases the reasons are unclear. Austroads (2007) uses a discount rate of 
7% in their calculations of costs per crash and per injury (ie, a risk 
premium of some 1.2%), but the stream is not a stream of healthy life 
calculated from WTP studies – rather it is a combination of cost 
components many of which do entail risk (see Section 3.3.2). 
> Inflation: The Reserve Bank has a clear mandate to pursue a 
monetary policy that delivers 2% to 3% inflation over the course of 
the economic cycle. This is a realistic longer run goal and an inflation 
rate in this range (2.8%) is used in arriving at the discount rate for 
healthy life below. It is important to allow for inflation in order to 
derive a real rather than nominal rate. 
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In discounting healthy life, an appropriate real discount rate for Australia 
is suggested as 5.8 – 2.8 = 3%. 
The estimate was triangulated with other discount rates from the 
literature. By far the most common rate used to discount healthy life in 
the literature reviewed is 3% – both in Australia (eg, Mathers et al, 1999; 
Begg et al, 2007, both AIHW) and overseas (eg, perhaps the most 
eminent being Nordhaus, 2002 (Yale); Murphy and Topel, 2005 
(University of Chicago); Cutler and Richardson, 1998 (Harvard); World 
Health Organization, 2002; Aldy and Viscusi, 2006). 
Returning to Australia, Abelson et al (2006) provides the following 
explanation for adopting a 3% discount rate in looking at the cost of 
foodborne illness in Australia, as it was ‘considered to best reflect the 
individuals’ time preference rates [which…] are generally lower than the 
opportunity cost of capital due to the tax wedge (see Chapter 7, Abelson 
2003a).’  
DOTARS commented in the consultation process that: ‘BTRE has argued 
strongly against including a risk premium in the discount rate for 
evaluation of public sector projects, see Reports 100 and 110 on our 
website15. While you are right to dismiss including a risk premium, even if 
risk were not taken account of in the source study for the VSL, the risk 
premium approach would only be correct under very restrictive 
assumptions that are most unlikely to hold in practice.’ 
Adding a risk premium to the discount rate to adjust for risk in cost–
benefit analyses (CBAs) of public sector projects can distort project 
rankings. It alters costs and benefits according to a particular pattern 
over time, which will be correct only under assumptions that would rarely 
hold in practice. (BTRE, 2005:v)  
General Critique and Overview of WTP Methods 
WTP methods are increasingly preferred to measure VSL and VSLY. Even 
organisations that have not yet moved to adopt these valuations (eg, 
DOTARS in the consultation process) acknowledge that WTP approaches 
are superior to productivity approaches due to their ability to assign 
value to time spent outside the workplace and hence reflect a more 
appropriate value of healthy life. Australian Transport Council (2006) 
notes that, in the transport sector: ‘The current Australian approach can 
be described as a human capital approach with an element of WTP 
grafted on… By way of comparison, WTP values used in European 
countries range from $1.8 million to $4.2 million (1998 Australian dollar 
equivalents)… If Australia switched to the WTP approach, higher unit 
                                      
15 BTRE (1999) and BTRE (2005). 
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crash costs would alter the pattern of infrastructure expenditure to give 
higher priority to safety.’  
Within the various WTP approaches, there is a paradox. In making 
revealed preference choices regarding the valuation of life, people are 
fundamentally constrained by budgets. To relieve the budget constraint 
using stated preference approaches may result in unrealistic choices. In 
both cases the true VSLY might be somewhat elusive. 
Revealed preference methods are generally preferred due to concerns 
about the accuracy and consistency of stated preference approaches and 
the conceptual superiority of data based on actual, real world, binding 
market transactions. While revealed preference data may also be subject 
to measurement error, the stated preference survey operator has a high 
burden of proof to satisfy before the results can be seen as meaningful. 
If people are unable to reveal their WTP for particular options through 
their purchases or by their behaviour, the only option for estimating WTP 
may be by asking them questions. Well designed stated preference 
models may be the only option available if, for some reason, a particular 
valuation is desired in relation to a specific intervention. For example, it 
may be desired to stratify toll road charges by the time of day (and 
week/month) travelled and in different road conditions (eg, rain/shine), 
in order to maximise the extraction of consumer surplus from toll road 
users. 
However, while stated preference models provide the opportunity to 
collect such specific (and stratified) information for particular types of 
variables (eg, travel time), their value is less clear in relation to the 
broader purpose of valuing life if, at the end of the day, there would be 
limited stratification of the intervention, as is mostly the case in publicly 
provided or financed interventions, due to equity or other policy 
objectives. 
A mixture of revealed preference and stated choice modelling (the latter 
pivoted from revealed preference) may be the best way to proceed (Rose 
et al, in press 2008).  
Assuming individuals are rational and fully informed, WTP valuations may 
differ depending on the base level of risk, the remaining time of healthy 
life remaining, and the health profile experienced. These a priori 
postulates are tested in the next chapter. 
> If an individual is risk averse, then the less health or safety that 
he/she possesses the less willing he/she is to risk some loss in health 
or safety for a monetary pay off. This is particularly so in health and 
safety as many risks are irreversible and not continuous.  
> The less time an individual has (eg, the older the individual) then the 
less willing the individual is to risk some loss in health for a monetary 
pay off. Again, this is particularly so if the time risked includes special 
life-moments such as Christmas or a grandchild’s birthday. 
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> The WTP may be dependent on the previous health profile and the 
health to be experienced in the future. For example, if an individual 
will experience a lower level of health in the future, they may value 
perfect health now more than another individual who will experience 
perfect health now and in the foreseeable future.  
Interventions that deliver health and safety benefits also result in 
additional impacts not captured by QALYs or resource usage, but do 
result in increased welfare. For example, location of care close to friends 
and family and the process of care may improve the individual’s sense of 
respect and privacy, or reassurance from obtaining additional information 
about their prognosis. The WTP may not capture this additional benefit, 
although this should be taken into account in evaluation analysis.  
There is difference of opinion regarding how well people can internalise 
tiny risks, although Rizzi and Ortuzar (2006) found that ‘people can 
internalise risk, expressed as fatal crashes, in a consistent way from an 
economic point of view.’ 
Finally there remains controversy regarding whose preferences should be 
included. Principles of consumer sovereignty would suggest that the best 
valuation is provided by the individual affected, although there is also a 
case for including family and friends as well other members of society 
who may place social welfare value on a stranger’s wellbeing (Donaldson 
et al, 2006). 
Despite these theoretical and methodological issues there are numerous 
practical advantages in using WTP compared to other measures of health 
benefit. First, it enables a global view of the impact of health programs: 
it captures not only the health benefit per se, but can also capture the 
future health care costs avoided and increased productivity due to better 
health. It can also capture the value of health programs beyond the 
direct health outputs, and the WTP for externalities. Finally it fits into the 
framework of cost-benefit analysis used by many Government 
departments in the evaluation of their programs (transport etc), and thus 
facilitates decisions regarding the allocation of resources across a broad 
range of Government programs. 
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Chapter 4: VSL and VSLY Estimates from the 
Literature 
This chapter provides the findings from the literature review of VSL and 
VSLY estimates produced by 244 studies (17 Australian and 227 
international studies) between 1973 and June 2007. Estimates are split 
by sector and country, as significant differences exist. The chapter also 
analyses VSLY estimates, although only 19 studies (nine Australian and 
ten international studies) have been found that discuss such estimates. 
The studies are categorised as stated preference, revealed preference, 
mixed and other/unknown (which include studies where the VSL/VSLY 
used is based on other literature, is unknown, or is based on implicit 
valuation eg, from the evaluation of a funded program). 
The study findings are first simply presented by sector and country, also 
making observations about the type of study and its age. However, in 
calculating an appropriate value for Australian use in public sector cost 
benefit analysis and decision making, the poorer quality studies are 
excluded and a meta-analysis is performed using MIX software of the 
high quality studies (ie, more recent studies that have either a midpoint 
and standard deviation or other minimum-maximum range). A summary 
of the results from all VSL and VSLY studies can be found in Appendix A. 
Findings from the Literature 
An important consideration in using international literature was 
consideration of the conversion rates from different currencies and 
periods to 2006 Australian dollars. In each case purchasing power 
parities were used for the relevant years based on published tables from 
the OECD16. Australian estimates were inflated based on consumer price 
inflation. Only studies since the 1970s and from economies with similar 
GDP per capita were included in the analysis in order to minimise any 
potential impact from income effects. The economies included North 
American and European countries, Japan, South Korea, Taiwan and Hong 
Kong. 
Translating results from other countries, even if similar in income, to 
2007 Australian dollars in this manner may not be valid if there are 
different approaches to study methods or to intrinsic valuations due to 
cultural or ethnic factors. For example, Rizzi and Ortuzar (2006) offer 
both reasons as explanations of why their Chilean VSL values differ from 
figures obtained in developed countries – namely lower risk 
consciousness and risk aversion of drivers in Chile, together with ‘the use 
                                      
16 While some of the studies were from before 1988 these had been converted in 
the meta-analyses into years from 1988 onwards. Hence, only data from 1998 
were required (see Appendix A). 
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of stated valuation as well as stated choice in developed country 
valuations’, highlighting the ‘importance of conducting local studies 
rather than transferring imported values.’ 
It is relevant to some degree that Australians are culturally and ethnically 
diverse. It is also possible to stratify studies by broad methodological 
group, so the conversion was not considered inappropriate in this case 
and differences between countries were thus deemed in general to 
potentially reflect actual differences in preferences and potentially in 
VSL/VSLY. 
 
Health And Safety Sectors 
While the health sector is an obvious choice for the measurement of the 
value of a statistical life, only twelve studies (two Australian and ten 
international studies) produced VSL estimates from the health sector. 
Most studies (97 studies, including four Australian and 93 international 
studies) focused on occupational safety when producing VSL estimates. 
This is usually done by measuring the wage premium people require in 
order to accept an increased risk in occupational safety. 
As can be seen in Figure 4—1 and Figure 4—2, estimates for occupational 
safety vary significantly by country and are highest for the UK and Japan, 
but lowest for Taiwan, Korea and Hong Kong. The Australian estimate for 
VSL in occupational safety is very close to the international average, 
while the estimate for VSL in health is lower than the international 
average, which is strongly caveated due to the fact that only two findings 
were included and both were based on implicit measurement (see next 
section). 
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Figure 4—1  Range of VSL estimates (means) by study and 




































Figure 4—2  Range of VSL estimates (medians) by study and 
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Health 
The value of a human life that is applied in the health sector is relatively 
low. In 12 studies from Australia, Canada and the US, it ranged from 
A$0.2 to A$9.0 million and had a mean of A$4.0 million and a median of 
A$3.7 million. 
Australian VSL estimates 
In Australia, VSL estimates in the health sector were based on Abelson et 
al (2006), which in turn were based on values from the year 2003 of $1 
million and $2.5 million (2003 dollars). The $1 million figure (and 
$60,000 for VSLY) is based on DoHA (2003), which notes it ‘represents a 
conservative valuation of the estimated willingness to pay values for 
human life that are used most often in similar studies.’ (DoHA, 2003:11-
12). The $2.5 million estimate is based on Abelson (2003b). The mean 
(and median) in 2006 prices is A$2.02 million (Table 4—1). Abelson et al 
(2006:3-4) summarises: 
‘When the data are not age-specific, the study adopts a value of life lost 
of $2.5 million. This figure is based on Abelson (2003b), which provides a 
comprehensive survey of methods and results for valuing life. 
Traditionally Australian authorities put a value on life of about $1.0 
million (for example e NSW Roads and Traffic Authority 2004). This figure 
is based on a human capital valuation in that it represents the present 
value of future earnings foregone. 
‘However, as shown in Abelson (2003b), this approach is not consistent 
with economic valuation (willingness-to-pay or WTP) principles. The value 
of something, including life and health, is what individuals are willing to 
pay for it. In the case of life, the value of a life is derived from what 
individuals are willing to pay to reduce the risk of death. If people are 
willing to pay $2,000 on average to reduce the risk of death by 1 in 
1,000, the value of one life is $2.0 million (that is, $2,000 x 1,000). 
Drawing on WTP studies, most estimates of WTP values for life 
fall in the range of $2.5 million to $7.0 million. [emphasis added] 
 ‘When there are data on deaths by age group, we estimate the present 
annual value of the number of years lost. To do this, we need estimates 
of the value of life over a year, the number of years lost and a discount 
rate. To obtain an annual value of life, we convert the life value of $2.5 
million to an annual figure. Assuming that 40 years of life are foregone 
and that an individual’s real rate of time discount is 3%, a capital value 
of $2.5 million equates to the $108,000 per annum used in this report.17 
The average numbers of years lost for each type of foodborne illness is 
estimated using life tables.’ 
                                      
17 $2.5 million = $108,000/1.03 + $108,000/(1.03)2 + ...$108,000/(1.03)40 
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Table 4—1  VSL estimates for health, Australian studies, 2006 
A$million 










Abelson et al 2006 Other --- --- 1.15 --- 
Abelson et al 2006 Other --- --- 2.88 --- 
Other signifies implicit, based on other literature or unknown source. 
International VSL estimates 
International (ie, US and Canadian) VSL estimates were based on a mix 
of stated and revealed preference methods (ie, higher quality data than 
Australia), averaging A$4.3 million but with substantial variation, 
between A$0.2 million and A$9.0 million (Table 4—2). The median was 
A$4.4 million. There was not much difference between US and Canadian 
studies, which had a median of A$4.4 million and A$4.5 million 
respectively. Post-1990 studies had a higher median VSL (A$4.7 million) 
than studies before 1990 (A$2.0 million). 
Table 4—2  VSL estimates for health, international studies, 2006 
A$million 

















US/Canada Mixed 0.20 9.00 4.32 4.43 --- 
US studies 1973-
2000 
US Mixed 0.20 8.69 4.27 4.43 --- 
Canadian 
studies 










US/Canada Mixed 0.20 6.01 2.73 1.99 --- 
Mixed signifies a combination of stated and revealed preference methods 
VSLY estimates 
The only VSLY estimate for the health sector was based on an Australian 
study for DoHA and had a value of A$108,000 in 2003 dollars (see 
citation above) which equates to A$124,378 in 2006 dollars, although 
Abelson et al (2006) conservatively did not inflate the 2003 estimate to 
2006 dollars. In line with the practice for other studies adopted in this 
report, we have converted to 2006 dollars (Table 4—3). 













Abelson et al 2006 Australia Other --- --- 124,378 --- 
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Occupational Safety 
Occupational safety and wage risk was the area that was analysed the 
most in the literature. In 97 international studies, VSL estimates ranged 
from A$0.3 million to A$117.0 million with a mean of A$11.1 million – 
the highest average VSL in the different sectors analysed – and a median 
of A$7.4 million. 
Australian VSL estimates 
In Australia, there was significant variation in the four VSL estimates for 
OHS, ranging from A$2.9 million to A$28.4 million with a mean of A$11.2 
million and a median of A$6.8 million (Table 4—4). However, excluding 
Miller et al’s study, which had an outlier VSL of A$28.4 million, the mean 
VSL for the three remaining Australian studies was A$5.5 million, which is 
lower than the mean VSL from the 97 international studies. The median 
was A$6.6 million. 
Table 4—4  VSL estimates for occupational safety, Australian 
studies, 2006 A$million 










Kniesner & Leeth 1991 Revealed --- --- 6.90 2.77 
Miller et al 1997 Other --- --- 28.40 2.16 
NOHSC 2004 Other --- --- 2.87 --- 
Viscusi 2005 Revealed --- --- 6.63 --- 
International VSL estimates 
VSL estimates for occupational safety from the 97 international studies 
had a mean ofA$11.1 million and a median of A$7.6 million (Table 4—5). 
The 54 US studies produced a mean VSL of A$10.7 million which was 
slightly lower than other studies (A$11.6 million), although the US 
median was higher (A$9.0 million, compared with A$6.4 million in other 
studies). Post-1990 studies produced a higher mean and median VSL 
(A$12.1 million and A$7.9 million) than pre-1990 studies (A$9.4 million 
and A$6.9 million). 
Table 4—5  VSL estimates for occupational safety, international 
studies, 2006 A$million 

















Multiple Mixed 0.32 117.04 11.08 7.59 --- 
US studies 1974-
2006 










Multiple Mixed 0.32 117.04 12.06 7.94 --- 
Pre-1990 studies 1990-
2007 
Multiple Mixed 0.47 25.93 9.44 6.90 --- 
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VSLY estimates 
Six studies (one Australian, one UK and four US studies) discussed VSLY 
estimates for occupational safety. Estimates varied between A$93,187 
and A$3.57 million per life year and had a mean VSLY of A$996,027 and 
a median of A$810,254 (Table 4—6). The Australian NOHSC policy study 
was based on what was assessed to be at the conservative end of the 
spectrum of WTP VSLY estimates, and the UK study was based primarily 
on compensation payments (ie, not WTP). While the 1990 Moore and 
Viscusi estimates are listed as ‘Other’, they are likely to be based on 
revealed preference, given the authors’ other work. 
 













NOHSC 2004 Australia Other --- --- 119,589 --- 
Davies & Teasdale 1995/6 UK Other --- --- 93,187 --- 
Moore & Viscusi 1990 US Other --- --- 1,167,20
7 
--- 
Moore & Viscusi 1990 US Other --- --- 1,500,47
0 
--- 
Moore & Viscusi 1988 US Revealed 424,870 481,730 453,300 --- 








Other sectors that use evaluation measures to evaluate programs and 
determine funding priorities include transport safety, environmental 
hazard control, crime prevention, fire safety and others. 
VSL in transport safety was discussed in 69 studies (four Australian and 
65 international studies), while a further 21 studies (two Australian and 
19 international studies) discussed VSL in environmental hazard control. 
The remaining 49 studies (five Australian and 44 international studies) 
are based on VSL estimates in other specified or unspecified sectors. 
As was the case with VSL estimates in health and occupational safety, 
VSL estimates in environmental protection, transportation and other 
sectors also vary by country. Again, UK estimates in environment and 
other sectors are much higher than those of other countries, while UK 
VSL estimates in transport safety are close to the average. France and 
Canada are the two countries with the highest VSL estimates when it 
comes to transport safety. Australia has lower than average VSL 
estimates in environment protection, transport safety and other sectors 
(Figure 4—3 and Figure 4—4). 
The Health of Nations: The Value of a Statistical Life 
Australian Safety and Compensation Council, [March 2008] 57 
Figure 4—3  Range of VSL estimates (means) by study and 




















































Note: ‘Other’ includes Consumption, Crime, Fire Safety and Mixed Studies 
Figure 4—4  Range of VSL estimates (medians) by study and 

















































Note: ‘Other’ includes Consumption, Crime, Fire Safety and Mixed Studies 
Transport 
Transportation imposes negative externalities on society (such as fatal 
and non-fatal accidents and air pollution) and governments often place a 
value on these externalities when evaluating programs to alleviate the 
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impacts. While road improvements are often aimed at reducing fatalities, 
not all road engineering treatments are aimed only at increasing road 
safety. Many have reduced travel times as the primary objective. 
Values for international VSL estimates in transport ranged from A$0.2 
million to A$50.8 million with a mean of A$7.9 million and a median of 
A$5.4 million.  
Australian VSL estimates 
VSL estimates in the four Australian transport studies included were 
lower than VSL estimates in international transport safety. In 2006 
dollars, they ranged from A$1.3 million to A$5.4 million and had a mean 
of A$3.0 million and a median of A$2.5 million (Table 4—7). The CASA 
estimate was provided by CASA based on current practice; the hybrid 
approach of the Australian Transport Council and BTE studies is discussed 
in Section 3.5; while the Black Spot Program estimate is implicit, based 
on evaluation of the program. Note that studies using ‘other’ valuation 
are excluded from the meta-analysis due to lower quality and to avoid 
the potential problem of determining future policy from past policy rather 
than from empirical evidence. 
Table 4—7  VSL estimates for transport safety, Australian 
studies, 2006 A$million 










CASA 2006 Other --- --- 3.00 --- 
Australian Transport 
Council 
2000 Other --- --- 1.99 --- 
BTE 2000 Other 1.29 1.80 1.55 --- 
BTE - Black Spot 
Program 
2001 Other --- --- 5.41 --- 
International VSL estimates 
VSL estimates from the 65 international studies varied between A$0.2 
million and A$50.8 million and had a mean of A$8.2 million and a median 
of A$5.4 million (Table 4—8). With A$6.4 million and $4.7 million, the 27 
US studies had slightly lower mean and median VSL estimates than the 
other international studies (A$9.5 million and $7.0 million respectively). 
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Table 4—8: VSL estimates for transport safety, international 




















Multiple Mixed 0.24 50.83 8.19 5.41 --- 
US studies 1973-
2006 
US Mixed 0.24 50.83 6.39 4.74 --- 




Multiple Mixed 0.24 50.83 9.47 6.95 --- 
Post-1990 studies 1990-
2007 
Multiple Mixed 0.24 50.83 8.34 3.23 --- 
Pre-1990 studies 1973-
1989 
Multiple Mixed 0.24 34.02 6.48 5.41 --- 
VSLY estimates 
VSLY in transport safety was analysed in four studies, with a median of 
$123,755. The two Australian ones were A$87,611 and A$131,993 and 
had a mean and a median of A$109,802 (neither are WTP studies), while 
the international studies varied between A$84,450 and A$884,487 with a 
mean and median of A$442,747, with the revealed preference study 
markedly higher (Table 4—9). 













CASA 2006 Australia Other --- --- 131,993 --- 
BTE 2000 Australia Other 74,727 100,495 87,611 --- 
Donaldson 2006 UK Other 84,450 146,582 115,516 --- 
Dreyfus & 
Viscusi 
1995 US Revealed 655,468 884,487 769,978 --- 
Environmental Protection 
Several government departments, such as the environmental protection 
agencies (EPAs), use a wide range of values in estimating the health 
benefit of reducing emissions and other environmental toxins in other 
industries. 
VSL estimates from the 21 studies (including two Australian and 19 
international studies) ranged from A$0.1 million to A$132.9 million and 
had a mean of A$11.2 million and a median of A$8.1 million. However, 
the extreme values were mainly due to a single study by Kochi et al 
(2006). Excluding this study, VSL estimates were a narrower, but still 
broad, range from A$0.9 million to A$31.4 million, with a mean of A$8.5 
million and a median of A$7.8 million. 
Australian VSL estimates 
VSL estimates used for environmental protection in Australia tended to 
be lower than their international counterparts, ranging from A$0.9 million 
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to A$7.2 million with a mean and median VSL of A$4.2 million (Table 4—
10). 
Table 4—10  VSL Estimates for environmental protection, 
Australian Studies, 2006 A$million 










Bryant et al. 1992 Other 0.86 1.43 1.15 --- 
RCG/Hagler 
Bailey 
1994 Other --- --- 7.21 --- 
International VSL estimates 
VSL estimates from the 19 international studies ranged from 
A$0.1 million to A$132.9 million and had a mean of A$12.0 million and a 
median of A$9.8 million. Most studies using VSL for environmental 
protection are US-based – only Kochi et al (2006) looks at the UK and 
Japan (as well as the US). US studies ranged from A$0.9 million to 
A$13.6 million with a mean of A$7.5 million and a median of 
A$8.9 million. US EPA valuations of a statistical life ranged from 
A$2.7 million to A$10.3 million, although the majority of EPA values were 
above A$8 million, which explains the mean of A$8.5 million and higher 
median – A$9.9 million (Table 4—11). 
Table 4—11  VSL estimates for environmental protection, 




















Multiple Mixed 0.14 132.8
5 
11.96 9.79 --- 
All international 
studies (excl. Kochi 
et al. 2006) 
1981-
2006 
Multiple Mixed 0.85 31.44 8.93 8.92 --- 
US studies 1981-
2006 
US Mixed 0.85 13.61 7.48 8.92 --- 
Other studies (excl. 
US) 
2006 Multiple Mixed 0.14 132.8
5 
24.49 13.08 --- 
Post-1990 studies 1990-
2006 
Multiple Mixed 0.14 132.8
5 
14.31 9.95 --- 
Pre-1990 studies 1981-
1989 
US Mixed 0.85 7.58 3.14 2.06 --- 
EPA studies 1985-
1999 
US Revealed 2.69 10.26 8.53 9.87 --- 
VSLY estimates 
Four studies looked at the VSLY in the context of environmental 
protection, with a median of A$155,327. While the only international 
study produced a VSLY as high as A$242,994 for the US, the three 
Australian studies averaged A$172,838, varying between A$32,609 and 
A$418,244 (Table 4—12). However, the Bryant et al (1992) study was a 
human capital ‘hybrid’ (like the BTE approach) and the NHMRC study 
(type unknown) is, given the period, also unlikely to be a WTP study. 
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Bryant et al. 1992 Australia Other 24,638 40,580 32,609 --- 
NHMRC 1993 Australia Other  --- --- 67,660 --- 
RCG/Hagler Baily 1994 Australia Other ---  ---  418,244 --- 
Ackerman & 
Heinzerling 
2004 US Other --- --- 242,994 --- 
Others 
VSL estimates are also derived from other areas including consumer 
choice, crime and fire safety. Estimates that are based on mixed study 
areas – particularly those from meta-analyses – are also included in this 
section. Again there is substantial variation between the VSL estimates 
from 44 studies analysed, from A$0.7 million to A$84.7 million with a 
mean of A$8.5 million and a median of A$6.0 million. 
Australian VSL Estimates 
Australian VSL estimates in other sectors vary between A$1.5 million and 
A$17.7 million and had a mean of A$5.5 million and a median of A$2.2 
million (Table 4—13). None were classified as revealed or stated 
preference approaches. 
Table 4—13  VSL estimates in other sectors, Australian studies, 
2006 A$million 














1990 Other --- --- 1.50 --- 
Mayhew 2003 Other --- --- 2.18 --- 
Mayhew 2003 Other --- --- 1.74 --- 
Miller 2000 Other 3.66 5.41 4.67 --- 
International VSL estimates 
As in most of the previous sections, international VSL estimates tended 
to be higher than their Australian counterparts, ranging from A$0.7 
million to A$84.7 million with an average of A$8.9 million and a median 
of A$6.5 million (Table 4—14). 
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Table 4—14  VSL estimates in other sectors, international 




















Multiple Mixed 0.66 84.70 8.90 6.50 --- 
US studies 1977-
2007 
US Mixed 1.02 42.27 11.77 8.26 --- 




Multiple Mixed 0.66 84.70 7.35 5.40 --- 
Post-1990 studies 1973-
1989 
Multiple Mixed 1.02 42.27 8.03 6.20 --- 
Pre-1990 studies 1990-
2007 
Multiple Mixed 0.66 84.70 10.50 5.36 --- 
VSLY estimate 
Three studies looked at VSLY estimates in other sectors with values for a 
life year ranging from a very low A$10,089 to A$107,924 and a mean of 
A$66,355 and a median of A$65,674 (Table 4—15). None were classified 
as revealed or stated preference approaches. 
















1990 Australia Other  ---  --- 65,674  --- 
Mason et al. 2003 UK Other 53,878 94,892 74,385 --- 
Baker et al. 2003 Multiple Other 10,089 107,924 59,007 --- 
Summary Of Simple Analysis 
Based on 244 studies analysed, the mean VSL estimate was A$9.4 million 
and the median was A$6.6 million. However, the 17 Australian estimates 
included had a lower mean (A$5.7 million) and median (A$2.9 million), 
reflecting the large number of implicit valuations in the Australian group 
(there were only two estimates based on revealed preference and none 
based on stated preference in Australia) and the small sample size. In 
contrast, the remaining 227 international studies had a mean of A$9.6 
million and a median of A$6.7 million (Table 4—16, Figure 4—5 and 
Figure 4—6). 
VSL estimates varied significantly by study area: a statistical life had a 
mean value of A$11.1 million and a median of A$7.4 million when it 
came to occupational safety, but only A$4.0 million and $3.7 million for 
health. 
Although the VSL has been analysed in many different studies, analyses 
focusing on the VSLY are much rarer. Only 19 studies were found where 
the VSLY was explicitly reported in the study – this is due in part to the 
fact that many studies have been framed in terms of preventing fatalities 
so only the VSL is reported (and rarely the mean age of the source group 
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from which to derive a VSLY). Those had a mean VSLY estimate of 
A$433,437 (Table 4—16) and a median of A$119,589, which was 
strongly influenced by the nine Australian estimates of which many were 
based on implicit valuation (around one third of the 19 studies included 
were Australian implicit valuation estimates). The Australian mean VSLY 
was only A$124,095 (median A$87,611). The ten international studies 
produced a much higher average VSLY (mean of A$711,845 and median 
of A$348,147) due to the different (higher quality) methods. 
Table 4—16  Summary of VSL and VSLY estimates 







Mean 4.0 11.1 7.9 11.2 8.5 9.4 
Media
n 




0.2-9.0 0.3-117.0 0.2-50.8 0.1-132.9 0.7-84.7 0.1-
117.0 
Mean 2.0 11.2 3.0 4.2 5.5 5.7 
Media
n 
2.0 6.8 2.5 4.2 2.2 2.9 
Australian VSL, 
2006A$m* 
Range 1.2-2.9 2.9-28.4 1.3-5.4 0.9-7.2 1.5-17.7 0.9-28.4 
Mean 4.3 11.1 8.2 12.0 8.9 9.6 





0.2-50.8 0.1-132.9 0.7-84.7 0.1-
132.9 










123,755 155,327 65,674 119,58
9 












* Australian estimates are influenced by a large proportion (over half) of implicit valuation (policy-
based) studies. 
The Health of Nations: The Value of a Statistical Life 
Australian Safety and Compensation Council, [March 2008] 64 
Figure 4—5  Summary of VSL estimates (means) by sector and 



























Figure 4—6  Summary of VSL estimates (medians) by sector and 

























Although the mean VSL was estimated to be around A$9.4 million, 
almost two-thirds of VSL estimates are below A$9 million, while nearly 
half of them are below A$6 million (the median was A$6.6 million). Only 
5% of studies had a VSL of A$30 million or higher (Figure 4—7 below). 
Note that, in the figure, the horizontal axis switches from a ‘single 
million’ scale up to A$30 million to three broader groups thereafter to 
condense the long right tail.  
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Compared to estimates from other countries, and reflecting the large 
number of implicit valuation estimates, Australia’s mean VSL from the 
studies was in the lower third of the range – only greater than the 
average for Denmark, Hong Kong, South Korea and Taiwan. Countries 
such as the UK and Japan had average VSL estimates that were three 
times as high as that for Australia (Figure 4—8). In the UK, for example, 
13 studies (50%) were revealed preference, seven were stated 
preference and only six were ‘other’. Table 4—17 shows the ranges of 
VSL estimates by country and study area. 
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Table 4—17  Ranges of VSL estimates by country, 2006 A$million 












Australia 17 1.2-2.9 2.9-28.4 1.3-5.4 0.9-7.2 1.5-17.7 0.9-28.4 5.7 2.9 
Austria 5 --- 2.6-13.2 --- --- 5.4-13.2 2.6-13.2 9.0 8.2 
Canada 17 2.7-9.0 0.8-7.8 0.7-41.1 --- 3.7-14.5 0.7-41.1 7.3 5.0 
Denmark 2 --- --- 1.3-1.9 --- 6.6-8.7 1.3-8.7 4.3 4.3 
Europe 1 --- --- 5.4 --- --- 5.4 5.4 5.4 





1 --- 2.7 --- --- --- 2.7 2.7 2.7 





10 --- --- 1.1-21.4 --- 2.8-4.2 1.1-21.4 7.0 5.3 
South 
Korea 
6 --- 1.3-2.5 --- --- 0.7-1.3 0.7-2.5 1.6 1.5 
Sweden 7 --- --- 2.1-44.1 --- 2.1-6.8 2.1-44.1 7.9 5.6 
Switzerlan
d 
5 --- 10.0-13.6 1.4-1.7 --- 7.3-12.9 1.4-13.6 6.8 7.7 
Taiwan 7 --- 0.3-2.9 --- --- 1.4-1.9 0.3-2.9 1.7 1.7 





US 117 0.2-8.7 0.5-32.9 0.2-50.8 1.1-13.6 1.0-42.3 0.2-50.8 9.0 7.1 












Mean --- 4.0 11.1 7.9 11.2 8.5 9.4 --- --- 
Median --- 3.7 7.4 5.4 8.1 6.0 6.6 --- --- 
Comparing different methodologies, studies based on the revealed 
preference approach produced slightly lower VSL estimates (mean of 
A$9.6 million, median of A$7.5 million) compared to studies based on the 
stated preference approach (mean of A$11.2 million, median of A$7.9 
million) (Figure 4—9). However, many of the studies could not be 
classified and fell into the ‘Other’ category, of which more were lower 
(implicit) value studies (mean of $8.7 million, median of $5.4 million). 
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As was the case with VSL estimates, VSLY estimates from the 19 studies 
that reported these varied significantly by country. While Australian 
studies produced an average VSLY of A$0.12 million, US studies 
estimated it to be an average of A$1.1 million. The international average 
was A$0.43 (Figure 4—10). In this case the variation can quite clearly be 
accorded to the nature of the studies included. In the case of Australia 
and the UK, all 12 studies are ‘other’ in type and all the Australian ones 
are policy-based estimates. In contrast, of the US studies, at least half 
and it appears five of the six are revealed preference studies. 
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Meta-Analysis of Selected Studies 
In order to get a better idea of the appropriate VSL estimate, a meta-
analysis was conducted using MIX (Meta-Analysis with Interactive 
Explanations) 1.61 software, since it is an easy-touse package validated 
by Bax et al (2006). 18 
Meta-analysis is a statistical technique that enables the calculation of a 
best estimate of a parameter from multiple studies. Either fixed effect or 
random effect models can be used. In this case a random effect model 
was used as this is appropriate when there is not one ‘true’ effect (the 
singular parameter in the fixed effect model) but rather there is certain 
(random/stochastic) distribution of effects that have produced the 
empirical values of the studies. This means that the expected variability 
among these empirical values is based on more than just sampling error 
(the latter is the case in fixed effect models). This extra variability is 
often described as ‘variability due to an unexplained variable’ and makes 
the interpretability of the resulting statistic no longer similar to the 
initially defined outcome parameter. Random effects models produce 
wider confidence intervals that are probably more realistic, particularly 
when measuring VSL from studies where age is likely to be the 
underlying ‘unexplained variable’ 
In a meta-analysis the empirical values of each study are weighted 
according to their informativeness of the produced data. The variance of 
the empirical values is used as an inversely related measure of 
informativeness (ie, the larger the variance, the smaller the 
informativeness). Inverse variance plus τ is the only random effects 
weighting method in the MIX program and was developed by 
DerSimonian and Laird. The weighting statistic is produced by adding ‘τ’ 
as an estimate of the variance of the parameter distribution (in the 
random effects approach the parameter of interest is assumed to have a 
normal distribution with variance τ). The τ is 0 when the heterogeneity 
statistic Q is smaller than it degrees of freedom, in which case the fixed 
effect inverse variance approach produces the same results as the 
random effects approach. 
The meta-analysis consisted of including or excluding studies on the basis 
of quality and comparability criteria, pooling the results from included 
studies and then reporting on the findings. The inclusion/exclusion 
criteria were as follows: 
1 Recency: only studies from 1980 onwards were included. The reason 
for this criterion was that uncertainty regarding the conversion to current 
US dollars and potential income effects is likely to be larger with the 
oldest studies. Thus 18 studies before 1980 were excluded. 
                                      
18 How to use MIX software to conduct meta-analysis is discussed on 
http://www.mix-for-meta-analysis.info/. 
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2 Reported range or standard deviation: it was considered desirable to 
include studies that reported a range or point estimate with a standard 
deviation, in particular given the software used to conduct the meta-
analysis, rather than just a point estimate alone, since a point estimate 
alone tends to impart a false sense of precision into the random effects 
model used19 and may also be indicative of poorer quality studies. 
Indeed, application of this criterion eliminated many of the implicit 
valuation studies (which also helps to remove the circularity effect of 
future policy being based on speculative past policy, again enhancing the 
quality of the estimate). Thus 111 studies that just reported a point 
estimate were excluded. 
3 Outliers: a few studies that report exceptionally high or low estimates, 
or exceptionally high standard deviation, were also considered to be of 
dubious quality. The specific studies excluded are summarised below, 
with rationale for their exclusion.  
> Bellavance et al (2007) reported four sub-studies where the standard 
deviation was over 70% of the point estimate in the US, over 80% in 
Australia and the UK and over 100% in Canada. 
> Kochi et al (2006) reported six sub-studies where the standard 
deviation averaged over 60% and the estimates were considerably 
higher than other comparable studies (see Section 4.1.2.2, for 
example). 
> There were three inexplicably high studies relative to their comparable 
groups – Arabsheibani and Marin (2000) and Sandy et al (2001) in 
the UK; and a 1999 EPA study in the US. The latter two also had high 
standard errors. 
> There were three unusually low studies relative to their comparable 
groups – Knieser and Leeth (1991) in the US; Bryant et al (1992) in 
Australia; and Miller (2000) in South Korea. 
Thus in total 16 outlier studies were excluded. 
Note that a sub-study of a different population, in a different country or 
of a different type (and thus generating a different estimate) is the unit 
of observation, although naturally some may be written up in the same 
publication. 
The remaining 99 of the original 244 studies were considered suitable to 
pool in the meta-analysis and these studies are highlighted in bold in the 
table at Appendix A. Those studies had a mean of A$9.4 million and a 
median of A$7.1 million, hence VSL estimates are similar to the overall 
sample. In the meta-analysis, the VSL was estimated to be A$6.0 million 
with a 95% lower confidence limit of A$5.4 million and a 95% upper 
confidence limit of A$6.7 million (see results in the following box). 
                                      
19 Recall that the reciprocal or inverse variance is used to weight the data. 
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Figure 4—11 presents the forest plot that charts the empirical values (red 
dots) on the x-axis together with the confidence intervals of the 99 
studies analysed, thus showing the relative differences between the 
results of the studies included in the meta-analysis. The size of the dots 
varies with the relative size of the weights of the studies in the analysis, 
but since the weights range from 0.01% to 2.13% for each of the 
studies, the dots appear to be of same size. Weights were automatically 
generated by the meta-analysis software as ‘Inverse Variance + t’ using 
random effects estimation. The bottom grey diamond refers to the pooled 
value. 
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Figure 4 – 11 Standard Forest Plot, Random Effects 
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The underlying methodology is crucial to the VSL estimate and – as it has 
been pointed out in previous studies (see, for instance, Ashenfelter and 
Greenstone, 2004) – omitted variables and publication bias may distort 
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results. These are explored below, and found not to be a problem in this 
analysis. 
Testing for publication bias: One way of assessing the presence of 
publication bias is to examine a funnel plot (Figure 4—12). Funnel plots 
display the studies included in the meta analysis in a plot of effect size 
against sample size. As smaller studies have more chance of variability 
than larger studies, the expected picture is one of a symmetrical inverted 
funnel. As VSL values are not negative, studies are clustered on the 
positive side. In this case, estimates with lower VSL values appear to 
have lower standard errors and the plot indicates an absence of 
publication bias. 
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Testing for exclusion sensitivity: Figure 4—13 is an exclusion sensitivity 
plot that shows the estimated VSL is not sensitive to the exclusion of 
single studies. In this case, there are no obvious outliers and excluding 
single studies does not affect the overall result significantly (ie, the value 
after exclusion remains within the confidence intervals of A$5.4 million 
and A$6.7 million). Excluding the most extreme studies leads to the 
following results: Hansen and Scuffham (1995) increases the VSL to 
A$6.3 million (with a minimum of A$5.6 million and a maximum of A$7.1 
million), while excluding Miller et al (1997) reduces the VSL to 
A$5.7 million (with a minimum of A$5.0 million and a maximum of A$6.3 
million). 
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Figure 4—13 Exclusion Sensitivity Plot 
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To summarise, the mean from the meta-analysis of quality studies was 
$6.0 million with a range from the exclusion sensitivity plot of $5.0 
million to $7.1 million. This provides a robust and replicable method for 
estimating an appropriate average VSL range for Australia and similar 
countries. 
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However, because of the greater variability shown across all the source 
studies, particularly across sectors, the suggested range is based on the 
‘raw’ study median values, which ranged from $3.7 million in the health 
sector to $8.1 million in the environment sector. 
Discussion and Conclusions 
A feature of the ‘raw’ VSL estimates presented above was the variation 
that reflects the fact that the people who were undertaking the studies 
were of different ages. A 65 year old worker could be expected to report 
a VSL around half that of a 15 year old worker, for example, in a wage-
risk study. Unfortunately in most studies the average age of the subjects 
of the study was not able to be determined (noting that the random 
effects meta-analysis was able to account for age and other variation). 
There were only a relatively small number of VSLY studies located and 
only three of these were known to be revealed preference studies 
(preferred). The differences in VSL and VSLY estimates that we could 
analyse from the literature reflected country and year of study (income 
and birth-year cohort effects) and methodology (sector, broad type of 
study). Variations that we were unable to analyse, but which may have 
contributed to the variation, include factors such as detailed methodology 
(eg, WTP compared to willingness to accept), the probability of death or 
harm (ie, risk) and how accurately people perceive it, private compared 
to public safety (relevant for transport safety) and the purpose of study 
(scholarly vs policy).  
De Blaeij et al (2003), for instance, found in their meta-analysis of 30 
international studies evidence that policy studies produced lower VSL 
estimates than scholarly studies, that studies based on stated preference 
methodology produced higher VSL estimates than studies based on 
revealed preference methodology (as we found, although the 
differencewas not great) and that, in the case of transport safety, private 
safety measures produced a higher VSL estimate than public safety 
measures (because of the free-rider problem inherent in relation to public 
goods). Aldy and Viscusi (2006) further argue that the VSL is not only 
determined by age, but also by birth-year cohort effects and the life-
cycle consumption pattern. 
Different Methodological Approaches, Similar Answers? 
A common question is, if stated and revealed preference methods yield 
similar findings, does this validate the robustness of the estimates? 
Interestingly the stated and revealed preference estimates in the studies 
included in this literature review were found to be very similar; however, 
this appears in our view to be coincidental, although the hypothesis could 
be tested econometrically. Although regression analysis was beyond the 
scope of this study, it may be useful if the key control variable (mean age 
at the time of the study) were able to be identified from the studies 
(noting this may not be possible) given further investigation. There were 
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no stated preference studies underlying the 19 VSLY estimates to 
compare with the revealed preference estimates although again, further 
research may uncover a greater number of VSLY estimates in the future, 
including stated preference estimates, from which econometric analysis 
would be recommended. 
The problem is one of multi-dimensional heterogeneity that single 
dimensional comparisons or single equation models do not handle well. 
Shogren and Stamland (2006) addressed this using a general method of 
moments approach that uses functional relationships between underlying 
parameters and observed data, to estimate a person’s WTP for mortality 
risk reduction. This approach yielded consistent estimates and performed 
well even when combining data from different sources that was sampled 
at different low frequencies. 
A similar research approach extended to morbidity as well as mortality is 
suggested for consideration in Australia over the longer term – namely, 
an extended search for parameters within existing studies in order to 
econometrically estimate functional parameters, and the estimation 
across sectors of WTP using revealed and carefully formulated stated 
choice studies, to provide further information on VSLY. 
Age-Gender Patterns 
Aldy and Smyth (2006) claim that VSL and hence VSLY estimates vary by 
age (following an inverted-U shape over the life cycle), as per Figure 4—
14. Other studies have not reported an n-curve in the VSLY (nor hence in 
the VSL) but, instead, a downward-sloping VSL and flat VSLY (Figure 4—
15). 
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Note: Hypothetical scales. 

































Note: Hypothetical scales. 
The n-curve was modelled by Mason et al (2005) taking into account 
factors other than future life expectancy (such as a basic value of living), 
and thus continues to place a significant value on an individual who only 
has a few days of life left to live. Suppose Mi is the ith individual’s 
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marginal rate of substitution of wealth for risk of death, Ei is the ith 
individual’s life expectancy, and u is the error rate. 
                                       Mi = α+ β* Ei 
The Mi-versus-age has been found to be an inverted U-shape, peaking in 
middle age. To estimate α (the basic value of living), the value of M of an 
80 year old individual (with assumed zero expected life expectancy) was 
used. Then β (the VSLY) can be estimated by taking the difference 
between Mi of a 40 year old and the 80 year old, taking into account 
expected life expectancy. The final model provided a distribution of the 
VSL depending on the remaining life expectancy. More complex functional 
forms can also be used where α may depend upon the age of the 
individual, and the relationship to life expectancy is not linear. 
Bruce and Halvorsen (2006) provide a useful summary of the state of 
play as follows: 
‘Attempts to empirically determine the relationship, if any, between VSL 
and age have been inconclusive. In a stated preference study cited by 
the EPA as supporting lower VSLs for the elderly, Jones-Lee et al (1985) 
obtained evidence that VSL was positively related to age and negatively 
related to age-squared, but the results were not consistently significant 
statistically. Also using the stated preference approach, Johannesson, 
Johansson and Löfgren (1997) obtained an inverted-U relationship and 
estimated that the VSL at age 60 is about four-fifths that of age 40 and 
the VSL at age 70 is about two-thirds that of age 40. 
‘While most stated preference studies have investigated individuals’ 
valuations of risks to themselves, Cropper et al (1994) investigated the 
general public’s preferences for saving persons of different ages. They 
asked respondents to choose between two programs, one of which would 
save 200 younger persons (either 20 or 40 years old) and a given 
number (ranging from 100 to 6,000) of 60- year olds. Their results 
indicate an inverted-U relationship, with the most preferred age to save 
lives being 28. The median number of 60-year-olds who are equivalent to 
one younger person is approximately seven, with the results largely 
unaffected by whether the younger age was specified to be 20 or 40. The 
responses were also not found to be significantly affected by the age of 
the respondents. 
‘Revealed preference studies have also found some evidence of an 
inverted-U shape for the VSL. Viscusi and Aldy (2006) note that of eight 
studies of labor markets that included an age-mortality risk interaction, 
five obtained statistically significant evidence of a U-shaped relationship. 
However, the results are often improbable, implying negative VSLs 
beginning at relatively low ages. Using age group specific mortality risk 
data, Viscusi and Aldy (2006) obtain more plausible results. They 
estimate that the VSL is highest for the 35-44 age group and that the 
VSLs for the 45-54 and 55-62 age groups are three-fifths and two-
fifths,respectively, of the VSL for the 35-44 age group.’ 
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Those who have not found the curve have suggested that it may be due 
to sample bias (eg, the inclusion of people under analysis who might are 
in the middle age group and hence value their own lives more than 
others – see Section 3.3.1) or due to a greater breakdown of the 
Walrasian framework (in particular information and rationality) for the 
very young and very old, or both. 
An important issue is that the magnitude of age differences, where the n-
curve has been found, has not been that substantial, so it may be a 
second order issue. Murphy and Topel (2005) mathematically derive the 
function of the VSL curve showing the predominantly downward slope of 
the curve (Figure 4—16). The VSL curve for females is slightly higher 
than for males at all ages due to higher life expectancy for women. 
The Murphy and Topel model is elegant in its mathematical formulation – 
so elegant that it is tempting just to plonk in an agreed VSL (with high 
and low sensitivities) and adopt it lock, stock and barrel. Indeed, after 
providing the rationale for the VSL that they adopt, the authors advocate 
this (Murphy and Topel, 2005:20). 
‘According to Viscusi’s (1993) survey, this literature yields a ‘reasonable 
range’ of values for Vλ(a) of US$4 million to US$9 million per statistical 
life, expressed in current (2004) dollars, while Viscusi and Aldy (2003) 
provide a tighter range for US data at US$5.5 to US$7.5 million. 
Government agencies and panels regularly update these estimates to 
account for economic growth, new methods, and evidence; for example 
since 1999 the Environmental Protection Agency used a value of US$6.3 
million per statistical life in its cost benefit analyses (Dockins et al, 
2004). These estimates are typically founded on regression analyses of 
risk income tradeoffs for working-age individuals, so for the calculations 
that follow we will assume that the survivorship-weighted average value 
of a statistical life for individuals between the ages of 25 and 55 is 
US$6.3 million. Readers who prefer a different value may adjust things 
accordingly, as most of our later estimates are scalable.’ 
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Figure 4—16  Murphy and Topel relationship between VSL and 
age 
 
However, the only point of contention might be that the lifecycle 
calibration of utility (v(t)) is determined wholly by income and 
consumption patterns. Despite the sophistication of the modelling, and 
while utility that is not income or consumption is valued (since the 
hedonic WTP is used for the VSL), the pattern of such utility is not 
captured in the shape or, more specifically, is presumed to follow the 
same patterns as income and consumption. The value to children of 
playing, or to the elderly of chatting with friends, is missed. 
Socioeconomic Status And Ethnicity 
Safety is a normal good, meaning that those with higher income have a 
higher WTP (or less of a budget constraint), resulting in higher VSL. The 
sensitivity of VSL to income has been shown in at least three individual 
studies (Viscusi and Evans, 1990; Persson et al, 1995; Jones-Lee et al, 
1987) and in a meta-analysis conducted by Miller (2000). This also 
explains why VSLY estimates in developing countries are so much lower 
than those in developed countries. 
Society’s willingness to pay is linked to people’s ability to pay. As noted 
earlier, poorer people have a different risk-cost trade-off than the more 
affluent; this is a reflection of their actual preferences. Viscusi and Aldy 
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(2003) found that a 10% increase in one’s income will raise the VSL by 
5% to 6% (using hedonic wage methods) and others have also quantified 
the extent of the elasticity – Aldy and Smyth (2006) show variation in 
VSLY by income and assets. 
This has many implications. In the private sector, it enables producers to 
target life-saving or life-enhancing innovations to higher income 
individuals – there is a strong correlation between low SES and poorer 
health outcomes across almost all therapeutic areas. Indeed, after age, 
SES is the prime single determinant of health status in Australia (noting 
that two way correlation may also be evident). In the public sector, does 
it then follow that the VSLY used in policies and regulations that reduce 
risks to higher income individuals should be higher than the VSLY for 
regulations that reduce risk for lower income people? This counters the 
equity externalities (recall Section 2.2.3) identified as the reason for the 
public intervention in the first place – discussed further in the discussion 
of policy implications in Section 5.1.3. 
Because income elasticity has been found to be positive, the US EPA has 
adjusted current VSL estimates for anticipated income growth over time 
(ie, increasing VSL over time to account for rising real income). However 
the EPA did not support adjustments to the base VSL for other factors 
that may differ between study and policy cases, and that may affect VSL, 
including cross-sectional income. 
The opening discussion in Section 4.1 noted that VSL/VSLY valuations 
may be different across different individuals, regions and countries 
because attitudes of people to risk are different in terms of risk aversion 
and in terms of cultural preferences for risks (Pearce, 1998; Rizzi and 
Ortuzar, 2006). Aldy and Smyth (2006) also observe that VSLY estimates 
vary by race and gender, but note that the main driver of this is SES – 
the differences in labour market compensation underlying the wage 
differential in the WTP calculations. Attitudes to risk aversion and cultural 
preferences for risk largely reflect the human capital investment process 
that, like education, is intricately linked in the income growth path. 
Moreover, like SES, this has different implications in the private and 
public contexts. For example, there have been questions surrounding the 
level of informed consent operating when pharmaceutical companies 
target people in very poor countries to participate in early phase human 
trials. However, this is a rational strategy given the ethnicity/SES-risk 
tradeoff relationship (albeit the ethics may well be monitored). 
Conclusions regarding the public policy implications are also drawn in 
Section 5.1.3. 
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Health Status, Risk Preferences AND Other Stratification 
Murphy and Topel (2005) argue that WTP for changes in survival do not 
depend on the level of health, which is consistent with the Environmental 
Protection Agency’s Science Advisory Board (2000): 
‘There are no published studies that show that persons with physical 
limitations or chronic illnesses are willing to pay less to increase their 
longevity than persons without those limitations. People with physical 
limitations appear to adjust to their conditions, and their willingness to 
pay to reduce fatal risks is therefore not affected.’ 
However, they also note that this does not mean that health has no 
value, so the DALY/QALY approach to measuring benefit for different 
states or aversion of negative ones is not invalidated (Sections 2.1.2 and 
2.1.3). 
Another question is how to treat differences in individual or situational 
risk preferences. Sunstein (2000) finds that people are willing to pay a 
VSLY premium (which we interpret to reflect social utility) to: 
> avoid deaths that involve a high degree of pain and suffering; 
> protect children; 
> avert catastrophes; 
> protect against dangers when the costs of risk avoidance are high; 
> protect vulnerable or traditionally disadvantaged groups against 
certain risks. 
Certainly there is a wealth of evidence that has and can be collected in 
this regard, but it is used more in the private sector than in public policy 
evaluations. Moreover, the importance of the experimental design of the 
stated preference studies that underlie such evidence cannot be 
overemphasised. As noted in Section 3.3.1, the shortfalls in experimental 
design of stated preference studies have substantially limited the quality 
and believability of findings in the past. 
However, over time and with the maturation of experimental design 
theory, researchers use increasingly more ‘complex’ choice settings to 
study choice behaviour (Hensher, 2006a).The generation of stated choice 
experiments has evolved to become an increasingly significant but 
complex component of stated choice studies, and construction of stated 
choice designs has very much become the domain of the specialist. ITLS 
has developed such expertise. Rose and Bliemer (2002) note that 
analysts are now able to determine when particular attribute level values 
should be shown to respondents in the choice survey and to specify and 
account for large numbers of attributes simultaneously. The attribute 
level values in the screenshot (Figure 4—17) relate to attribute levels of a 
design associated with each of the alternatives, which may differ for each 
individual as well as over each choice situation, generating potentially 
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infinite numbers of attribute parameters. The assignment of these values 
can then occur in a systematic (ie, non-random) manner through 
application of experimental design theory. Steps in designed stated 
choice experiments are illustrated in Figure 4—18 and described in detail 
in Rose and Bleimer (2002). These include defining the amount of 
information as the number of attributes associated with each choice set, 
investigating how this information is processed as complexity is varied, 
and the development of ordered heterogeneous logit models (Hensher, 
2006a). Using this approach (Hensher, 2006a) found that individuals 
adopt a range of ‘coping’ strategies consistent with how they process 
information in real markets, so aligning ‘choice complexity’ with the 
amount of information to process is potentially misleading – it is 
relevancy that matters. 
Figure 4—17  An example of a labelled stated choice situation 
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Figure 4—18  Steps in designing a stated choice situation 
 
Source: Rose and Bliemer (2002:3). 
The use of well-designed stated preference models is important in 
building an information base to solve a particular problem. It can also be 
used to stratify the VSLY in accord with any dimension desired. However, 
the implications of basing policy on any particular dimension, such as age 
or SES, are complex (Section 5.1.3). Moreover Hensher (2006b) found 
that although, when each design dimension was assessed without 
controlling for the other dimensions there was evidence to support 
differences in aggregate mean WTP attributable to certain dimensions, 
but when aggregated mean estimates were conditioned on all design 
dimensions, there were no systematic differences due to specific design 
dimensions. 
‘Net’ Values and Other Adjustments 
A final consideration before drawing conclusions regarding the range and 
sensitivity of estimates from our literature review and the available 
theory and evidence, is a technical question in relation to whether and 
how the VSLY should be adjusted for: 
> any benefits (and costs) to third parties from their life; and 
> any other costs or benefits to the individual calculated in that process, 
to avoid double counting. 
In relation to the first question, Goulder (2006) notes that the calculation 
of benefits from avoided premature mortality should include both the 
WTP of individuals likely to benefit directly but also the WTP of third 
parties who have empathy for or are affected in other ways by the 
directly affected individuals. For example, the elderly receive significant 
taxpayer funded pensions and health care benefits so in deciding to 
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purchase a year of extra healthy life, there is also an implicit assumption 
to fund such expenditures. 
To address this depends on which method has been used in the 
calculation of the VSLY; 
1 a stated preference method using others’ views; or 
2 a stated or revealed preference method using the individual’s own 
utility. 
The first is essentially measuring social utility. With the assumption of 
perfect information, these factors are already taken into account in the 
WTP valuation. As such, there is no need to ‘net out’ any transfers. 
The second method reflects the individual’s utility and may include only 
some (presumably limited) third-party effects, such as the preferences of 
close family members and general social conscience, reflected in the WTP 
measure. Essentially, though the WTP reflects the individual’s valuation, 
again with an assumption of perfect information regarding current and 
future costs and benefits. It may be important to take other third party 
impacts into account in the analysis, so that cost and benefits can be 
calculated by bearer and the distributional impacts analysed. For the 
individual, it thus becomes important to net out the costs that would 
theoretically at least, have already been taken into account in their WTP 
valuation. 
These costs typically include: 
> health expenditures that they themselves would bear; 
> productivity impacts and out-of-pocket expenses; and 
> welfare or other transfer payments received. 
Murphy and Topel (2005) include a netting process to deduct the rising 
costs of medical care from technological progress over time, concluding 
that some 36% of the gains in healthy life over 1970-2000 were 
purchased through health expenditures and should be netted out of the 
calculation of the total gains in healthy life over the period. This is similar 
in concept to what Access Economics undertakes when we calculate the 
‘net’ estimate of healthy life. All the costs paid for by the individual are 
subtracted from the ‘gross’ value of healthy life to estimate the net value 
of healthy life gained. It is a simple accounting process as illustrated in 
Table 4—18. 
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Table 4—18  Worked example of netting out costs borne by the 
individual 
 Individuals $m 
 Gross cost of lost wellbeing 500 
  Minus production losses net of tax 50 
  Minus health costs borne out-of-
pocket 10 
  Minus transfers 20 
  Minus other costs borne out-of-
pocket 10 
 Net cost of lost wellbeing 410 
The netting out process is undertaken at the end of the analysis when the 
distribution of all costs and benefits is known. This is partly due to 
practical considerations but also avoids the problem of netting out 
productivity costs and other costs that have strong age associations. The 
reasons for avoiding the age allocation are that (a) it is usually not 
required and (b) the netting out process can occasionally lead to 
anomalous results. An example of this is briefly presented below. 
An anomaly occurs when the price of an intervention increases, and the 
individual pays for a large proportion of it, the net value of the burden of 
disease falls. Although of course the price increase of the therapy is still 
counted in total costs, the distributional effect is a little counter-intuitive. 
Clearly this is a product of the assumption of perfect information of 
current and future prices and the averaging process for the VSLY. Our 
conclusion is that anomalies like this one rarely have impacts on overall 
CEA results and need to be lived with. 
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Chapter 5: The Role of VSLY in Decision Making 
Core Issues 
Large Estimates and Budget Constraints 
The estimates from the literature for VSL and VSLY in the previous two 
chapters are high in the sense that it is unlikely that the lives of all 
Australians could be purchased for the prices calculated from the 
literature in any given period, due to budget constraints. It is important 
to understand the reasons for this. 
First, the estimates are calculated based on changes at the margin. Some 
studies relate to people making decisions involving only small 
incremental changes in health or risk, but many are based on the risk or 
actual aversion of death. However, in this case ‘at the margin’ really 
refers to the fact that not all of the adverse events contemplated in the 
literature are likely (on the basis of actuarial probabilities) to occur 
simultaneously and it is not currently technologically or biologically 
feasible to purchase vast quantities of years of healthy life all in one go 
from postulated interventions. While life expectancy is increasing at 
around three weeks per annum, and while investments in healthy life are 
occurring across a number of fronts, we are constrained in our ability to 
gain large quantities of extra healthy life. Cancer and cardiovascular 
disease account for some 37% of Australia’s burden of disease (Begg 
etal, 2007) and, although mortality rates from both conditions have been 
declining for decades, we are technologically constrained in our ability to 
accelerate reduction in incidence or mortality from these conditions. 
While investment in health research is being prioritised (with more than 
doubling of real expenditures through NHMRC in recent years), research 
itself has limited capacity to resolve these immediate constraints. 
Hence the price expressed in the VSLY reflects what individuals and 
society on average will currently pay for any life-enhancing opportunities 
currently available, acknowledging the reality that we cannot yet 
purchase extra units of life in a planned way at a going, average market 
rate. If it were ever the case that we could trade life in this way, some 
might expect the VSLY to fall to something in line with GDP per capita 
minus a subsistence level of consumption (since without such 
consumption the person would be dead anyway). However, in such a 
situation GDP per capita itself might change fundamentally as people 
altered their labour-leisure choice patterns and other decisions in order to 
overcome income constraints to getting more healthy life into their 
basket of consumption. We might expect fundamental changes in the 
socially optimal general equilibrium set of prices. On the other hand, 
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healthy life would still be inextricably linked to both income and 
consumption. 20 
There are two important points in relation to the budget constraint. 
> While some individuals might trade all they own for another year of 
their own healthy life, their budget constraint may still underestimate 
the utility value of healthy life to that individual – and current 
economic frameworks (not to mention imperfect capital markets) do 
not deal well with goods of such an order of magnitude of individual 
utility, particularly when healthy life is required in order to consume 
all other goods and services and to produce income. 
1. What would happen if a terrorist group (or aliens) threatened to 
bombard the country with nuclear warheads that would eliminate all 
Australian life, in exchange for a monetary sum? Without exploring 
possible counterterrorism strategies (ie, assuming the threat was real, 
imminent and the terrorist could not be identified or located), what sum 
would we be willing to pay to avert this threat, and would it be in the 
order of, say, $4 million (VSL)*20 million people ie, $80 trillion? While we 
might be WTP $80 trillion, we could not actually make the payment given 
that our annual GDP is around $900 billion and our national net worth is 
around $5 trillion (not counting the value of natural endowments). Now 
suppose we could scrounge grants of some $45 trillion from international 
allies, and the terrorist agreed that with an upfront payment of $50 
billion, they would not set loose the warheads if we paid them the real 
value of the $80 trillion, and we had until 2027 to do this. This would 
mean changing national labour leisure choices to increase GDP to around 
$2bn pa in real terms, at a 3.3% discount rate (since immigration and 
emigration are impossible in the hypothetical scenario) and changing our 
environmental preferences potentially also to exploit a greater proportion 
of our natural heritage. We would have to live largely in subsistence 
living conditions for the period, except for assets not convertible to cash. 
Would we make this choice, or decide to bring on the nukes? 
2. Conversely suppose an Australian researcher invented a process that 
slowed oxidation processes such that life expectancy increased to 200 
years, with associated prolongation of middle but not old age? At what 
price would we purchase the technology? And would we make the same 
sorts of reallocation choices, mortgaging the now higher productive 
capacity elements of our now longer lives into partial slavery effectively, 
to make the purchase? 
> However, in a policy-making context (and also in a private purchasing 
context) we are in fact buying marginal units of life in the current 
constrained way, so the VSLY from the literature (the average of 
                                      
20 It might be interesting in this context to consider some hypothetical situations 
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similar incremental decisions21) is the appropriate VSLY to apply in 
decision-making. In a sense it is still currently irrelevant whether life 
is or is not more valuable than all other goods and services combined 
(as counted in GDP). However, this aspect (the government budget 
constraint) does come into play when considering interventions 
delivered to large numbers of Australians from taxation financed 
expenditures (see Section 5.3). 
For public policy making purposes though, it is also important to address 
two other major issues: 
1.  the potential difference between individual valuations of life and 
government decisions to intervene (essentially to trade health between 
individuals by deciding which programs to fund or which regulations to 
enact); and 
2.  the stratification of VSLY by various criteria. 
Whose Value? 
A clear message from the analysis was that there is a difference between 
the social utility derived from governments intervening to protect human 
life and individuals’ valuation of it at the margin. 
In the case of revealed preference studies, it could fairly safely be 
assumed that the estimates reflect individuals’ choices regarding their 
own lives (although this would be an approximation as they might, for 
example, take into account the perceived impacts on others eg, 
bystanders, loved ones). In the stated preference studies, the estimates 
reflect a combination of individuals’ and others’ choice (people in surveys 
may be asked questions about choices regarding their own life or about 
the lives of others). The lack of major differences between the findings of 
the stated preference and revealed preference models did not distinguish 
between these effects, and it would be interesting to test this 
econometrically, controlling for a number of confounding factors (eg, age, 
gender, SES, sector/intervention, fatality/disability, other relevant 
factors), to see if there is a significant difference. We would see this 
further research as valuable, potentially also to shed light on democratic 
views in relation to the extent of intervention in different situations. 22 
                                      
21 This is relevant as it means it is not necessary to apply the ‘rule of half’ that 
might apply in relation to other decisions where consumer surplus is involved 
(eg, BTE, 1999). 
22 It was not possible in the time available for this analysis to itemise the studies 
reviewed by whether the individual themselves or someone else was making the 
life-risk tradeoff. To do this would require the acquisition and audit of all the 
source studies in various meta-analyses, for example and, even so, may not 
enable the determination of the precise framing of questions asked in each 
study. 
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The distinction is important because the implication for policy-makers is 
that, on average across all interventions and sectors, government should 
intervene to the social VSLY only, after which point individuals (who could 
afford to) could ‘top up’ their spending to the intervention point. Recall 
the ‘subsidy’ amount P’-P from Figure 2—2 and the regulation impacts in 
Figure 2—3. However, a concern with this is that the only potential 
method of obtaining data of this nature would be from stated preference 
approaches, which are less well accepted than revealed preference 
studies. Only very high calibre stated preference studies should be 
included, if this approach were to be adopted, with the proviso that 
coverage were still deep enough to increase certainty in the estimates. 
This becomes relevant in the consideration of public financing thresholds 
in Section 5.4. 
Stratification of the VSLY 
The richness of stated preference models permit, if desired, the 
stratification of the VSLY by an almost infinite range of possible criteria. 
Even some revealed preference studies show variation of VSLY by key 
characteristics. 
In some situations, governments are unable to distinguish whose lives 
will be saved or enhanced through interventions – for example, in 
spending on national defence. In other cases, interventions might be 
targeted at population groups that exhibit particular characteristics, with 
the most common stratifications of interest being by age, gender, SES, 
sector, regionality and jurisdiction (eg, speed limitations in school zones, 
obstetric services in regional Australia, interventions for the frail aged, 
OHS regulations in the mining sector). 
A key question is whether, when a particular groups of people can be 
identified, different VSLYs should be used, reflecting the most reliable 
stratification possible from the data. There are different views on this 
issue. For example, in an unpublished paper Kenkel (2001) concludes: 
‘When different agencies reduce similar health risks for similar 
populations, they should use consistent estimates of the VSL; but each 
agency should use VSL estimates that are specific to the health risk and 
population affected by its regulations. This presents a challenge for both 
the research community that generates VSL estimates and the 
policymaking community that uses them.’ 
There are a number of important arguments why such stratification may 
not be desirable, even if it were possible (ie, if robust data were 
available). 
1 Stratification would need to rely primarily on stated preference 
approaches with its associated limitations, uncertainty and lack of general 
acceptance of these studies currently. Designing new studies for each 
intervention may impose large costs and time delays on implementing 
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any intervention, which may not be desirable for life saving interventions 
where timing as well as budget can be very important.23 
2 Normative principles of social justice would be brought into question. 
These are embedded in many sectors of Australian society, most notably 
in the health and aged care sector where principles of universal 
entitlement and equal access to services are espoused. To deny certain 
groups treatment received by others may be particularly counterintuitive 
in relation to SES, since higher SES people would be more likely to 
qualify for treatment based on their higher VSLY, yet the health equity 
externality and raison d’etre for public financing is premised on providing 
access to lower SES groups. Most groups can be stratified by SES, which 
would result in higher VSLY for air travellers compared to rail or road 
travellers (since people who fly are generally of higher SES), lower VSLY 
for women (who have lower lifetime earnings relative to men) and lower 
VSLY for particular ethnic groups (eg, indigenous Australians), regional 
Australians, and jurisdictions with lower Gross State Product per capita. 
Within OHS, on this basis different standards might be applicable to 
professionals rather than to manufacturing sector workers. The 
implications of such stratification would be challenging, although such 
measures have been suggested overseas (eg, waste dumping in Africa 
where measured VSLY is relatively low). 
3 The ‘slippery slope’. It might nonetheless be tempting to stratify the 
VSLY based on particular criteria. For example, a lower VSLY may be 
preferred in the road transport sector for historical and stakeholder 
reasons, and perhaps due to the view that the VSLY is indeed lower in 
this setting or that the social preference for intervening is lower (we were 
unable to find evidence for either view in this analysis). Another example 
might be where a health intervention is targeted at a large group of older 
people, and a lower VSLY is desired to be used for budget restraint 
reasons (and perhaps due to the view that the VSLY is lower for older 
people, which is not supported by strong evidence overall in the 
literature). We would suggest that if a different VSLY is desired in 
different sectors (or other different groups), that sensitivity analysis is 
also always presented using the benchmark VSLY (see Sections 5.4 and 
5.6), which would assist policy makers in relation to comparability across 
sectors, interventions and target groups. 
In summary, in public decision making processes there seems to be a 
strong case for moving to a benchmark average VSLY to be used in 
evaluation analysis, at least as one scenario presented to decision 
makers. 
                                      
23 That said, Claxton (1999) also notes that while delays may cause health 
losses, making mistakes from using the wrong VSLY can also cause health losses 
by funding the wrong programs or enacting poor regulations (which are hard to 
undo). So there may also be benefits from delaying until better data on social 
preferences are obtained. 
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Efficiency Evaluation in Policy Making 
Cost effectiveness analysis measures the efficiency of an intervention in 
relation to its desired outcome. 
Cost benefit analysis (CBA) and cost utility analysis (CUA) are the most 
common evaluation tools in policy analysis where health and safety are 
involved. Cost efficacy and cost minimisation analysis (CMA) are mostly 
used in relation to funding pharmaceutical interventions, where the 
proposed drug is demonstrated to be no worse therapeutically than other 
drugs, at the same or a lower price (ie, fewer dollars per patient spent 
maintaining a specified level of blood pressure control). Figure 5—1 
shows different methods of economic evaluation of medicines by PBAC. 



























Sources: George et al (1999) and PBS Public Summary Documents (July 2005 to March 2006). 
The decision box (Figure 5—2) is typical in the pharmaceutical sector, 
where the comparator drug is highly relevant to the financing decision. If 
the drug has a lower price and is at least as effective, it is approved 
(CMA); if higher and less effective, it is not approved; and in any other 
case, other analysis is required (usually CUA) 
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Economic Analysis of Cost 
effectiveness Required 
Approve Economic Analysis of Cost 
effectiveness Required - but 
generally sticky in this 
direction. 
Do Not Approve 
 
Cost efficacy analysis is declining in use in PBAC, and also in other parts 
of the health sector and, anecdotally at least, in other sectors. The major 
tool used by the Office of the ASCC and OBPR is CBA, which is rarely 
used in the health sector since either the health benefits of the treatment 
are ignored (which is often the significant outcome of the treatment) or it 
requires explicitly placing a value on each QALY, which may be more 
controversial than simply reporting the $/QALY. 
CBA has long been the tool used most commonly in justifying public 
policy ‘if it produced social gains in excess of social losses so that it was 
possible for winners from the policy to compensate losers’ (Persky, 
2001). 
One solution to this problem is to include the VSLY conversion in the 
CBA, but also to report the cost per QALY (ie, to report both CUA and 
CBA). This is easy to do, since essentially the same cost and benefit 
components are calculated in each approach. The only difference is that 
the VSLY is required for the CBA. 
The CBA would include all the costs and benefits in dollar terms. It is 
considered desirable to report the CUA as well since the VSLY component 
is different from the other components in that it: 
> is frequently very large; 
> is different in nature (less tangible, healthy life is not included in 
GDP); 
> its valuation is consequently less certain; and 
> sensitivity analysis with high and low VSLY estimates may change the 
outcomes of the CBA. 
These differences might be masked in a CBA but are considered relevant 
in public policy decision making processes, hence the suggestion that 
CUA ratios are also reported.  
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The $/QALY ratio should include the net dollar costs from the CBA (ie, 
excluding the net dollar value of the QALYs) in the numerator, and the 
QALYs in the denominator. If the numerator is negative (ie, there are net 
dollar benefits without valuing QALYs) and the denominator is positive, 
the intervention is described in CUA as cost saving rather than cost 
effective. This distinction in terminology might also be useful in the case 
of other interventions where the primary purpose of the intervention may 
be another outcome and the improvement in healthy life is secondary. 
Technological innovation continues to enhance the scope to delay death 
and improve the QoL of Australians. However, the technology generally 
comes at a higher cost and governments are thus faced with the problem 
of funding these escalating costs, particularly in the health and aged care 
sector, either through: 
> increasing funding through taxes or decreasing expenditure on other 
programs; or 
> quantitative rationing of who receives interventions (usually through 
waiting lists); or 
> making price-based choices regarding the level of care governments 
are willing to provide. 
Other Public Financing Considerations 
In the market for health and safety, many governments attempt to 
collect the best available information and (from a society’s perspective) 
either reimburse or otherwise publicly finance certain interventions on 
the basis of decisions about externalities relating to that intervention 
(Arrow et al, 1996). Formal CEA or CBA is sometimes (but not always) 
used in this decision making process. This section addresses other public 
financing considerations, using the pharmaceutical sector as a brief case 
study. 
> Total budgetary (opportunity) cost – if financing an intervention 
consumes a large proportion of the available budget, then other 
interventions cannot be financed or additional revenue must be 
raised, which may not be politically popular. Fully financing 
interventions that target large numbers of people and/or have a high 
cost per person would violate the goal of equal access for other people 
in need of other interventions  (eg, people with different health 
conditions) and may also bring into question the ‘incremental’ nature 
of the VSLY price (see Section 5.1.1). 
-  The budget cost is generally the major limiting consideration in 
publicly financed interventions. 
> Health equity – in order to ensure that small sections of the 
population do not bear an inordinate proportion of the stock of poor 
health (again for equity reasons), governments may be more inclined 
to fund interventions that are the only intervention available to a 
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particular sub-group (eg, ‘orphan drugs’, unsniffable fuel subsidies) or 
conditions that are acute and life threatening (the ‘rule of rescue’). 
> Socioeconomic equity – in order to ensure everyone has access to 
essential interventions and to slow the slide into poverty due to 
sickness, governments may be more inclined to reimburse particular 
interventions if the market price would be high relative to income 
and/or wealth, possibly pushing the person below the poverty line. 
> Whether considered a lifestyle drug – governments may be less 
inclined to reimburse treatment that is considered non-essential or 
the prevalence/severity of the condition can be (perhaps better) 
reduced through changes in lifestyle, such as diet, exercise or 
avoidance of an addictive substance (eg, tobacco). 
> Whether the condition is chronic or acute – as years of life saved is 
much easier to measure than changes in QoL, severe acute conditions 
may be more likely to be reimbursed compare to chronic conditions. 
> The degree of innovation – governments may be more inclined to 
reimburse highly innovative interventions in order to promote further 
R&D into treatments. 
> Availability and effectiveness of alternative therapies – governments 
may consider interventions providing only marginal improvements in 
cost effectiveness to be ‘nonessential’, especially in economies where 
choice is relatively less valued. Because each person is different, there 
may be diversification value in having alternative intervention 
alternatives. 
Evidence of the balancing of these various priorities in practice can be 
illustrated by analysing data from the pharmaceutical sector. The 
relationship between incremental cost effectiveness ratio (ICER) 
thresholds and the probability of recommendation for PBS listing in 
Australia was investigated by Access Economics using multiple regression 
analysis, using data from PBS Summary documents for the period July 
2005 to March 2006 for 72 drugs (excluding minor submissions) including 
type of submission, type of analysis, budgetary impact, number of people 
treated and the ICER, if applicable. While 54% of the submissions 
resulted in a positive recommendation, submissions that were for an 
extension in the use of the drug (such as a new indication or extension to 
a greater population) were more likely to be successful than a new 
submission or a re-submission of a drug that was previously rejected. 
Submissions that provided a cost minimisation analysis were more likely 
to receive a positive recommendation than a cost utility or cost efficacy 
analysis. Over the period, 33 submissions were based on a cost utility 
analysis (equally distributed across new, extensions and re-submissions), 
of which 33% were accepted. 
Using a pooled probit model of the natural log of the midpoint of the 
ICER, the initial analysis found that a higher ICER had a statistically 
significant negative impact on the likelihood of receiving a positive 
recommendation (-1.35, Χ2>0.0166). When a variable representing the 
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budgetary impact was introduced, the results for that variable were not 
significant, but this was likely to be due to sample size limitations, large 
bandwidths of budget impacts, and because part of the budgetary effect 
would be captured by the higher ICER. As more data become publicly 
available, a more detailed analysis will become possible. 
The relationship is illustrated in Table 5—1 and Figure 5—3. A negative 
non-linear relationship is evident between the ICER and the probability of 
reimbursement in Australia rather than a consistent ‘threshold’ for 
decision making purposes, reflecting the other policy considerations 
taken into account. The analysis suggests that a drug with an ICER of 
A$32,000/QALY has a 50% chance of being accepted, which falls to 12% 
for an ICER of A$75,000/QALY and 6% for an ICER of A$100,000/QALY. 







Variable Coefficient Standard Error Pr > Chi Sq 
Constant 13.9970 5.9995 0.0196 
Log(ICER) -1.3497 0.5632 0.0166 
Log-likelihood -16.77901   
Number of observations 33   
 
Figure 5—3  Likelihood of PBAC acceptance for listing, Australia 
 
Source: Based on data from PBS Public Summary documents (July 2005 
to March 2006). 
In Australia, although guidelines are provided, the weighting given to 
other policy considerations is not explicitly provided. However, this 
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process has recently become a great deal more transparent – the advice 
is as follows. 24 
 ‘In making decisions as to whether to recommend that a proposed drug 
be listed on the PBS, PBAC considers many factors. Each of these factors 
might have a separate influence on the decision to list the proposed drug 
on the PBS and, depending on the circumstances of each consideration, 
might influence PBAC in favour of, or against, a recommendation to list. 
More than one factor might be relevant to each consideration. 
‘Tables A1.1 and A1.2 in Appendix 1 list relevant factors, which are 
divided into two groups: quantitative and qualitative. The qualitative 
factors (Table A1.2) include some of the underlying assumptions implicit 
in such concepts as quality adjusted life-years and discounting. To enable 
consistency across submissions regarding these factors, a particular 
position has been adopted (which is specified in these guidelines in the 
sections indicated by the cross-references in the tables). However, in 
certain circumstances, it might be reasonable to argue that a different 
position should be considered. 
‘Individual factors are not weighted equally by PBAC in its decision-
making process, and different factors might be more or less important in 
different situations. In other words, the importance of any particular 
factor cannot be quantified. The descriptions provided in Appendix 1 
represent PBAC's understanding at the present time. PBAC continues to 
reflect on its processes and to further develop its understanding of these 
matters.’ 
Thresholds and Benchmarks 
Given the interplay of different considerations in public policy making 
processes and most notably the government budget constraint in the 
case of healthy life, are benchmarks or threshold financing levels 
appropriate as guidelines to industry and in decision-making processes? 
This may relieve some of the externalities and underlying reasons for 
government intervention while also enabling a balance of priorities. 
Recalling the decision box in Figure 5—2, if CUA is used, there remains 
the need to define criteria in quadrants I and III (top right and bottom 
left) to determine which interventions will be financed. If an intervention 
option is not dominant (higher benefit, lower costs) or dominated (lower 
                                      
24 Pharmaceutical Benefits Advisory Committee (2002) Guidelines for the 
Pharmaceutical Industry, Commonwealth Department of Health and Aged Care, 
Australia and 
http://www.aodgp.gov.au/internet/wcms/publishing.nsf/Content/pbacguidelines-
index~pbacguidelinespart1~ pbacguidelines-part1+4 More detail can be found in 
Appendix 1 of 
http://www.aodgp.gov.au/internet/wcms/publishing.nsf/content/pbacguidelines-
index~pbacguidelines-appendixes 
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benefit, higher costs), then comparison of the ICER to the threshold is 
required. This decision is made in one of two main ways: 
> a league table of ICERs is drawn up until the available budget is 
entirely utilised; or 
> a benchmark is developed against which the intervention is compared 
and financed in whole or in part, in conjunction with other public 
policy criteria. 
It should be noted that while the league table approach has intuitive 
appeal from a fiscal restraint perspective, it is generally much harder to 
withdraw an approved intervention than to introduce a new one 
(regardless of how much more cost effective it may be). 
Marquez (2006) recommends establishing and adjusting ‘floors and 
limits’ to regulation expenditure through statutory measures such as 
minimum and maximum values for life saved, adjusting these for 
qualitative factors, and resisting the urge to ‘respond to social fear’ 
achieved not through ‘regulating or over regulating but through 
education and reassurance’. 
For regulatory purposes, the goal of the calculations is to estimate how 
much societies value the government’s efforts to reduce risks to their 
healthy life. For example, Scandinavian countries and other social 
democracies may have higher ICER thresholds for refusing intervention 
than in Australia or other liberal democracies, to align with preferences 
for political systems that place greater emphasis on social justice 
achieved through higher taxation. More empirical research in this area 
may be of value. 
The fundamental issue here is that the VSLY from the literature is not 
equal to the public financing threshold per se and is not an argument for 
the government to pay for its purchase up to $VSLY/QALY. The extent 
that the government should pay depends upon a different set of 
arguments in relation to the extent of externalities (of which a major one 
is the social equity objective in relation to healthy life) or the public good 
nature (eg, roads) that constrain private purchasing decisions. 
For example, band-aids may be very cost effective, even cost-saving, but 
this is not a reason for government to fund them. In this example, the 
cost of bandaids to the individual is small and the budget impact and 
clinical impacts of failure to provide the intervention are judged not to 
warrant public sector intervention on health equity grounds. The decision 
to intervene is made on a different basis from cost effectiveness alone, 
and may be better assessed from social choice models designed to 
establish the thresholds for particular groups of interventions (call them 
‘portfolios’ and, indeed, they may well align with government 
departments or groups of departments) than from the incremental VSLY. 
If an externality exists that warrants public sector intervention, 
theoretically the threshold used to determine funding for new 
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interventions should be the shadow price of the budget constraint within 
that portfolio: the opportunity cost of the marginal intervention 
displaced. Ideally this would equate across all portfolios, if budgets were 
set optimally through the political process. However, in the real world 
portfolio budgets may not be set optimally, so the threshold would be 
based on the ICER of the marginal program displaced by the new 
program, calculated by the relevant government department in order to 
allocate resources efficiently (Claxton et al, 2007). Differing budget 
constraints across government budgets may thus mean that different 
thresholds might emerge in different portfolios. 
Claxton’s conclusion may indeed already be evident in the sectoral 
interventions publicly financed historically in Australia and around the 
world (Section 4.1). Conceptually, in sectors where there are frequent 
and substantial potential interventions, the budget constraint may loom 
larger (eg, health and aged care). Interventions in transport and other 
sectors such as fire or crime represent mid-range levels of risk to mid-
sized populations (hence providing a case for a mid-range threshold level 
for financing, while interventions that reduce very small risks or are 
targeted at smaller populations may require warrant higher thresholds 
(eg, in environmental regulations or occupational safety). In each case, 
the reason for the departure from an average threshold will need to be 
carefully and explicitly communicated to stakeholders. 
In practice, the ICER threshold or threshold range is then the one used in 
cost effectiveness analysis. Call this λi where λ depicts a threshold used in 
a public financing decisions and I reflects the portfolio (the sector or 
group of interventions within the sector sharing similar externalities that 
warrant that threshold). Consequently the decision rule is to approve the 
intervention is: 
                                                               ΔC/ ΔQ < λi 
Where ΔC is the change in costs of the intervention and ΔQ is the change 
in the QALYs gained. This equation can be rearranged to: 
                                                       λi * ΔQ$ -Δ C > 0 
                                      where ΔQ$= ΔQ*VSLY. 
This is equivalent to the cost benefit approach using the threshold 
(Claxton 1999). 
We suggest that such thresholds are developed across portfolios 
concerned with implementing lifesaving measures, using cost 
effectiveness thresholds to evaluate programs and determine funding 
priorities. Naturally, policy makers are still able to take factors other than 
the social utility into account in their decisions, should they choose. 
COAG (2004:38-39) does not comment on the appropriate valuation of 
life and, while noting the range in one study, does not make mention that 
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VSL may vary depending on age or the method of valuation, which may 
be important factors in explaining such differences.  
‘The main disadvantage of cost benefit analysis is that difficulties can 
arise in evaluating costs and benefits for which there are no market 
prices. The application of cost-benefit analysis to regulations intended to 
reduce risk inevitably requires that a value be placed on human life. 
While this has been done in some of the literature, there is a wide variety 
of approaches used to arrive at this value as well as a wide range of 
values. For example, in the United States, one study of various measures 
showed a variation from $0.1 m per life saved to $125 m per life saved. 
In a climate of limited resources, it is probably not difficult to decide 
which of these two measures it would be preferable to introduce. Such 
attempts have often been viewed as controversial. In contrast, cost-
effectiveness analysis avoids explicitly valuing human life and instead 
focuses on the costs of a specified output such as that of saving a life (or 
reducing injury at a specified level).’ 
However, Access Economics suggest that both metrics (net benefit and 
ICER) are presented in prospective and retrospective evaluation findings. 
Indexation Over Time 
Since the VSLY is expressed in dollar terms, it should be indexed over 
time by an appropriate inflator. In this case CPI is used as it is consistent 
with the deflator in the discount rate discussion (Section 3.4). ABS 
(2004) in its Measures of Australia’s Progress that a good headline 
indicator should: 
> be relevant to the particular dimension of progress; 
> where possible, focus on outcomes for the dimension of progress 
(rather than on say, the inputs or processes used to produce 
outcomes); 
> show a 'good' direction of movement (signalling progress) and 'bad' 
direction (signalling regress) - at least when the indicator is 
considered alone, with all other dimensions of progress kept equal; 
> be supported by timely data of good quality; 
> be available as a time series; 
> be sensitive to changes in the underlying phenomena captured by the 
dimension of progress; 
> be summary in nature; 
> preferably be capable of disaggregating by, say, geography or 
population group; and 
> be intelligible and easily interpreted by the general reader. 
That said, Claxton (2006) argues that it is not true that a budget 
threshold (λi in the previous section) should be indexed, since 
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government budgets do not necessarily increase with CPI over time or 
maintain their relativities to GDP. Moreover, the marginal program 
displaced may be more effective due to technology improvements, in 
which case the threshold may actually decrease over time. 
Best Practice Principles and Next Steps 
Drawing together the evidence from previous sections, this section 
summarises some principles to bear in mind in undertaking evaluation 
analyses and suggestions for some next steps, in particular in relation to 
develop pubic financing criteria. In designing analyses for public decision 
making purposes regarding regulation and financing interventions to 
enhance safety and wellbeing in Australia going forward, the following 
principles are suggested. 
1 Be aware that any attempt to value life in dollar terms is limited by the 
unique nature of healthy life and that neoclassical assumptions of perfect 
information and rationality may not apply. It is the extent of these 
market failures and externalities that is the raison d’etre for the 
government intervention, rather than the value of human life per se. 
2 Measuring changes in risks to life provides a value for safety while 
valuing the utility of different health states provides estimates of 
wellbeing. Estimate safety/wellbeing in QALYs or DALYs, preferably with 
separate estimates of life years saved (LYS) and morbidity avoided as per 
Begg et al (2007). 
3 For health states other than mortality, use disability weights from DALY 
tables (Appendix B) to allocate utility associated with various health 
states. If a disability weight is required that is not available in the table, 
use the most robust utility value available from the literature (or expert 
opinion in the worst case) and triangulate it against similar health states 
that have weights in the table; conduct sensitivity analysis around the 
disability weight. (Use the metric ‘$/QALY’ rather than ‘$/DALY averted’ 
for simplicity of terminology.) 
4 Calculate all of the costs and benefits associated with the intervention 
by who bears them – individuals (if families are included use the term 
‘households’), Federal and State governments, employers, and other 
relevant entities in society. The net costs to the individual must be netted 
out of from the gross value of wellbeing. 
5 A variety of techniques may be used to evaluate the efficiency of an 
intervention, including: 
>  - cost benefit analysis (CBA), which measures the net present value 
(NPV) of dollar costs compared to the net present value of dollars 
saved; 
>  - cost efficacy analysis, which measures the net costs (excluding the 
dollar value of QALYs) per LYS (or another outcome measure); and 
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>  - cost utility analysis (CUA), which measures the net costs (excluding 
the dollar value of QALYs) per QALY gained. If the net cost is negative 
(ie, if there is a net benefit excluding the dollar value of QALYs), the 
intervention’s CUA could be described as cost saving rather than cost 
effective. 
6 Because the dollar value for the VSLY estimate is likely to be large and 
associated with a higher level of uncertainty than most financial 
estimates, it is suggested that:  
>  - sensitivity analysis accompanies the estimates, for example using 
high and low levels of a VSLY; and 
>  - cost utility analysis (CUA), and potentially also $/LYS, is used 
alongside cost benefit analysis (CBA) in public decision making so that 
the dollar value of the QALY benefit is transparently reported. 
7 Avoid productivity or hybrid approaches to value safety/wellbeing, 
although the productivity impacts may still need to be calculated as part 
of the analysis. 
> In general, if the goal is to measure individual utility, and revealed 
preference data are available, they should be used, reflecting 
consumer sovereignty. 
> If no revealed preference data are available, or if the goal is to 
measure social or private utility in specific situations, stated 
preference approaches may be more appropriate. 
8 A suggested ballpark average VSL is $6.0 million in 2006 Australian 
dollars with sensitivity analysis suggested at $3.7 million and $8.1 
million. 
> This equates to an average VSLY of $252,014 ($155,409 to 
$340,219), using a discount rate of 3% over an estimated 40 years 
remaining life expectancy. 
9 The empirical evidence appears inadequate currently to robustly stratify 
the average VSLY on the basis of age. 
10 The externalities that provide the raison d’etre for government 
interventions are based largely on social utility from enhancing 
socioeconomic equity and health equity, so it would seem self-defeating 
to stratify VSLY on the basis of income, wealth, ethnicity, or other criteria 
that correlate strongly with SES, in public policy making. 
11 Naturally policy makers are still able to take factors other than the 
social utility into account in their decisions. An important consideration is 
the budget constraint, which may vary across different portfolios of 
interventions given different types of externalities in different sectors 
(eg, some sectors may have more ‘public good’ characteristics than 
others) and given imperfect historical budget allocation mechanisms. 
Thus the value of the marginal intervention displaced may not equate 
across portfolios. 
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12 While the VSLY should be used in public decision making, as needed, 
to apply to individual’s own valuation of healthy life, social valuations for 
public financing decisions should be based on thresholds reflecting the 
extent of externalities, potential compensation of any losers and budget 
constraints. 
13 The decision rule to approve an intervention should be (CUA): 
                                                             ΔC/ ΔQ < λi 
where ΔC is the change in costs of the intervention, ΔQ is the change in 
the QALYs and λi is the ICER threshold for portfolio i. Rearranging, the 
CBA decision rule is: 
                                                      λi * ΔQ$ -Δ C > 0 
                                     where ΔQ$= ΔQ*VSLY. 
14 It will therefore be important to determine financing thresholds in 
different sectors/portfolios. Further carefully designed research may be 
desirable to this end, using specialists capable in experimental design 
theory and practice. 
> _ Portfolio thresholds should also be surrounded with sensitivity 
analysis based on high and low bounds, as with VSLY. 
15 Since the VSLY and portfolio thresholds are expressed in dollar terms, 
they should be indexed over time to inflation (CPI is suggested here), 
reviewing λi/VSLY over time for each portfolio to reflect potential changes 
in technology and preferences. 
 
Table 5—2  Average VSLY under different longevity and discount 
rate assumptions (2006A$) 
Life expectancy at 
average VSL 
43 years 40 years 
Discount rate 3% 3.30% 3%* 3.30% 
Base case ($6.0m) 242,902 254,739 252,0
14 
263,612 
Low case ($3.7m) 149,789 157,089 155,4
09 
162,561 
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Appendix A – Studies In The Literature Analysis 
Range of Statistical Life Values by Study and Country – 
Health and Occupational Safety (2006 A$Million) 
Study Year25 Study Area Study Type Min VSL Max VSL VSL Std. Dev. 
Australia 
Abelson et al 2003 Health Other 1.15 --- 
Abelson et al 2003 Health Other 2.88 --- 
Australian 
Transport Council 
2000 Transport Other 1.99 --- 
Bellavance et al. 2007 Other Other 17.65 15.20 
Bryant et al. 1992 Environment Other 0.86 1.43 
BTE 2000 Transport Other 1.29 1.80 
BTE - Black Spot 
Program 
2001 Transport Other 5.41 --- 
CASA 2006 Transport Other 3.00 --- 




1990 Other Other 1.50 --- 
Mayhew 2003 Other Other 2.18 --- 
Mayhew 2003 Other Other 1.74 --- 
Miller 2000 Other Other 3.66 5.41 4.67 
Miller et al. 1997 Occ. Safety Other 28.40 2.16 
                                      
25 Conversion is based on the year of the study where possible and otherwise the 
year of publication. 
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NOHSC 2004 Occ. Safety Other 2.87 --- 
RCG/Hagler Bailey 1994 Environment Other 5.38 9.04 7.21 --- 
Viscusi 2005 Occ. Safety Revealed 6.63 --- 
Austria 
Bellavance et al. 2007 Other Other 13.20 --- 
Maier et al. 1989 Occ. Safety Stated 2.64 7.30 
Miller 2000 Other Other 5.41 7.85 5.58 --- 
Viscusi 2005 Occ. Safety Revealed 6.16 10.27 
Weiss et al. 1986 Occ. Safety Revealed 13.22 --- 
Canada 
Alberini et al. 2002 Occ. Safety Other 0.76 1.39 
Alberini et al. 2002 Occ. Safety Other 1.96 5.54 
Belhadji 1994 Transport Stated 1.57 --- 
Bellavance et al. 2007 Other Other 14.47 16.41 
Cousineau et al. 1991 Occ. Safety Revealed 7.59 0.73 
Dionne & Lanoie 2002 Other Mixed 6.00 --- 
Hara Associates 2000 Health Other 2.69 9.00 
Krupnick et al. 2000 Health Stated 3.20 --- 
Lanoie et al. 1995 Transport Stated 41.09 13.00 
Martinello & 
Meng 1992 Occ. Safety Revealed 4.97 1.50 
Meng 1989 Occ. Safety Revealed 6.38 3.69 
Meng & Smith 1990 Occ. Safety Revealed 1.92 3.56 
Meng & Smith 1999 Occ. Safety Other 3.72 0.96 
Miller 2000 Other Other 3.66 5.41 4.43 --- 
Transport 
Canada 1996 Transport Other 0.68 5.46 
Viscusi 2005 Occ. Safety Revealed 6.16 7.42 
Vodden et al. 1994 Occ. Safety Revealed 7.83 --- 
Denmark 
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Kidholm 1995 Transport Stated 1.27 1.88 
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Miller 2000 Other Other 6.63 8.72 6.96 --- 
Europe 




1995 Transport Stated 1.50 35.83 
Miller 2000 Other Other 5.06 7.32 5.21 --- 
Hong Kong 
Siebert & Wei 1998 Occ. Safety Other 2.69 --- 
Japan 
Bellavance et al. 2007 Occ. Safety Other 20.24 --- 
Kniesner & Leeth 1991 Occ. Safety Revealed 20.24 10.59 
Miller 2000 Other Other 7.67 12.21 8.16 --- 
Viscusi 2005 Occ. Safety Revealed 15.32 --- 
New Zealand 
Guria et al. 1999 Transport Stated 4.00 --- 
Hansen & 
Scuffham 
1995 Transport CPLS 1.08 1.23 
Leung & Guria 2006 Transport Stated 4.99 21.37 
Leung & Guria 2006 Transport Stated 6.16 14.05 
Leung & Guria 2006 Transport Stated 6.16 21.37 
Leung & Guria 2006 Transport Stated 7.08 18.00 
Leung & Guria 2006 Transport Stated 4.99 8.25 
Miller 2000 Other Other 2.79 4.19 3.52 --- 
Miller & Guria 1991 Transport Stated 1.87 2.99 
The Health of Nations: The Value of a Statistical Life 
Australian Safety and Compensation Council, [March 2008] 106 
Miller & Guria 1991 Transport Revealed 2.43 --- 
South Korea 
Bellavance et al. 2007 Occ. Safety Other 2.45 --- 
Kim 1985 Occ. Safety Other 1.66 --- 
Kim & Fishback 1993 Occ. Safety Other 1.26 --- 
Kim & Fishback 1999 Occ. Safety Revealed 2.45 0.51 
Miller 2000 Other Other 0.70 1.40 0.66 --- 




1996 Transport Stated 8.90 10.72 
Miller 2000 Other Other 4.88 6.80 5.63 --- 
Persson 1989 Transport Other 3.33 --- 
Persson & 
Cedervall 
1991 Transport Stated 2.08 44.06 
Persson et al. 1995 Transport Stated 7.24 8.26 
Persson et al. 2001 Transport Stated 3.92 --- 




2001 Occ. Safety Other 9.95 13.27 
Miller 2000 Other Other 7.32 12.91 7.73 --- 
Schwab Christe 1995 Transport Stated 1.54 --- 
Schwab Christe 
& Soguel 
1995 Transport Stated 1.39 1.67 
Viscusi 2005 Occ. Safety Revealed 9.95 13.58 
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Taiwan 
Bellavance et al. 2007 Other Other 1.89 --- 
Hsueh & Wang 1987 Occ. Safety Other 2.88 --- 
Liu & Hammitt 1999 Occ. Safety Other 1.11 --- 
Liu & Smith 1996 Occ. Safety Other 1.67 --- 
Liu et al. 1997 Occ. Safety Other 1.89 0.17 
Miller 2000 Other Other 1.40 1.92 1.43 --- 




2000 Occ. Safety Revealed 45.58 9.76 
Beattie et al. 1998 Transport Stated 2.28 25.79 
Bellavance et al. 2007 Other Other 41.31 33.17 
Carlin & Sandy 1991 Transport Revealed 1.31 --- 
Carthy et al. 1999 Transport Stated 6.84 8.91 
Davies & Teasdale 1995/6 Occ. Safety Other 2.12 --- 
Donaldson 2006 Transport Other 2.93 --- 
Elliott & Sandy 1996 Occ. Safety Revealed 84.70 --- 
Folsom & Leigh 1984 Occ. Safety Revealed 15.90 --- 
Folsom & Leigh 1984 Occ. Safety Revealed 17.68 --- 
Ghosh et al. 1975 Transport Revealed 2.87 --- 
Jones-Lee 1992 Other Stated 6.61 --- 
Jones-Lee 1976 Transport Revealed 7.72 --- 
Jones-Lee 1976 Transport Stated 34.02 --- 
Jones-Lee et al. 1983 Transport Stated 1.01 17.23 
Jones-Lee et al. 1985 Transport Stated 8.55 --- 
Kochi et al. 2006 Environment Revealed 31.44 6.82 
Maclean 1979 Other Stated 8.95 --- 
Marin & 
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Psacharopailos 
1982 Occ. Safety Revealed 9.55 2.11 
Melinek 1974 Transport Revealed 1.33 --- 
Melinek et al. 1973 Other Revealed 1.43 --- 
Miller 2000 Other Other 3.66 5.58 4.80 --- 
Sandy et al. 2001 Occ. Safety Other 9.00 117.04 
Siebert & Wei 1994 Occ. Safety Revealed 22.40 10.66 




1988 Other Other 2.74 --- 




2004 Environment Other 5.53 --- 
Acton 1973 Health Stated 0.20 --- 
Alberini et al. 2002 Occ. Safety Other 1.05 2.30 
Alberini et al. 2002 Occ. Safety Other 1.66 7.22 
Aldy & Viscusi 2003 Occ. Safety Revealed 4.99 --- 
Aldy & Viscusi 2003 Occ. Safety Revealed 14.26 --- 
Aldy & Viscusi 2003 Occ. Safety Revealed 15.56 --- 
Aldy & Viscusi 2003 Occ. Safety Revealed 12.59 --- 
Aldy & Viscusi 2006 Occ. Safety Revealed 4.99 15.56 
Aldy & Viscusi 2006 Occ. Safety Revealed 5.95 --- 
Aldy & Viscusi 2006 Occ. Safety Revealed 7.42 
Aldy & Viscusi 2006 Occ. Safety Revealed 9.81 
Aldy & Viscusi 2006 Occ. Safety Revealed 8.12 
Aldy & Viscusi 2006 Occ. Safety Revealed 2.42 
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Arnould & Nichols 1983 Occ. Safety Other 2.13 --- 
Atkinson & 
Halvorson 
1990 Transport Revealed 7.71 --- 
Baker 1973 Transport CPLS 1.40 21.03 
Baker 1973 Transport Revealed 11.29 --- 
Bellavance et al. 2007 Other Other 10.76 7.85 
Berger & Gabriel 1991 Occ. Safety Other 12.03 2.11 
Blomquist 1979 Transport Revealed 2.56 --- 
Blomquist & 
Miller 
1992 Transport Revealed 2.45 9.49 
Blomquist et al. 1996 Transport Other 2.69 15.64 
Brown 1980 Occ. Safety Other 3.86 2.22 
Butler 1983 Occ. Safety Other 2.05 --- 
Caltrans 2006 Transport Other 4.32 --- 
Chestnut et al. 1999 Environment Other 7.05 
Cohen 1980 Transport CPLS 0.65 --- 
Corso et al. 2000 Transport Stated 3.97 9.42 
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CPSC 1995 Other Revealed 8.84 --- 
CPSC 2000 Other Revealed 7.90 --- 
Dardis 1980 Other Revealed 1.22 --- 
Dickens 1984 Occ. Safety Other 5.53 6.48 
Dillingham 1979 Occ. Safety Other 3.25 --- 
Dillingham 1985 Occ. Safety Revealed 6.62 3.67 
Dillingham & 
Smith 
1984 Occ. Safety Other 5.20 2.47 
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Dillingham et al. 1984 Occ. Safety Other 4.72 9.50 
Dillingham et al. 1990 Occ. Safety Other 5.41 8.84 
Dorman & 
Hagstrom 
1998 Occ. Safety Other 13.74 32.06 
Dorsey 1983 Other Other 15.16 --- 
Dorsey & Walzer 1983 Occ. Safety Other 18.59 --- 
Dreyfus & Viscusi 1995 Transport Revealed 6.89 --- 
EPA 1985 Environment Revealed 2.69 --- 
EPA 1988 Environment Revealed 7.58 --- 
EPA 1996 Environment Revealed 9.95 --- 
EPA 1997 Environment Revealed 9.95 --- 
EPA 1998 Environment Other 9.79 --- 
EPA 1999 Environment Revealed 9.95 --- 
EPA 1999 Environment Revealed 6.16 9.95 
EPA 1999 Environment Other 10.26 6.84 
FAA 1985 Transport Revealed 1.58 --- 
FAA 1988 Transport Revealed 2.37 --- 
FAA 1990 Transport Revealed 3.16 --- 
FAA 1996 Transport Revealed 4.74 --- 
FAA 1998 Transport Other 4.74 --- 
FDA 1996 Health Revealed 4.74 --- 
FDA 1996 Health Revealed 8.69 --- 
FNS (USDA) 1994 Health Revealed 2.69 5.53 
Frankel 1979 Other Stated 42.27 --- 
FSIS (USDA) 1996 Health Revealed 3.00 --- 
Garbacz 1989 Other Revealed 5.36 --- 
Garbacz 1991 Other Revealed 7.45 --- 
Garen 1988 Occ. Safety Revealed 25.93 5.59 
Gayer et al. 2000 Health Other 5.05 5.84 
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Gerking et al. 1988 Occ. Safety Stated 6.90 --- 
Gilbert & Smith 1984 Occ. Safety Other 1.42 --- 
Hakes & Viscusi 2005 Transport Other 2.71 11.98 
Herzog & 
Schottleman 
1987 Occ. Safety Revealed 20.89 --- 
Ippolito & Ippolito 1984 Health Revealed 1.99 --- 
Jenkins et al. 2001 Transport Other 2.21 6.79 
Jenkins et al. 2001 Transport Other 2.21 4.58 
Jenkins et al. 2001 Transport Other 1.90 4.42 
Jenkins et al. 2001 Transport Other 3.32 6.79 
Jondrow et al. 1983 Transport Revealed 3.23 --- 
Kniesner & Leeth 1991 Occ. Safety Revealed 0.73 0.49 
Kniesner & Viscusi 2005 Occ. Safety Revealed 8.05 --- 
Kniesner et al. 2005 Occ. Safety Revealed 7.68 9.71 
Kniesner et al. 2006 Occ. Safety Other 7.97 10.87 
Kochi et al. 2006 Environment Revealed 11.82 6.82 
Landefeld 1979 Health Other 6.01 --- 
Leigh 1987 Occ. Safety Revealed 21.12 --- 
Leigh 1991 Occ. Safety Other 11.29 3.44 
Leigh 1995 Occ. Safety Other 17.55 3.29 
Lott & Manning 2000 Occ. Safety Other 2.37 4.74 
Low & 
McPheters 
1983 Occ. Safety Other 2.20 1.59 
Ludwig & Cook 2001 Other Stated 8.44 --- 
McDaniels 1992 Transport Stated 14.14 50.83 
 
Miller 2000 Other Other 5.76 7.85 6.40 --- 
Moore & Viscusi 1988 Occ. Safety Revealed 14.47 3.78 
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Moore & Viscusi 1988 Occ. Safety Revealed 14.82 --- 
Moore & Viscusi 1989 Occ. Safety Revealed 15.84 --- 
Moore & Viscusi 1990 Occ. Safety Other 32.89 --- 
Moore & Viscusi 1990 Occ. Safety Other 32.85 --- 
Moore & Viscusi 1990 Occ. Safety Other 32.85 --- 
Morrall 1986 Transport CPLS 0.24 3.17 
Mulligan 1977 Other Stated 1.02 --- 
Needleman 1980 Occ. Safety Other 0.47 --- 
Olson 1981 Occ. Safety Other 19.54 --- 
Portney 1981 Environment Revealed 0.85 --- 
Smith 1974 Occ. Safety Other 14.58 6.08 
Smith 1976 Occ. Safety Other 9.34 --- 
Smith 1983 Occ. Safety Revealed 1.42 --- 
Smith et al. 1984 Occ. Safety Other 14.49 17.07 
Thaler & Rosen 1975 Occ. Safety Other 1.54 0.94 
US Department of 
Transportation 
2006 Transport Other 4.34 --- 
Violette & 
Chestnut 
1983 Environment Other 1.14 1.71 
Viscusi 1992 Environment Other 6.13 13.61 
Viscusi 1980 Other Other 8.69 24.01 
Viscusi 2003 Other Other 25.49 2.40 
Viscusi 2004 Other Other 8.07 0.95 
Viscusi 1978 Occ. Safety Other 3.86 2.22 
Viscusi 1981 Occ. Safety Other 13.20 --- 
Viscusi 2005 Occ. Safety Revealed 11.06 --- 
Viscusi & Aldy 2003 Occ. Safety Mixed 1.11 32.85 10.58 8.84 
Viscusi et al. 1989 Transport Other 5.43 --- 
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Viscusi et al. 1991 Transport Stated 15.48 --- 
Winston & 
Mannering 
1984 Transport Revealed 3.23 --- 
Multiple Countries 
Bellavance et al. 2007 Other Other 0.73 84.70 15.04 16.08 
De Blaeij et al. 2003 Transport Mixed 0.24 50.83 
De Blaeij et al. 2003 Transport Revealed 1.33 9.49 
De Blaeij et al. 2003 Transport Stated 1.01 50.83 
De Blaeij et al. 2003 Transport CPLS 0.24 21.03 
Dionne & Lanoie 2002 Other Mixed 10.62 --- 
Dionne & Lanoie 2002 Transport Mixed 7.25 --- 
Dionne & Lanoie 2002 Transport Mixed 6.64 --- 
Dionne & 
Michaud 
2002 Occ. Safety Other 0.47 30.04 11.08 8.56 
Gegax et al. 1991 Occ. Safety Revealed 4.32 2.18 
Kochi et al. 2006 Environment Mixed 0.14 132.85 
Kochi et al. 2006 Environment Mixed 0.97 19.34 7.51 3.34 
Kochi et al. 2006 Environment Revealed 13.08 6.54 
Kochi et al. 2006 Environment Stated 3.90 1.81 
Leeth & Ruser 2003 Other Other 4.30 --- 
Miller 1990 Other Other 5.02 1.48 
Mrozek & Taylor 2002 Other Other 3.3 --- 
Note: ‘Other’ in column 3 (study area) includes Consumption, Crime, Fire 
Safety and Mixed Studies. 
‘Other’ in column 4 (study type) signifies implicit valuation, based on 
other studies or unknown. 
CPLS = cost per life saved 
Bolded studies were included in the meta-analysis after applying the 
exclusion criteria. 
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VSLY ESTIMATES BY COUNTRY (2006A$) 
Study Year Study Area Study Type Min VSLY Max VSLY VSLY Std. Dev. 
Australia 
Abelson et al 2003 Health Other 69,099 
Abelson et al 2003 Health Other 124,378 
Bryant et al. 1992 Environme 
nt 
Other 24,638 40,580 
BTE 2000 Transport Other 74,727 100,495 




1990 Crime Other 65,674 
NHMRC 1993 Environment Other 67,660 
NOHSC 2004 Occ. Safety Other 119,589 
RCG/Hagler Baily 1994 Environment Other 418,244 
United Kingdom 
Davies & Teasdale 1995/6 Occ. Safety Other 93,187 
Donaldson 2006 Transport Other 84,450 146,582 




2004 Environment Other 242,994 
Dreyfus & 
Viscusi 
1995 Transport Revealed 655,468 884,487 
Moore & Viscusi 1990 Occ. Safety Other 1,167,207 
Moore & Viscusi 1990 Occ. Safety Other 1,500,470 
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Moore & Viscusi 1988 Occ. Safety Revealed 424,870 481,730 
Moore & Viscusi 1989 Occ. Safety Revealed 1,713,694 3,571,118 
Multiple Countries 
Baker et al. 2003 Various Other 10,089 107,924 
PARAMETERS USED IN CONVERSION RATES, BY YEAR 
AUS AUT CAN DK F JP KOR NZ SWE SWI UK US AUS CPI 
1987 1.25 0.96 1.24 8.91 1.02 198.99 470.79 1.42 7.87 2.00 0.54 1.00 
83.4 
1988 1.32 0.94 1.25 8.95 1.01 193.86 489.80 1.51 8.09 1.99 0.55 1.00 
89.4 
1989 1.37 0.93 1.26 9.05 1.01 191.09 498.96 1.53 8.42 1.98 0.57 1.00 
96.2 
1990 1.38 0.93 1.25 8.97 0.99 188.40 530.91 1.52 8.82 1.99 0.59 1.00 
103.2 
1991 1.37 0.93 1.25 8.90 0.98 187.38 567.69 1.48 9.28 2.03 0.61 1.00 
106.5 
1992 1.35 0.94 1.23 8.85 0.98 186.15 597.20 1.47 9.16 2.03 0.62 1.00 
107.6 
1993 1.34 0.95 1.22 8.70 0.97 182.93 620.86 1.47 9.23 2.03 0.62 1.00 
109.5 
1994 1.33 0.95 1.21 8.66 0.97 179.32 655.67 1.46 9.28 2.02 0.62 1.00 
111.6 
1995 1.32 0.95 1.21 8.59 0.96 174.85 690.04 1.46 9.42 2.00 0.62 1.00 
116.8 
1996 1.32 0.94 1.21 8.55 0.95 170.45 711.81 1.47 9.31 2.01 0.63 1.00 
119.8 
1997 1.32 0.94 1.21 8.56 0.93 168.52 732.44 1.45 9.37 1.93 0.62 1.00 
120.1 
1998 1.31 0.94 1.19 8.52 0.93 166.58 766.56 1.45 9.46 1.90 0.63 1.00 
121.1 
1999 1.30 0.93 1.19 8.41 0.93 162.04 754.89 1.43 9.34 1.93 0.64 1.00 
122.9 
2000 1.31 0.91 1.23 8.41 0.92 154.93 753.19 1.45 9.19 1.90 0.63 1.00 
128.4 
2001 1.33 0.92 1.22 8.33 0.90 149.42 761.49 1.47 9.32 1.89 0.62 1.00 
134.0 
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2002 1.34 0.91 1.23 8.43 0.90 143.67 778.77 1.47 9.36 1.80 0.61 1.00 
138.1 
2003 1.35 0.88 1.24 8.47 0.93 138.47 783.30 1.46 9.25 1.76 0.62 1.00 
141.9 
2004 1.36 0.87 1.25 8.40 0.92 133.10 782.19 1.47 9.18 1.73 0.62 1.00 
145.2 
2005 1.38 0.87 1.25 8.40 0.90 127.52 755.82 1.46 9.21 1.70 0.62 1.00 
149.1 
2006 1.39 0.86 1.23 8.37 0.89 124.50 744.47 1.47 9.17 1.68 0.62 1.00 
154.4 
Source: OECD for purchasing power parity, Australian Bureau for 
Statistics for CPI. 
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Source: Mathers et al (1999) 
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Appendix C – Example of a RIS Cost Benefit 
Analysis 
A Regulatory Impact Statement (RIS) in occupational health and safety 
(OHS) regulation typically requires cost benefit analysis (CBA) that, in 
turn, can require the estimation of the benefits of occupational incidents 
averted and the consequent saving of human life and wellbeing. Valuing 
the prevention of fatalities and disability can be complex and Access 
Economics has thus provided this guide as an appendix to the main 
report, to assist the Office of the ASCC in preparing CBAs for RIS 
purposes. This accords with OBPR (2007:68): 
‘The Government requires that RISs include a comprehensive assessment 
of the expected impact (costs and benefits) of each feasible option. The 
objective should be to choose the most appropriate option for resolving 
the identified problem and to provide readily accessible evidence to 
support this decision.’ 
In turn, this aligns with COAG (2004:2) that Regulatory Impact 
Assessments should ‘identify the need for regulation and quantify the 
potential benefits and costs of regulation.’ OBPR (2007:69-87) 
summarise the key issues to be addressed in the RIS (noting that 
consultation with affected parties is a requirement of the process) as 
follows: 
> Who is affected by the problem and who is likely to be affected by 
proposed solutions? Identify and categorise the expected economic, 
social and environmental impacts of the proposed options as likely 
costs and benefits. 
> Assess the costs and benefits that will be experienced by different 
stakeholder groups, including small business, and by the community 
as a whole. 
> Quantify these impacts where significant. Quantify the compliance 
costs on business. Examine the effect of each option on individuals, 
and on the cumulative burden on business. 
> Summarise outcomes for each option examined. Identify the data 
sources and assumptions used in making these assessments, and any 
gaps in data. 
This guide sets out a practical approach to undertaking CBA in the 
context of RIS consideration, using a worked example. The detailed 
approach to each RIS will naturally vary. That said, the following broad 
process is typical in CBA analysis and accords well with the OBPR dot-
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points above and with the nine CBA steps in OBPR (2007:116-123).26 The 
appendix is structured to reflect this process. 
1 Identify options, costs and benefits conceptually expected to be 
associated with each option and the timeframes over which these are 
likely to occur.  
2 Establish methodological processes to quantify the costs and benefits. 
3 Estimate the costs and benefits using modelling techniques. 
4 Report the findings and perform sensitivity testing. 
Step 1: Identify Options, Costs, Benefits and 
Timeframes 
In the RIS context, CBA is undertaken in relation to a number of potential 
policy options, with: 
1 the first option typically retention of the status quo; 
2 other option(s) typically some proposed change(s) to a standard or 
regulation; and 
3 the final option typically involves a non-regulatory, self-regulatory or 
co-regulatory approach. 
In this guide, a deliberately generalised example is used along these lines 
as follows, for a proposed regulation in the mining industry that provides 
additional protections to prevent falls. The scenario and data in the CBA 
guide are all hypothetical. 
> Option 1 – Retention of current diverse arrangements between 
different jurisdictions. 
> Option 2 – Develop a national regulation that brings consistency to 
jurisdictional practices and is expected a priori to increase safety 
overall. 
> Option 3 – Encourage industry to self-regulate towards general safety 
objectives. 
The CBA then compares: 
                                      
26 OBPR (2007:127) also notes that, in the case of costs and benefits that are 
difficult to measure, such as health and safety: ‘When policy officers do not have 
the resources or expertise to conduct an original study, they may want to ‘plug 
in’ values from previous studies. Frequently used plug-ins include the value of a 
statistical life or life year, value of travel time savings, the cost of noise pollution 
and the cost of air pollution.’ This report is designed to assist the Office of the 
ASCC both with the CBA process and with appropriate, best available ‘plug-ins’ 
for VSLY. 
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> Option 2 relative to Option 1; and 
> Option 3 relative to Option 1. 
In this guide only Option 2 relative to Option 1 is considered, as Option 3 
relative to Option 1 can be evaluated in a similar manner. 
The main evaluation criterion is incremental net benefit, measured in 
terms of the net present value (NPV) of benefits minus the NPV of costs 
over a particular time horizon. This can also be presented easily as the 
benefit: cost ratio – ie, the NPV of benefits divided by the NPV of costs. 
In line with the body of the report, it is also suggested that the 
incremental cost effectiveness ratio (ICER) is reported too, due to the 
uncertainty surrounding the Value of a Statistical Life Year (VSLY). The 
ICER metric should be presented as net financial benefits per Disability 
Adjusted Life Year (DALY) averted (ie, $/DALY). Net financial benefits 
exclude the dollar value of DALY savings and hence avoid the need to 
agree on an appropriate VSLY. 
Identify Conceptual Costs and Benefits 
Typically there are costs and benefits associated with any regulatory 
change. These can be considered a priori and tabulated so that the 
relationships are clear, together with sources for how they can be 
estimated. A suggested framework for the worked example is provided in 
the table below. In the example, the costs and benefits are incurred by 
workers, firms and governments. In the real world, other stakeholder 
groups such as consumers and interest groups may also naturally 
experience costs or benefits that should be considered in the CBA as well, 
but for simplicity are not included in this example. 
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CBA FRAMEWORK FOR AN EXAMPLE RIS CBA 
Cost/Benefit category Source of data/ method 
Option 2 relative to Option 1  
Costs (1) = 1.1 + 1.2 + 1.3  
1.1 Compliance costs for firms changing to new 
arrangements 
Survey 
1.2 Additional costs for workers Survey 
1.3 Additional costs for governments Direct consultation process 
Benefits (2) = 2.1 + 2.2  
2.1 Benefits of consistent regulation Survey 
2.2 Incidents averted due to OHS compliance multiplied by 
average cost per incident averted (including direct and 
indirect costs*) equals Value of incidents averted (financial, 
QALYs, total), shared between worker, firm, 
government/society 
NDS for trends in incidents; literature 
analysis for the impact of the change; 
NOHSC (2004) and this report for wellbeing 
Net social benefits: 
NPV of (2)-(1) 
 
Benefit:Cost Ratio and $/QALY  
Note: NOHSC= National Occupational Health and Safety Commission. * 
As per NOHSC (2004), cost components included are: production 
disturbance costs; human capital costs; medical and rehabilitation costs; 
administrative costs (including legal investigation and travel costs); other 
costs (caring for disabled workers, aids and home modifications); 
suffering costs (measured in QALYs, with the option of converting to a 
dollar indicative value, using the VSLY). 
Timeframes 
The most common timeframes for CBAs are around ten years, as this 
typically allows times for benefits to flow through and for the effect of 
any lumpy up-front costs to be absorbed. It is also important to select a 
base year, which is usually the year that the regulation is likely to take 
effect. In this guide example, it is assumed that the regulation will take 
affect on 1 July 2008 so the base year is financial year 2008-09 (reported 
as 2008 for brevity in the tables and other financial years are similarly 
reported by opening year ie, the periods can be interpreted as ‘financial 
year starting 1 July of’). The period for the CBA is 2008-2017. 
Step 2: Establish a Methodology for Quantifying Costs 
and Benefits 
To accurately measure economic costs and benefits, it is frequently 
necessary to ascertain the views of stakeholders and to search the 
literature and data sources to ascertain likely impacts and appropriate 
valuation methodologies used in other similar studies, if these exist. 
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Consultation processes and literature and data search protocols should 
naturally be clearly described and referenced in the CBA. 
Consultation Processes 
Consultation processes are often necessary to validate that all 
appropriate costs and benefits have been included in the CBA and to 
quantify the extent of impacts. Consultation processes may include 
workshops, telephone or face-to-face interviews, surveys, focus groups 
and/or comments processes on draft documents. 
In the example in this guide, in the mapping of costs and benefits in Step 
1, it was thought appropriate to determine the potential compliance costs 
of firms and workers (Cost Items 1.1  and 1.2) and the benefits of 
consistent regulation (Benefit Item 2.1) using a purpose designed survey 
of firms. It is advantageous to collect data as far as possible stratified by 
type of cost/benefit, year it is likely to be incurred and who experiences it 
(the firm, the employee, the government, or others). Sometimes there is 
a desire to stratify the impacts by other factors, such as whether the firm 
is small, medium sized or large, or by the age/gender or industry of the 
employee, for example. 
For a survey it is necessary to: 
> decide on the form of the survey eg, paper-based, electronic – 
emailed or web-based, or computer assisted telephone interview 
(CATI); 
> decide who will field the survey; 
> decide an appropriate sample size given likely response rates; 
> carefully design the survey questions; 
> identify the target respondents and the pilot sample; 
> pilot the survey and modify questions in light of pilot responses; 
> field the final survey; and 
> analyse the results to acquire the desired parameters. 
For Cost Item 1.3 (the costs to government of changing to the new 
regulation) in the example, are collected by direct telephone conversation 
discussions with contacts in each jurisdiction that currently does not have 
the regulation – identifying the additional costs that these jurisdictions 
would face, by type of cost and when it is likely to be incurred. 
Literature And Data Searches 
Literature review and data searches are commonly used to establish the 
parameters of change. These are crucial to the analysis and typically 
drive the findings. 
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Common sources of information are the National Data Set for 
Compensation-based Statistics (NDS), data from Australian Bureau of 
Statistics (ABS) surveys and publications (eg, Work Related Injuries, the 
Labour Force Survey, demographic data and employment data by 
industry). 
In the example in this guide, the reduction in incidents needs to be 
calculated for Benefit Item 2.2. In this case, suppose a literature search 
is used, assisted by the DEEWR library, to identify the effect of a 
particular regulatory change on incidents based on overseas experience 
with an almost identical regulatory intervention and with mining working 
conditions in that country similar to those in Australia. Published peer-
reviewed journal articles are identified by the DEEWR library that show a 
range of different estimated findings from various samples of mines 
resulting from the proposed change in storage arrangements.  
MIX meta-analysis is used to determine the overall impact on incidents 
and it is found that over all the samples there is a 30% (95% CI: 25%-
35%) reduction in falls incidents per 1,000 workers over the year 
following the introduction of the regulation, compared to before the 
regulation, after controlling for other factors. After this one-off fall in 
rates, the literature also suggests there is no further change to trends in 
rates. 
The severity pattern of the reduction in incidents, however, was found to 
be slightly more concentrated on fatalities (2% of incidents resulted in 
fatalities), due to the nature of the proposed regulation. If this were not 
the case, the default position would be that neither fatalities nor less 
severe incidents are over-represented in the reductions ie, they should 
follow the severity pattern of incidents before the regulatory change and, 
if no data are available, the default parameter from NOHSC (2004) 
across all incidents (injury and disease, compensated and 
uncompensated) is 1.5%. 
The next step is to analyse NDS data in relation to the trends in falls 
incidents per 1,000 workers in Australia in the mining industry. These 
show a downward trend over five years of 2% per annum as illustrated in 
the figure below. Moreover, from the data by jurisdiction, a significant 
difference in the level of incidents per 1,000 workers is found between 
the jurisdictions that already have the proposed regulation (introduced 
before 2000) and those that do not, with the former some 29.9% lower 
than the latter (see table over page). 
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Falls incidents in mining, jurisdictions with and without 
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As such, the literature and cross-sectional data corroborate each other to 
imply that a parameter of a one-off decrease of 29.9% is appropriate to 
model as the impact effect for the jurisdictions currently without the 
regulation, to bring them to the rates of the other jurisdictions from the 
year the regulation is introduced and thereafter. Note that in a CBA it is 
unusual to have two sources of parameters estimates – from the 
international literature and from cross-sectional data – that corroborate 
each other so well. In most cases, there is only one source available, or 
the estimates do not corroborate each other well and a best estimate 
needs to be made. 
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Falls incidents in mining, jurisdictions with and without 











2000 13.10 18.70 15.80 
2001 12.84 18.33 15.48 
2002 12.58 17.96 15.17 
2003 12.33 17.60 14.87 
2004 12.08 17.25 14.57 
2005 11.84 16.90 14.28 
Source: Hypothetical NDS data 
While analysing the data on falls incidents in mining, it is usually 
important to identify the component of total falls historically that result in 
fatalities. In this case, however, the proportion of fatalities in reduced 
incidents will be modelled as 2% in line with the literature findings. If this 
proportion were not available, it is possible to use the average from 
NOHSC (2004) across all incidents of 1.5% (as mentioned above). 
NDS data are also useful to estimate the unit cost of a compensation 
claim, which is another important input for estimating Benefit Item 2.2. 
Suppose the Office of the ASCC has data for mean and median costs for 
mining industry claims, with the latest available data being for (the year 
starting 1 July) 2005, which generally include all severity categories 
except the cost of injuries of less than one week (since these are rarely 
compensated so data are usually too sparse to confidently report). 
However, the mean cost data are less reliable in the most recent years, 
because the largest cost claims can take the longest to settle. As such 
only mean cost data from 2000 to 2003 are used. Median costs are 
affected in a similar way, but tend to be affected to a lesser extent. As 
such, median costs are a better indication of trends, while mean costs 
are a better indication of levels. Both data series show nominal increases 
in costs of 6% on average per annum for the years available, so this 
nominal increase in cost per claim is projected over the whole period. 
Real costs are also calculated (in 2008 dollars) with an imputed inflation 
rate of 3% per annum, based on (hypothetical) wage inflation rates in 
the mining sector from ABS data since a large component of these costs 
are productivity losses. 
Falls incidents in mining, financial costs per claim, Nominal and 
real, Australia, 2000-2005 
Nominal Real (2008 dollars) Year starting 
1 July Mean   Median Mean Median 
2000 22,250 16,000 27,995 20,131 
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2001 23,585 16,960 28,835 20,735 
2002 25,000 17,978 29,700 21,357 
2003 26,500 19,056 30,591 21,998 
2004 28,090 20,200 31,509 22,658 
2005 29,776 21,412 32,454 23,338 
Source: Hypothetical NDS data in bold; other data derived and projected.   
Note: NDS data on compensated costs is updated annually for five years and should be 
revisited for currency. 
It is unusual for mean and median costs to rise at the same rate as 
portrayed in this example. If they differ, the median rate should be used 
as it is more reliable, but the mean cost for 2000 should be used to 
benchmark against average costs for all Category 2-5 compensated 
incidents in all industries. The latter is estimated as $21,080 (also from 
NDS data), so falls in mining are slightly more costly than the mean of all 
incidents by a factor of 1.056. If costs had been found to be less than the 
overall mean, this factor would be less than unity. 
The NOHSC (2004) Report 
The cost of occupational injury and disease, estimated by Access 
Economics in 2004 for NOHSC for the base year 2000-01, is useful in the 
calculation of the average benefit of the incidents averted (Benefit Item 
2.2), while noting it might soon be appropriate to revisit this estimate 
and undertake a costing of OHS incidents for a later year. 
The report obtained an estimate of (financial) costs of $33.2 billion (5.0% 
of then GDP), plus an estimate of the cost of pain and early death of 
some $57 billion. The study utilised an incidence approach to cost 
measurement, which is appropriate for CBAs in RIS work, and 
distinguished: 
> compensated from uncompensated cases; 
> injury from disease; 
> (five) different severity categories those being: 
_ Category 1 – off work for less than one week; 
_ Category 2 – off work for more than one week, full return to work; 
_ Category 3 – off work for more than one week, partial return to work; 
_ Category 4 – do not return to work (permanently disabled); 
_ Category 5 – fatality; 
> types of costs by six conceptual cost groups; and 
> who bears the cost (employer, worker or society). 
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The report also developed a more structured categorisation of costs that 
distinguished real economic costs from financial transfers. This avoided 
previous double-counting and misallocation, for example of including 
welfare payments and taxation losses as part of total real costs, when 
they are in fact transfers from society to the worker. 
The study identified six conceptual cost groups, consistent with the thrust 
of the literature, where each group can be viewed as contributing a total 
net cost to Australia. Within each group there may be flows between the 
‘burden-bearers’ – employers, workers and society. 
The conceptual groups are outlined below, with costs in 2000-01 dollars. 
> Production disturbance costs ($1.4 billion) comprise the value of 
production lost between the incident and when a worker either returns 
to work or is (fully or partially) replaced, as well as the staff turnover 
costs – the latter treated as a cost ‘brought forward’. The employer 
bears a significant proportion of the PDC burden ($600 million) 
through overtime premium payments, sick leave and employer excess 
payments. 
> Human capital costs ($25.7 billion) are the most important single 
item, reflecting the lost productive capacity of the worker over the 
longer term – until retirement age. Some $11.7 billion of this cost is 
borne by workers through lower incomes, while $14 billion is borne by 
society through welfare payments ($4.8 billion), taxation losses ($4.3 
billion) and compensation payments (around $4.8 billion). 
> Medical costs ($2.0 billion), including rehabilitation costs of $1 billion, 
cover the health and ‘return to work’ expenses of the worker. These 
may be understated since it is unclear the extent to which the 
compensation data is capturing unbilled transactions such as 
treatment at public hospitals, as well as private health insurance 
claims or other gaps. 
> Administration costs ($1.4 billion in total) include legal costs ($454m), 
the cost of investigating claims and administration of the 
compensation system ($524m), travel costs for workers ($419m) and 
the cost of bringing forward funerals ($8m). 
> Transfer costs ($1.5 billion in total) are the deadweight loss (DWL) of 
administering the welfare system ($257m) and the efficiency losses 
associated with the need to fund additional welfare payments and 
replace lost income tax ($1.1 billion) following occupational incidents. 
> Other costs result from changes to the scope of the estimates. 
> These include the real costs of carers ($895m) and of aids and 
modifications ($281m) that can be required by Category 4 workers 
who develop disabilities as a result of occupational incidents. 
> Damage to property was considered conceptually different and 
excluded from the costs of occupational incidents that result in injury 
or illness to humans. Loss of goodwill consequent on injury or disease 
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was also excluded since it was considered neither substantial nor 
readily measured. 
> An important suggestion was to include an estimate of the cost of 
suffering and early death, utilising willingness to pay methodology and 
the concept of the value of a statistical life (VSL). This produced 
results in line with those from a major study in the US, in that this 
cost item is substantially higher than all the other cost items put 
together, ranging from $57 billion to as much as $126 billion. 
Since the underlying concepts and their measurement are somewhat 
controversial, it was suggested that this cost item be separately reported. 
> The report identified the number of incidents by injury, disease, 
compensated and uncompensated cases, and by severity of the 
incident. Overall there were just under 350,000 occupational incidents 
estimated in 2000-01, around 3.8% of the workforce.  
Employers bore an estimated $1 billion (3%) of the total costs. Workers 
bore around $13.7 billion (41%) and society – through the compensation 
system and government sector – bore $18.5 billion (56%). However, it is 
important to note that employers also pay the workers’ compensation 
premiums from which society meets in part its lion’s share. Were an ‘ex 
ante’ measurement approach adopted rather than an ‘ex-post’ one, the 
community share would be lower (around 35%) and the employer share 
would be higher (around 24%), since over $7 billion extra would be 
borne by the employers. It was also noted that employers, in turn, may 
pass on the higher premiums in higher prices, or may use them to 
negotiate lower overall wage and salary payments. Thus in general 
equilibrium the compensation costs are spread across the economy. 
A final point to note is that the cost per incident (benefit per incident 
averted) is not likely to vary much by the size of the firm or by 
jurisdiction, since the main elements are healthy life, human capital, 
production and medical costs, which would be dependent much more on 
the nature and severity of the incident rather than on the size of the firm 
or the jurisdiction in which the incident occurred. The implicit assumption 
is thus that while incident rates might vary in respect of these two 
factors, the average cost per incident would remain broadly constant. 
The average cost per incident from NOHSC (2004) is presented in the 
next table. 
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Average financial cost per incident, 2000-01 
Severity category Average cost per incident 
1 Full return to work, absence < 1 
week 
$1,481 
2 Full return to work, absence > 1 
week 
$11,803 
3 Partial return to work $188,847 
4 Permanent disability, no return 
to work 
$859,035 
5 Fatality $674,108 
Average cost, all categories $94,865 
Source: NOHSC (2004). 
 
The average financial cost per incident of $94,865 was found to be 
substantially higher than the average compensated cost per claim for 
Category 2-5 compensated incidents only, which was estimated as 
$21,080 in 2000-01 in the previous section, by a factor of 4.50. 
Step 3: Estimate Costs and Benefits 
The third step is to estimate the costs and benefits from the parameters 
identified in the literature and data search. 
Compliance Costs for Firms and Workers 
In a CBA, different types of costs would each be separately identified – 
eg, additional expenditure on falls protection equipment, productivity 
losses due to changed work practices, and so on. However, since the 
total is all that is necessary as an input to the CBA, for simplicity for this 
worked example, this is the only aspect reported in the table below, with 
the data directly from the survey highlighted in bold. 
 
Cost of changing to the new regulation borne by firms and 
workers, jurisdictions without regulation, 2008 and future years 
(2008 dollars) 
 Year starting 
1 July 2008 
Future years 
Firm costs, $ per firm 120,000 30,000 
Average workers per 
firm 
150 150 
Costs for firms, $ per 800 200 
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worker 
Costs for workers, $ 
per worker 
200 100 
Workers (number)* 10,000 10,000 
Total costs, firms ($) 8,000,000 2,000,000 
Total costs, workers ($) 2,000,000 1,000,000 
Total costs, firms & 
workers ($ pa) 
10,000,000 3,000,000 
Source: Bolded items – hypothetical specialised mining industry survey data; * ABS data. 
 
> In this case there are no costs of changing for the jurisdictions that 
already have the regulation, so the Australian totals are simply the 
total of the jurisdictions without regulation (10,000 workers in all). 
Firms and workers were asked to report their costs in estimated 2008 
dollars. 
> In the survey, firms could only report their firm-wide costs ($120,000 
per firm, on average in 2008 and $30,000 per annum thereafter) and 
number of workers (150 per firm on average, with no change 
expected), so an average cost per worker is derived ($800 per annum 
in 2008 and $200 per annum thereafter). 
> In the survey of workers, workers estimated the costs they would 
bear personally as $200 in 2008 and $100 per annum thereafter. 
> The number of workers in the industry would be derived from ABS 
data (projected – in this case with flat projected growth) and the total 
costs thus calculated. 
The cost of the proposed regulatory change to firms is thus estimated as 
$8 million in 2008 and $2 million per annum thereafter, in 2008 dollars.  
The cost of the proposed regulatory change to workers is thus estimated 
as $2 million in 2008 and $1 million per annum thereafter, in 2008 dollars.  
Additional Costs for Governments 
In our hypothetical example, talking to each of the relevant policy 
implementation areas of jurisdictions that did not have the proposed 
regulation, enabled estimates of costs for each of the jurisdictions of 
changing to the new regulation that would be borne by State/Territory 
Governments. Once again, in the CBA such costs would be specifically 
identified eg, public sector staff costs, costs of education and awareness 
raising materials (information dissemination), enforcement, and so on. 
However, since the total for each is all that is necessary for the CBA, for 
simplicity this is the only aspect reported in the table below. 
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Cost of changing to the new regulation borne by state/territory 
governments, jurisdictions without regulation, 2008 and future 
years (2008 dollars) 
 Year starting 
1 July 2008 
Future years 
Jurisdiction 1 1,000,000 500,000 
Jurisdiction 2 2,000,000 1,000,000 
Jurisdiction 3 3,000,000 1,500,000 
Jurisdiction 4 4,000,000 2,000,000 
Total costs, 
governments ($ pa) 
10,000,000 5,000,000 
Source: Hypothetical consultation processes. 
The cost of the proposed regulatory change to government is thus 
estimated as $10 million in 2008 and $5 million per annum thereafter, in 
2008 dollars. 
Benefits of Greater Consistency 
In the survey of firms, only small benefits of greater consistency were 
estimated to be derived, as presented, on average in the following table. 
(The benefit from consistency would vary depending on the extent that 
firms operated across jurisdictions and their size.) 
Benefits of greater consistency from changing to the new 
regulation for firms, all jurisdictions, 2008 and future years (2008 
dollars) 
 Year starting 
1 July 2008 
Future years 
Firm benefits, $ per 
firm 
7,500 1,500 
Average workers per 
firm 
150 150 
Benefits for firms, $ per 
worker 
50 10 
Workers (number)* 20,000 20,000 
Total benefits, firms ($) 1,000,000 200,000 
Source: Bolded items – hypothetical specialised mining industry survey data; * 
Hypothetical ABS data. 
The benefit of the proposed regulatory change to firms due to greater 
consistency is estimated as $1 million in 2008 and $0.2 million per 
annum thereafter, in 2008 dollars. 
The Health of Nations: The Value of a Statistical Life 
Australian Safety and Compensation Council, [March 2008] 145 
Benefits of Reduced Incidents 
The calculation of the benefits of reduced incidents is the most complex 
part of the analysis. A key assumption in the analysis is that the 
difference in incident rates between jurisdictions with legislation and 
those without legislation is attributable to the lack of legislation, and 
evidence supporting this assumption should be provided in the CBA. Then 
the reduction in incidents per annum is derived, as explained in the next 
section. 
Number of incidents 
The reduction in the number of incidents is derived from the parameters 
and data from the literature and data section above. The number of 
workers is found to be equally divided between the jurisdictions currently 
with the regulation and those without, according to (hypothetical) ABS 
data, with flat growth in both sets of jurisdictions projected over the CBA 
time horizon. The 2% per annum decline in mining falls incidents is 
assumed to continue in the absence of the regulatory change, but in the 
case of Option 2, the incident rate for the jurisdictions without the 
regulation decreases by 29.4% to the incident rate of the jurisdictions 




Falls in mining, incidents, 2008-2017, Option 1 and Option 2 
Year starting 1 July 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Workers
Jurisdictions with regulation 10,000    10,000    10,000    10,000    10,000      10,000    10,000    10,000    10,000    10,000    
Jurisdictions without regulation 10,000    10,000    10,000    10,000    10,000      10,000    10,000    10,000    10,000    10,000    
Total workers 20,000    20,000    20,000    20,000    20,000      20,000    20,000    20,000    20,000    20,000    
Incident rate
Jurisdictions with regulation 11.14      10.92      10.70      10.49      10.28        10.07      9.87        9.68        9.48        9.29        
Jurisdictions without regulation 15.91      15.59      15.28      14.97      14.67        14.38      14.09      13.81      13.54      13.26      
Incidents
Jurisdictions with regulation 111.4      109.2      107.0      104.9      102.8        100.7      98.7        96.8        94.8        92.9        
Jurisdictions without regulation, Option 1 159.1      155.9      152.8      149.7      146.7        143.8      140.9      138.1      135.4      132.6      
Jurisdictions without regulation, Option 2 111.4      109.2      107.0      104.9      102.8        100.7      98.7        96.8        94.8        92.9        
Total incidents, Option 1 270.5      265.1    259.8    254.6    249.5      244.5    239.7     234.9      230.2      225.6    
Total incidents, Option 2 222.9      218.4    214.1    209.8    205.6      201.5    197.5     193.5      189.6      185.8    
Difference 47.6        46.7      45.8      44.8      43.9        43.1      42.2       41.4        40.5       39.7       
The number of incidents estimated to be averted due to the proposed 
regulatory change gradually declines over the period from 47.6 incidents 
averted in 2008 to 39.7 incidents averted in 2017 for Option 2 compared 
to Option  
The gradual decline reflects the gradual tapering of the percentage 
decline in incidents overall as rates gradually approach zero (due to other 
factors). 
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Financial cost per incident 
Factoring up costs by 4.50 (to allow for costs that are not compensated), 
the average cost per fall in mining is calculated in real terms as shown in 
the next table. 
Mean cost per fall in mining (2008 dollars) 
Year starting 1 
July 




















These real costs can then be applied to the difference in incidents 
between Option 1 and Option 2, in order to estimate the total financial 
benefits of falls averted. 
Falls averted in mining, financial benefits, 2008-2017, Option 2 
 (2008 dollars) 
Year starting 1 July 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Difference 47.6        46.7        45.8        44.8        43.9          43.1        42.2        41.4        40.5        39.7        
Average real cost ($2008) per fall 159,592  164,380  169,312  174,391  179,623    185,011  190,562  196,279  202,167  208,232  
Financial benefit (falls averted), $m 7.60        7.67      7.75      7.82      7.89        7.97      8.04        8.12        8.19      8.27       
The real financial benefits of potential mining falls averted due to the 
proposed regulation are estimated as $7.60 million in 2008, rising to 
$8.27 million in 2017, for Option 2 compared to Option 1. 
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Burden of Disease 
The financial benefits of falls averted are, however, not the only benefits. 
There is also the value of the ‘burden of disease’ that is averted – both 
the premature mortality component and the disability component. 
Burden of disease is measured in disability adjusted life years (DALYs) 
and is comprised of two components – the premature mortality 
component measured in Years of Life Lost due to premature death (YLL) 
and the disability component measured in Years of healthy life Lost due 
to Disability (YLD). 
Estimating the value of the burden of disease is a two-step process: 
1 estimating the number of DALYs averted; and 
2 ascribing a value to these DALYs, both in gross and net terms. 
To estimate the number of DALYs, it is necessary to employ the split 
between fatal and nonfatal incidents averted from the literature and data 
section above, which was found to be 2% for fatalities. 
Thus in 2008, for example, of the 47.6 incidents estimated to be averted 
due to the proposed regulation, 0.95 of these are fatalities and 46.69 are 
estimated to be non-fatal. 
YLL is then calculated by multiplying 0.95 by the estimated and 
discounted number of years of life remaining based on average life 
expectancy. This requires data on the age-gender distribution of the 
deaths due to falls in mining, which may be able to be derived from NDS 
data. However, the usual case is that the age-gender distribution of 
deaths is not available. In this case, an estimate of 23.81 years is used, 
which is an estimate of the average life years remaining across all 
incidents, discounted at 3% per annum. The selection of this discount 
rate is explained in Section 3.4, and 23.81 is the ratio of the suggested 
(base case) VSL to VSLY27, for consistency with the other calculations in 
the CBA. 
Thus, in 2008 the YLL averted due to the proposed regulatory change is 
estimated as 22.7 DALYs, falling to 18.9 DALYs by 2017. 
YLD is calculated by multiplying the non-fatal falls averted by an 
appropriate disability weight, as outlined in the Appendix B tables (based 
on weights used by the AIHW in turn derived from the global burden of 
disease disability weights). For falls, this weight is 0.141. As with YLL, it 
is also necessary to estimate the period over which this weight applies ie, 
                                      
27 VSL(Y): Value of a statistical life (year) estimates – see Chapter 4 and Section 
5.6 (especially Table 5—2). 
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the period of the disability, which could be derived from NDS data if the 
age-gender distribution and the severity distribution are known. 
However, also as with YLL, this is usually not the case, so an estimate is 
used based on the average distribution of non-fatal incidents by severity 
from NOHSC (2004). 
> Category 1 incidents comprise over half with an imputed duration of 
half a working week (2.5 days). 
> Category 2 incidents comprise 33.9% with an imputed average 
duration of six months. 
> Category 3 and 4 incidents together comprise the remaining 14.7% of 
non-fatal incidents and are permanent, so the disability weight applies 
to remaining life expectancy, estimated (see above) as 23.81 years on 
average. For Category 3, if the worker has a period off work and then 
only ever returns part-time, it implies that the injury has an effect 
that has will last the rest of his or her life ie, the same duration of 
impact on average as for the workers who never return (Category 4). 
Average duration of OHS incidents 
 All OHS 
incidents (2000-
01) 
% non-fatal Average 
duration (years) 
Less than five days 177,098 51.4% 0.01 
Temporary full 
return 
116,620 33.9% 0.50 
Temporary partial 
return 
23,213 6.7% 23.81 
Permanent non-fatal 27,355 7.9% 23.81 
Total non-fatal 344,286 100% 3.67
Source: Based on NOHSC (2004).  Note: Totals may not sum exactly due to rounding. 
The weighted average duration of a non-fatal OHS incident is thus 
estimated as 3.67 years and, for 2008, YLD = 3.67 * 0.141 * 46.69 = 
24.16 DALYs. 
Thus, in 2008 the YLD averted due to the proposed regulatory change is 
estimated as 24.2 DALYs, falling to 20.1 DALYs by 2017. 
Total DALYs averted are then calculated as YLL + YLD for each year and 
multiplied by the VSLY of $266,843 for 2008 in 2008 dollars. This 2008 
VSLY is the 2006 VSLY estimated in the main body of the report of 
$252,014 multiplied by two years of inflation (2.9% in each year, from 
the Access Economics Macroeconomic model) to calculate the ‘gross’ 
value of the DALYs averted – 46.8 DALYs in 2008 ($11.8 million) falling 
to 39.1 DALYs by 2017 ($9.9 million). 
However, it is necessary to bear in mind that the wage-risk studies 
underlying the calculation of the VSL take into account all known 
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personal impacts – suffering and premature death, lost wages/income, 
out-of-pocket personal health costs and so on – so the estimate of the 
value of DALYs should be treated as a ‘gross’ figure. However, costs 
specific to the falls that are unlikely to have entered into the thinking of 
people in the source wage/risk studies should not be netted out (eg, 
publicly financed health spending, care provided voluntarily). 
The netting out process utilises the parameter from NOHSC (2004) that 
the average individual’s share of the financial costs of OHS incidents is 
41%. Thus: 
         Net DALYs = Gross DALYs minus 41% * Financial benefits from  
incidents averted 
In this case, net DALYs in 2008 equal 11.8 – 41% * 7.6 = $8.7 million. 
Thus, in 2008 the net value of the DALYs averted due to the proposed 
regulatory change is estimated as $8.7 million, falling to $6.5 million by 
2017. 
Falls in mining, burden of disease averted and its value, 2008-
2017, Option 1 and Option 2 
Year starting 1 July 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Fatalities averted (2%) 0.95       0.93       0.92       0.90       0.88          0.86       0.84       0.83       0.81       0.79       
Non-fatal falls averted 46.69     45.76     44.84     43.94     43.07        42.20     41.36     40.53     39.72     38.93     
YLL 21.43     21.00     20.58     20.17     19.76        19.37     18.98     18.60     18.23     17.86     
YLD 22.88     22.42     21.97     21.53     21.10        20.68     20.27     19.86     19.47     19.08     
DALYs 44.31     43.42     42.55     41.70     40.87        40.05     39.25     38.46     37.69     36.94     
Gross value of DALYs averted ($m) 11.82     11.59     11.35     11.13     10.90        10.69     10.47     10.26     10.06     9.86       
Net value of DALYs averted ($m) 8.71       8.44     8.18     7.92     7.67        7.42     7.18      6.93       6.70      6.47      
Step 4: Report Findings and Sensitivity Analysis 
The final part of the CBA is to compare the NPV of the costs and benefits, 
to report the findings in the ‘base case’ with potential sensitivity analysis 
surrounding key parameters. 
Cost Benefit and Cost Effectiveness Analysis 
For the year starting 1 July 2008, costs of the proposed new regulation 
(Option 2 compared to Option 1) are estimated as $20 million – of which 
$8 million were borne by firms, $2 million by workers and $10 million by 
governments. Financial benefits are estimated as $8.6 million, of which 
$1 million are the benefits to firms of greater consistency and the 
remainder are the financial benefits of mining falls averted. So there is a 
net financial cost of $11.4 million in 2008. However, this is reversed in 
later years, although the NPV over the whole period still shows a net 
financial cost of $10.2 million in 2008 dollars, using a discount rate for 
these real streams of 3% per annum. 
> The NPV of the DALYs averted, however, more than offsets the net 
financial costs, so the total net benefit over the forecast horizon is 
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estimated as $57 million, although noting there is still a total net cost 
in 2008 of $2.7 million. 
> The benefit-cost ratio over the period in NPV terms is 0.88 for the 
financial streams and 1.69 for the total streams, including the value of 
the DALYs averted. 
> The ICER overall is $28,475/DALY averted, being $257,230/DALY in 
the first year but cost saving thereafter. 
It can also be informative to summarise who bears the net costs and 
benefits. 
> Workers are the clear beneficiaries with $18.7 million the NPV of net 
financial benefits and $85.7 million the NPV of total benefits (workers 
gain the whole value of the net DALYs, as well as 41% of the financial 
benefits from incidents averted). 
> Firms gain only 3% of the financial benefits from incidents averted 
and Governments 56% (NOHSC, 2004), and firms are worst off, 
losing $18.9 million in NPV terms in 2008 dollars. 
Cost benefit and cost effectiveness summary, 2008-2017 
Year starting 1 July 2008 2009 2010 2011 2012 2013 2014
Costs
1.1 8.00            2.00            2.00            2.00            2.00            2.00            2.00                  
1.2 2.00            1.00            1.00            1.00            1.00            1.00            1.00                  
1.3 10.00          5.00            5.00            5.00            5.00            5.00            5.00                  
Total costs 20.00          8.00          8.00          8.00          8.00            8.00           8.00                
Benefits
2.1 1.00            0.20            0.20            0.20            0.20            0.20            0.20                  
Financial component of 2.2 7.60            7.67            7.75            7.82            7.89            7.97            8.04                  
Total financial benefits 8.60            7.87          7.95          8.02          8.09            8.17           8.24                
DALYs averted 44.31          43.42          42.55          41.70          40.87          40.05          39.25                
$ DALYs 8.71            8.44            8.18            7.92            7.67            7.42            7.18                  
Total benefits (inc DALYs) 17.31          16.31        16.13        15.94        15.76          15.59         15.42              
Net benefits (financial), $m 11.40-          0.13-            0.05-            0.02            0.09            0.17            0.24                  
Net benefits (total), $m 2.69-            8.31            8.13            7.94            7.76            7.59            7.42                  
Benefit:cost ratio (financial) 0.43            0.98            0.99            1.00            1.01            1.02            1.03                  
Benefit:cost ratio (total) 0.87            2.04            2.02            1.99            1.97            1.95            1.93                  
net fin. costs/DALY averted 257,230      2,881        1,245        cost saving cost saving cost saving cost saving cost
Summary of financial benefits and net benefits by bearer, 2008-
2017 
Year starting 1 July 2008 2009 2010 2011 2012 2013 2014
Financial benefits by bearer
Firms 1.23            0.43            0.43            0.43            0.44            0.44            0.44                  
Workers 3.12            3.15            3.18            3.21            3.24            3.27            3.30                  
Government 4.26            4.30            4.34            4.38            4.42            4.46            4.50                  
Net financial benefits by bearer
Firms 6.77-            1.57-            1.57-            1.57-            1.56-            1.56-            1.56-            -       
Workers 1.12            2.15            2.18            2.21            2.24            2.27            2.30                  
Government 5.74-            0.70-            0.66-            0.62-            0.58-            0.54-            0.50-            -       
Net total benefits by bearer
Firms 6.77-            1.57-            1.57-            1.57-            1.56-            1.56-            1.56-            -       
Workers 9.82            10.59          10.35          10.13          9.90            9.69            9.47                  
Government 5.74-            0.70-           0.66-           0.62-           0.58-            0.54-           0.50-           -       
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Sensitivity Analysis 
This report suggests use of a VSLY in 2006 dollars of $252,014 in CBAs, 
with sensitivity analysis conducted at $155,409 and $340,219. Inflating 
to 2008 dollars for this Appendix example means a base case of 
$266,843 with sensitivity analysis at $164,553 and $360,238. Other 
parameters that would be likely candidates for sensitivity analysis might 
be: 
> 29.9% reduction compared to a higher or lower rate; 
> average costs for firms ($800/worker in 2008 and $200/worker 
thereafter) 
> average costs for workers ($200/worker in 2008 and $100/worker 
thereafter) 
> costs for governments ($10 million in 2008 and $5 million thereafter) 
> benefits for firms ($1 million in 2008 and $0.2 million thereafter) 
> 3% increase in real costs per compensated case; 
> the factors for total cost per incident of 4.5 and 1.056; 
> 2% fatalities and 23.81 estimated life years remaining for fatalities; 
and 
> disability weight of 0.141 and 3.67 years average duration. 
Approaches to sensitivity analysis can include modelling high and/or low 
scenarios, or performing more complex distributional modelling (eg,  
@RISK) if warranted – perhaps if the outcome is very marginal between 
Options. 
In this case a high-low sensitivity analysis on the VSLY is presented as an 
example, which simply involves substituting the parameters above in the 
modelling, as well as the associated values for the VSL. 
> Naturally the net financial benefits do not change, nor the financial 
benefit-cost ratio or ICER. 
> The total benefits range between $20 million and $90 million and the 
benefit-cost ratio is thus estimated to lie between 1.24 and 2.09. 
Base case, high and low scenario of VSL and VSLY 
Base High Low
VSL 6,000,000   8,100,000   3,700,000   
VSLY 266,843      360,238      164,553      
Net financial benefits 10.19-          10.19-          10.19-          
Net total benefits 56.77          90.19          20.17          
Financial benefit-cost 0.88            0.88            0.88            
Total benefit-cost 1.69            2.10            1.25            
$/DALY averted 28,475      28,475      28,475       
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